<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003212.pub3" GROUP_ID="NEONATAL" ID="305399091508130017" MERGED_FROM="" MODIFIED="2017-01-31 17:00:04 +0000" MODIFIED_BY="Colleen Ovelman" NOTES="&lt;p&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Short title (no longer in use): NCPAP vs NIPPV for preterm neonates&lt;/p&gt;&lt;p&gt;October 1999&lt;br&gt;Unresolved issues: 1. Abstract of Chang, Lin, Yeh (1993) - awaiting clarification by authors - ?subset of 1998 publication Lin et al, published elsewhere. Currently not mentioned in review.&lt;br&gt;2. Khalaf's abstract - listed as awating review ? time of completion&lt;br&gt;3. Barrington's manuscript&lt;br&gt;4. Lin's data: medians/ranges - awaiting response from authors regarding means and SDs. Issue of pre and post apnea/bradycardia rates ? should we use a change score.&lt;/p&gt;&lt;p&gt;CL 3/03 (update)&lt;/p&gt;&lt;p&gt;sent to Loni for update Dec 5/06&lt;/p&gt;&lt;p&gt;Potentially eligible trial identified from Central - Yllescas (2004) - an abstract from a Mexican group identified in Central as an RCT although this is not clear from the abstract text. Outcomes are presented as percentages rather than actual numbers. Flag this to be included in next update, hopefully as a published article.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2017-01-25 10:18:42 -0500" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="004" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2017-01-25 10:17:09 -0500" MODIFIED_BY="[Empty name]">
<TITLE>Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation</TITLE>
<CONTACT>
<PERSON ID="15265" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Brigitte</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Lemyre</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>blemyre@ottawahospital.on.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Division of Neonatology</DEPARTMENT>
<ORGANISATION>Children's Hospital of Eastern Ontario</ORGANISATION>
<ADDRESS_1>401 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>KlH 8L1</ZIP>
<REGION>ON</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>1 613 737 2415</PHONE_1>
<PHONE_2/>
<FAX_1>1 613 738 4847</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2017-01-25 10:17:09 -0500" MODIFIED_BY="[Empty name]">
<PERSON ID="15265" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Brigitte</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Lemyre</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>blemyre@ottawahospital.on.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Division of Neonatology</DEPARTMENT>
<ORGANISATION>Children's Hospital of Eastern Ontario</ORGANISATION>
<ADDRESS_1>401 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>KlH 8L1</ZIP>
<REGION>ON</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>1 613 737 2415</PHONE_1>
<PHONE_2/>
<FAX_1>1 613 738 4847</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="17716" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS>G</MIDDLE_INITIALS>
<LAST_NAME>Davis</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>pgd@unimelb.edu.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>The University of Melbourne</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Melbourne</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 3 83453763</PHONE_1>
<PHONE_2/>
<FAX_1>+61 3 83453789</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15202" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Antonio</FIRST_NAME>
<MIDDLE_INITIALS>G</MIDDLE_INITIALS>
<LAST_NAME>De Paoli</LAST_NAME>
<SUFFIX>FRACP</SUFFIX>
<POSITION>Neonatologist</POSITION>
<EMAIL_1>antonio.depaoli@dhhs.tas.gov.au</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Paediatrics</DEPARTMENT>
<ORGANISATION>Royal Hobart Hospital</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Hobart</CITY>
<ZIP>7001</ZIP>
<REGION/>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+61 3 62227946</PHONE_1>
<PHONE_2/>
<FAX_1>+61 3 62264864</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15255" MODIFIED="2017-01-25 10:17:09 -0500" MODIFIED_BY="[Empty name]" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Haresh</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Kirpalani</LAST_NAME>
<SUFFIX/>
<POSITION>Professor</POSITION>
<EMAIL_1>KIRPALANIH@email.chop.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Pediatrics</DEPARTMENT>
<ORGANISATION>University of Pennsylvania School of Medicine and Department of Clinical Epidemiology and Biostatistics, McMaster University</ORGANISATION>
<ADDRESS_1>Children's Hospital of Philadelphia</ADDRESS_1>
<ADDRESS_2>South 34th Street &amp; Civic Center Blvd</ADDRESS_2>
<CITY>Philadelphia</CITY>
<ZIP>19104</ZIP>
<REGION>Pennsylvania</REGION>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2015-12-14 13:11:59 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Minor update: 25/03/08&lt;/p&gt;&lt;p&gt;New studies sought but none found: 14/04/03&lt;/p&gt;" NOTES_MODIFIED="2015-12-14 13:11:59 -0500" NOTES_MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="28" MONTH="9" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="28" MONTH="9" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="28" MONTH="9" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="1999"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2017"/>
</DATES>
<WHATS_NEW MODIFIED="2017-01-15 17:38:02 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;This review updates the previous version of &amp;quot;Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure NCPAP) for preterm infants after extubation &amp;quot; last updated in The Cochrane Library, Issue 1, 2003. &lt;br&gt;&lt;br&gt;A repeat literature search showed no new trials eligible for inclusion and there have been no substantive changes to the review. One potentially eligible trial (Yllescas, 2004) was presented at APS and may be included in future updates.&lt;/p&gt;" NOTES_MODIFIED="2017-01-15 17:38:02 -0500" NOTES_MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-01-15 17:38:02 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="9" YEAR="2015"/>
<DESCRIPTION>
<P>Two new studies were added to the meta-analysis.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2017-01-15 17:37:59 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="9" YEAR="2015"/>
<DESCRIPTION>
<P>Search was updated 28 September 2015.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2017-01-17 20:25:37 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-01-17 20:25:28 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>This review updated the previous version of "Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure NCPAP) for preterm infants after extubation," which was last updated in the Cochrane Library, Issue 3, 2003 (Davis 2003).<BR/>
<BR/>A repeat literature search found no new trials eligible for inclusion. No substantive changes have been made to the review. One potentially eligible trial (Yllescas 2004) was presented at APS and may be included in a future update.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-01-17 20:25:37 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>The review was converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-01-13 15:05:02 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="4" YEAR="2003"/>
<DESCRIPTION>
<P>A repeat literature search showed no new trials eligible for inclusion; no substantive changes were made to the review. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2017-01-13 15:05:14 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="9" MONTH="5" YEAR="2001"/>
<DESCRIPTION>
<P>This was a new review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2017-01-24 11:08:51 -0500" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Royal Women's Hospital, Melbourne</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Murdoch Children's Research Institute, Melbourne</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>University of Melbourne</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Royal Hobart Hospital</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>University of Tasmania</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2017-01-24 11:08:51 -0500" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>National Health and Medical Research Council</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2017-01-17 18:32:04 -0500" MODIFIED_BY="[Empty name]">
<NAME>Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION>
<P>Editorial support of the Cochrane Neonatal Review Group has been funded with Federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C.</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2017-01-24 11:08:51 -0500" MODIFIED_BY="[Empty name]">
<NAME>National Institute for Health Research</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>Editorial support for Cochrane Neonatal has been funded with funds from a UK National Institute of Health Research Grant (NIHR) Cochrane Programme Grant (13/89/12). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, or the UK Department of Health.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2017-01-25 10:18:42 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2017-01-17 20:31:12 -0500" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-04-14 09:28:01 -0400" MODIFIED_BY="[Empty name]">Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation</TITLE>
<SUMMARY_BODY MODIFIED="2017-01-17 20:31:12 -0500" MODIFIED_BY="[Empty name]">
<P>
<B>Review question </B>
</P>
<P>Does nasal intermittent positive pressure ventilation (NIPPV) confer short-term and long-term benefits without causing harm to premature infants coming off a ventilator? How does it compare with nasal continuous positive airway pressure (NCPAP)?</P>
<P>
<B>Background </B>
</P>
<P>Evidence suggests that NIPPV increases the effectiveness of NCPAP in preterm babies who no longer need an endotracheal tube (tube in the windpipe). Preterm babies with breathing problems often require help from a machine (ventilator) that provides regular breaths through a tube in the windpipe. The process of extubation or removal of this tube does not always go smoothly, and the tube may need to be re-inserted if the baby cannot manage without assistance. NCPAP and NIPPV are ways of supporting babies' breathing in a minimally invasive way - the tubes are short and reach only to the back of the nose, thus causing minimal damage to the lungs. NCPAP and NIPPV may be used after extubation to reduce the number of babies who need re-insertion of the endotracheal tube. NCPAP provides steady pressure to the back of the nose that is transmitted to the lungs, helping the baby breathe more comfortably. NIPPV provides the same support along with some breaths via the ventilator.</P>
<P>
<B>Study characteristics </B>
</P>
<P>We searched scientific databases for studies comparing NCPAP versus NIPPV in preterm infants (born before 37 completed weeks of pregnancy) who no longer need an endotracheal tube. We looked at breathing problems, the need for the endotracheal tube to be re-instated and side effects. Evidence is current to September 2015.</P>
<P>
<B>Key results </B>
</P>
<P>We found ten trials comparing NCPAP versus NIPPV. Six of ten studies that compared NCPAP and NIPPV showed that NIPPV reduced the need for re-insertion of the endotracheal tube. Future studies must determine how NIPPV can best be delivered to infants.</P>
<P>
<B>Quality of the evidence </B>
</P>
<P>In clinical trials, clinicians and investigators were aware of the intervention received by each infant (NIPPV or NCPAP). Therefore, we graded the quality of evidence for the primary outcome (breathing problems and need for re-insertion of the endotracheal tube) as moderate.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2017-01-25 10:18:03 -0500" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2017-01-13 15:07:25 -0500" MODIFIED_BY="[Empty name]">
<P>Previous randomised trials and meta-analyses have shown that nasal continuous positive airway pressure (NCPAP) is a useful method for providing respiratory support after extubation. However, this treatment sometimes 'fails' in infants, and they may require endotracheal re-intubation with its attendant risks and expense. Nasal intermittent positive pressure ventilation (NIPPV) can augment NCPAP by delivering ventilator breaths via nasal prongs. Older children and adults with chronic respiratory failure benefit from NIPPV, and the technique has been applied to neonates. However, serious side effects including gastric perforation have been reported with older methods of providing NIPPV.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2017-01-15 17:43:55 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>
<B>Primary objective</B>
</I>
</P>
<P>To compare effects of management with NIPPV versus NCPAP on the need for additional ventilatory support in preterm infants whose endotracheal tube was removed after a period of intermittent positive pressure ventilation.</P>
<P>
<I>
<B>Secondary objectives</B>
</I>
</P>
<P>To compare rates of gastric distension, gastrointestinal perforation, necrotising enterocolitis and chronic lung disease; duration of hospitalisation; and rates of apnoea, air leak and mortality for NIPPV and NCPAP.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2017-01-13 15:09:51 -0500" MODIFIED_BY="[Empty name]">
<P>We used the standard search strategy of the Cochrane Neonatal Review Group to search the Cochrane Central Register of Controlled Trials (CENTRAL; 2015, Issue 9), MEDLINE via PubMed (1966 to 28 September 2015), Embase (1980 to 28 September 2015) and the Cumulative Index to Nursing and Allied Health Literature (CINAHL; 1982 to 28 September 2015). We also searched clinical trials databases, conference proceedings and reference lists of retrieved articles for randomised controlled trials and quasi-randomised trials.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2017-01-15 17:44:28 -0500" MODIFIED_BY="[Empty name]">
<P>We included randomised and quasi-randomised trials comparing use of NIPPV versus NCPAP in extubated preterm infants. NIPPV included non-invasive support delivered by a mechanical ventilator or a bilevel device in a synchronised or non-synchronised way. Participants included ventilated preterm infants who were ready to be extubated to non-invasive respiratory support. Interventions compared were NIPPV, delivered by short nasal prongs or nasopharyngeal tube, and NCPAP, delivered by the same methods.</P>
<P>Types of outcomes measures included failure of therapy (respiratory failure, rates of endotracheal re-intubation); gastrointestinal complications (i.e. abdominal distension requiring cessation of feeds, gastrointestinal perforation or necrotising enterocolitis); pulmonary air leak; chronic lung disease (oxygen requirement at 36 weeks' postmenstrual age) and mortality.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2017-01-15 17:45:23 -0500" MODIFIED_BY="[Empty name]">
<P>Three review authors independently extracted data regarding clinical outcomes including extubation failure; endotracheal re-intubation; rates of apnoea, gastrointestinal perforation, feeding intolerance, necrotising enterocolitis, chronic lung disease and air leak; and duration of hospital stay. We analysed trials using risk ratio (RR), risk difference (RD) and the number needed to treat for an additional beneficial outcome (NNTB) or an additional harmful outcome (NNTH) for dichotomous outcomes, and mean difference (MD) for continuous outcomes. We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to assess the quality of evidence.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2017-01-25 10:18:03 -0500" MODIFIED_BY="[Empty name]">
<P>Through the search, we identified 10 trials enrolling a total of 1431 infants and comparing extubation of infants to NIPPV or NCPAP. Three trials had methodological limitations and possible selection bias.</P>
<P>Five trials used the synchronised form of NIPPV, four used the non-synchronised form and one used both methods. Eight studies used NIPPV delivered by a ventilator, one used a bilevel device and one used both methods. When all studies were included, meta-analysis demonstrated a statistically and clinically significant reduction in the risk of meeting extubation failure criteria (typical RR 0.70, 95% CI 0.60 to 0.80; typical RD -0.13, 95% CI -0.17 to -0.08; NNTB 8, 95% CI 6 to 13; 10 trials, 1431 infants) and needing re-intubation (typical RR 0.76, 95% CI 0.65 to 0.88; typical RD -0.10, 95% CI -0.15 to -0.05; NNTB 10, 95% CI 7 to 20; 10 trials, 1431 infants). We graded evidence for these outcomes as moderate, as all trial interventions were unblinded. Although methods of synchronisation varied (Graseby capsule or pneumotachograph/flow-trigger), the five trials that synchronised NIPPV showed a statistically significant benefit for infants extubated to NIPPV in terms of prevention of extubation failure up to one week after extubation.</P>
<P>Unsynchronised NIPPV also reduced extubation failure. NIPPV provided via a ventilator is more beneficial than that provided by bilevel devices in reducing extubation failure during the first week. When comparing interventions, investigators found no significant reduction in rates of chronic lung disease (typical RR 0.94, 95% CI 0.80 to 1.10; typical RD -0.02, 95% CI -0.08 to 0.03) or death, and no difference in the incidence of necrotising enterocolitis. Air leaks were reduced in infants randomised to NIPPV (typical RR 0.48, 95% CI 0.28 to 0.82; typical RD -0.03, 95% CI -0.05 to -0.01; NNTB 33, 95% CI 20 to 100). We graded evidence quality as moderate (unblinded studies) or low (imprecision) for secondary outcomes.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2017-01-17 20:29:48 -0500" MODIFIED_BY="[Empty name]">
<P>
<I>
<B>Implications for practice</B>
</I>
</P>
<P>NIPPV reduces the incidence of extubation failure and the need for re-intubation within 48 hours to one week more effectively than NCPAP; however, it has no effect on chronic lung disease nor on mortality. Synchronisation may be important in delivering effective NIPPV. The device used to deliver NIPPV may be important;
 
however, data are insufficient to support strong conclusions.
 
NIPPV does not appear to be associated with increased gastrointestinal side effects.</P>
<P>
<I>
<B>Implications for research</B>
</I>
</P>
<P>Large trials should establish the impact of synchronisation of NIPPV on safety and efficacy of the technique and should compare the efficacy of bilevel devices versus a ventilator for providing NIPPV.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2017-01-25 10:18:42 -0500" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2017-01-17 21:36:24 -0500" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2017-01-17 21:34:30 -0500" MODIFIED_BY="[Empty name]">
<P>Preterm infants may experience difficulty with spontaneous, unassisted breathing for a variety of reasons, including lung immaturity, chest wall instability, upper airway obstruction and poor central respiratory drive. Historically, the primary method of support for these infants has consisted of endotracheal intubation and intermittent positive pressure ventilation. Although this method is effective, it is accompanied by complications (upper airway damage, bronchopulmonary dysplasia, sepsis) and is associated with considerable economic cost. Minimising the duration of endotracheal intubation or avoiding it completely has been a goal of neonatal intensive care. Nasal continuous positive airway pressure (NCPAP) is a less invasive way of providing respiratory support for neonates at risk of, or actually experiencing, respiratory failure. One systematic review of trials comparing NCPAP versus treatment with oxyhood concluded that NCPAP begun immediately after a period of endotracheal intubation reduced the rate of adverse events (apnoea, respiratory acidosis and increased oxygen requirements) leading to re-intubation (<LINK REF="REF-Bancalari-2013" TYPE="REFERENCE">Bancalari 2013</LINK>; <LINK REF="REF-Davis-2003b" TYPE="REFERENCE">Davis 2003b</LINK>). In this systematic review, approximately 25% of all preterm infants allocated to NCPAP failed extubation; therefore, the need exists to improve outcomes further for infants thought to no longer require an endotracheal tube.</P>
<P>Adults and older children with acute or chronic ventilatory failure of various origins, including chronic obstructive pulmonary disease (<LINK REF="REF-Bott-1993" TYPE="REFERENCE">Bott 1993</LINK>), severe kyphoscoliosis (<LINK REF="REF-Ellis-1988" TYPE="REFERENCE">Ellis 1988</LINK>) and pre-lung transplantation cystic fibrosis (<LINK REF="REF-Piper-1992" TYPE="REFERENCE">Piper 1992</LINK>), have been treated with intermittent positive pressure ventilation delivered via a nasal interface. Clinicians have reported improvements in respiratory function.</P>
</CONDITION>
<INTERVENTION MODIFIED="2017-01-17 21:35:16 -0500" MODIFIED_BY="[Empty name]">
<P>Nasal intermittent positive pressure ventilation (NIPPV) is a simple, effective mode of respiratory support. NIPPV augments continuous positive airway pressure (CPAP) with superimposed inflations to a set peak pressure (typically 15 to 22 cmH<SUB>2</SUB>O). NIPPV may be delivered by nasal mask or prongs, which may be short or long, single or binasal. Some devices attempt to synchronise inflations with the infant's respiratory efforts (<LINK REF="REF-Owen-2007" TYPE="REFERENCE">Owen 2007</LINK>). Synchronisation can occur via pneumatic capsules detecting abdominal wall movements or by airway-derived flow signals. Trigger delays occur, and trigger response is less consistent at high spontaneous breathing rates (<LINK REF="REF-Owen-2016" TYPE="REFERENCE">Owen 2016</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2017-01-17 21:36:24 -0500" MODIFIED_BY="[Empty name]">
<P>NIPPV has been used in neonates for a variety of indications. About 53% of Canadian tertiary care nurseries reported using NIPPV in the mid-1980s (<LINK REF="STD-Ryan-1989" TYPE="STUDY">Ryan 1989</LINK>). More recently, 44 of 91 (48%) neonatal units in the UK reported using NIPPV (<LINK REF="REF-Owen-2008" TYPE="REFERENCE">Owen 2008</LINK>). The physiological benefits of this technique have been evaluated. NIPPV reduces asynchronous thoracoabdominal motion, perhaps by reducing tube resistance or providing better stabilisation of the chest wall, or both (<LINK REF="REF-Kiciman-1998" TYPE="REFERENCE">Kiciman 1998</LINK>). Its use improves tidal and minute volumes and decreases the inspiratory effort required by neonates compared with NCPAP (<LINK REF="STD-Moretti-1999" TYPE="STUDY">Moretti 1999</LINK>). NIPPV has not been provided without problems in neonates; <LINK REF="REF-Garland-1985" TYPE="REFERENCE">Garland 1985</LINK> reported an association between use of ventilation via nasal prongs and increased risk of gastrointestinal perforation. In the past, lack of high-quality evidence has led to variability in practice between neonatal intensive care units with respect to NIPPV.</P>
<P>Newer devices now on the market, which are not ventilators, provide bilevel respiratory support (higher positive pressure followed by lower pressure); however, they have limited peak pressure capabilities (i.e. they generally cannot provide more than 10 cmH<SUB>2</SUB>O of peak positive pressure). Some devices have the ability to synchronise higher pressure with the infant's own breaths by using a trigger biphasic mode. Whether these devices are comparable with more conventional NIPPV delivered via a ventilator is unclear, as they cannot attain peak inspiratory pressure (PIP) similar to that achieved by NIPPV delivered via a ventilator. Whether synchronisation adds clinical benefit remains unclear (<LINK REF="REF-Davis-2009" TYPE="REFERENCE">Davis 2009</LINK>). For the purposes of this review, we will use the term 'NIPPV' to describe all forms of non-invasive ventilation that intermittently provide supportive breaths or higher pressure.</P>
</THEORY>
<IMPORTANCE MODIFIED="2017-01-15 19:04:12 -0500" MODIFIED_BY="[Empty name]">
<P>Avoiding or reducing time spent on invasive ventilation is a goal of treatment for all premature infants. Many published studies have reported use of various forms of NIPPV or bilevel support, often including a small number of infants or a single centre. We are conducting this review to provide bedside clinicians with the best available evidence regarding their choice of non-invasive support.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2017-01-15 19:04:33 -0500" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="2">Primary objective</HEADING>
<P>To determine effects of management with NIPPV versus NCPAP on the need for additional ventilatory support in preterm infants whose endotracheal tube was removed after a period of intermittent positive pressure ventilation.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Secondary objectives</HEADING>
<P>To compare rates of gastric distension, gastrointestinal perforation, necrotising enterocolitis and chronic lung disease; duration of hospitalisation; and rates of apnoea, air leak and mortality for NIPPV and NCPAP.</P>
</SUBSECTION>
</OBJECTIVES>
<METHODS MODIFIED="2017-01-22 16:23:30 -0500" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2017-01-17 21:38:25 -0500" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2014-06-21 08:29:32 -0400" MODIFIED_BY="Anne Lawson">
<P>Randomised and quasi-randomised trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2017-01-15 19:09:36 -0500" MODIFIED_BY="[Empty name]">
<P>Preterm infants (i.e. those born before 37 completed weeks' gestation) extubated after a period of endotracheal intubation.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2017-01-15 19:09:56 -0500" MODIFIED_BY="[Empty name]">
<P>Intermittent positive pressure ventilation provided by a ventilator or a bilevel device and administered via the nasal route by short nasal prongs or nasopharyngeal tubes versus NCPAP delivered by the same methods. NIPPV included non-invasive support delivered by a mechanical ventilator or a bilevel device in a synchronised or non-synchronised way.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2017-01-17 21:38:25 -0500" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2017-01-15 19:11:04 -0500" MODIFIED_BY="[Empty name]">
<UL>
<LI>Respiratory failure defined by respiratory acidosis, increased oxygen requirement or apnoea that was frequent or severe, leading to additional ventilatory support during the week post extubation</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2017-01-17 21:38:25 -0500" MODIFIED_BY="[Empty name]">
<UL>
<LI>Endotracheal re-intubation during the week post extubation</LI>
<LI>Rates of abdominal distension requiring cessation of feeds</LI>
<LI>Rates of gastrointestinal perforation diagnosed radiologically or at operation</LI>
<LI>Rates of necrotising enterocolitis (NEC), defined according to modified Bell's criteria (stage 2 to 3)</LI>
<LI>Rates of chronic lung disease (CLD), defined as requirement for supplemental oxygen at 28 days of life or at 36 weeks' postmenstrual age</LI>
<LI>Duration of hospitalisation</LI>
<LI>Rates of apnoea and bradycardia expressed as events per hour</LI>
<LI>Rates of pulmonary air leak</LI>
<LI>Mortality</LI>
<LI>Neurodevelopmental status at 18 to 24 months (post hoc, 2015 update)</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2017-01-15 19:15:52 -0500" MODIFIED_BY="[Empty name]">
<P>We used the criteria and standard methods of Cochrane and the Cochrane Neonatal Review Group (see <A HREF="http://neonatal.cochrane.org/resources-review-authors">the Cochrane Neonatal Group search strategy for specialized register</A>).</P>
<P>We conducted a comprehensive search including the Cochrane Central Register of Controlled Trials (CENTRAL; 2015, Issue 9) in the Cochrane Library; MEDLINE via PubMed (1966 to 28 September 2015); Embase (1980 to 28 September 2015); and the Cumulative Index to Nursing and Allied Health Literature (CINAHL; 1982 to 28 September 2015) using the following search terms: (nasal continuous positive airway pressure OR NCPAP OR nasal intermittent positive pressure ventilation OR NIPPV OR nasal intermittent mandatory ventilation OR NIMV OR nasal distending pressure OR nasal positive pressure OR nasal ventilation OR non-invasive positive pressure ventilation OR synchronized intermittent mandatory ventilation OR SIMV OR nasopharyngeal synchronized intermittent mandatory ventilation OR bilevel CPAP OR BiCPAP OR BiPAP OR SiPAP), plus database-specific limiters for randomised controlled trials (RCTs) and neonates (see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for the full search strategies used for each database). We applied no language restrictions.</P>
<P>We searched clinical trials registries for ongoing and recently completed trials (<A HREF="http://clinicaltrials.gov">clinicaltrials.gov</A>; the World Health Organization International Trials Registry and Platform (<A HREF="http://www.whoint/ictrp/search/en/">www.whoint/ictrp/search/en/</A>) and <A HREF="http://apps.who.int/trialsearch/">the ISRCTN Registry</A>).</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2017-01-22 16:23:30 -0500" MODIFIED_BY="[Empty name]">
<P>Three review authors (BL, PGD and HK) used standard methods of Cochrane and the Cochrane Neonatal Review Group to assess the methodological quality of trials.</P>
<STUDY_SELECTION MODIFIED="2017-01-15 20:00:52 -0500" MODIFIED_BY="[Empty name]">
<P>We included all randomised and quasi-randomised controlled trials of NIPPV compared with NCPAP in ventilated preterm infants ready for extubation. Three review authors (BL, PGD and HK) independently reviewed results of the updated search and selected studies for inclusion. We resolved disagreements by discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2017-01-15 20:01:05 -0500" MODIFIED_BY="[Empty name]">
<P>Three review authors (BL, PGD and HK) independently extracted data, compared entries and resolved differences by discussion. For the 2015 update, one review author (BL) and the Cochrane Neonatal Review Group Editor extracted data, compared entries and resolved differences.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2017-01-17 21:42:31 -0500" MODIFIED_BY="[Empty name]">
<P>Three review authors (BL, PGD and HK) independently assessed the quality of studies using the following criteria: blinding of randomisation, blinding of intervention, completeness of follow-up and blinding of outcome measurement. We sought additional information from study authors when required.</P>
<P>For the update, we assessed risk of bias using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) and presented this information in the 'Risk of bias tables'.</P>
<P>We assessed the methodological quality of studies by using the following criteria.</P>
<UL>
<LI>Sequence generation (checking for possible selection bias): For each included study, we categorised the method used to generate the allocation sequence as:</LI>
<UL>
<LI>low risk (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk (any non-random process, e.g. odd or even date of birth; hospital or clinic record number); or</LI>
<LI>unclear risk.</LI>
</UL>
<LI>Allocation concealment (checking for possible selection bias): For each included study, we categorised the method used to conceal the allocation sequence as:</LI>
<UL>
<LI>low risk (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth); or</LI>
<LI>unclear risk.</LI>
</UL>
<LI>Blinding (checking for possible performance bias): For each included study, we categorised the methods used to blind study participants and personnel from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. We categorised methods as:</LI>
<UL>
<LI>low risk for participants, personnel and outcome assessors;</LI>
<LI>high risk for participants, personnel and outcome assessors; or</LI>
<LI>unclear risk for participants, personnel and outcome assessors.</LI>
</UL>
<LI>Incomplete outcome data (checking for possible attrition bias through withdrawals, drop-outs, protocol deviations): For each included study and for each outcome, we described completeness of data including attrition and exclusions from the analysis. We noted whether attrition and exclusions were reported, numbers included in the analysis at each stage (compared with the total number of randomised participants), reasons for attrition or exclusion when reported and whether missing data were balanced across groups or were related to outcomes. When sufficient information was reported or supplied by trial authors, we re-included missing data in the analyses. We categorised methods as:</LI>
<UL>
<LI>low risk (less than 20% missing data);</LI>
<LI>high risk (20% or more missing data); or</LI>
<LI>unclear risk.</LI>
</UL>
<LI>Selective reporting bias: For each included study, we described how we investigated the possibility of selective outcome reporting bias and what we found. We assessed methods as:</LI>
<UL>
<LI>low risk (when it was clear that all of the study's prespecified outcomes and all expected outcomes of interest to the review had been reported);</LI>
<LI>high risk (when not all of the study's prespecified outcomes had been reported; one or more reported primary outcomes were not prespecified; outcomes of interest were reported incompletely and so could not be used; or study did not include results of a key outcome that would have been expected to have been reported); or</LI>
<LI>unclear risk.</LI>
</UL>
<LI>Other sources of bias: For each included study, we described any important concerns that we had about other possible sources of bias (e.g. whether a potential source of bias was related to the specific study design, whether the trial was stopped early owing to some data-dependent process). We assessed whether each study was free of other problems that could put it at risk of bias as:</LI>
<UL>
<LI>low risk;</LI>
<LI>high risk; or</LI>
<LI>unclear risk.</LI>
</UL>
</UL>
<P>We made explicit judgements regarding whether studies were at high risk of bias, according to the criteria given in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We assessed the likely magnitude and direction of the bias, and whether we considered it likely to impact findings. If needed, we planned to explore the impact of the level of bias by undertaking sensitivity analyses (see <LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Quality of evidence</HEADING>
<P>We assessed the quality of evidence for the main comparison at the outcome level using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach (<LINK REF="REF-Guyatt-2011a" TYPE="REFERENCE">Guyatt 2011a</LINK>). This methodological approach considers evidence from RCTs as high quality that may be downgraded on the basis of consideration of any of five areas: design (risk of bias), consistency across studies, directness of the evidence, precision of estimates and presence of publication bias (<LINK REF="REF-Guyatt-2011a" TYPE="REFERENCE">Guyatt 2011a</LINK>). The GRADE approach results in an assessment of the quality of a body of evidence according to one of the following four grades. High: We are very confident that the true effect lies close to that of the estimate of effect. Moderate: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different. Low: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect. Very low: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect (<LINK REF="REF-Sch_x00fc_nemann-2013" TYPE="REFERENCE">Schünemann 2013</LINK>).<BR/>
<BR/>Review authors independently assessed the quality of the evidence found for outcomes identified as critical or important for clinical decision making. These outcomes included:</P>
<UL>
<LI>Respiratory failure (defined by respiratory acidosis, increased oxygen requirement or apnoea that was frequent or severe, leading to additional ventilatory support during the week post extubation);</LI>
<LI>Endotracheal re-intubation during the week post extubation;</LI>
<LI>Rates of CLD, defined as requirement for supplemental oxygen at 36 weeks' postmenstrual age;</LI>
<LI>Rates of pulmonary air leak;</LI>
<LI>Rates of NEC, defined according to modified Bell's criteria (stage 2 to 3);</LI>
<LI>Mortality; and</LI>
<LI>Neurodevelopmental outcomes at 18 to 24 months.</LI>
</UL>
<P>When we considered risk of bias arising from inadequate concealment of allocation, randomised assignment, complete follow-up or blinded outcome assessment to reduce our confidence in effect estimates, we downgraded the quality of evidence accordingly (<LINK REF="REF-Guyatt-2011b" TYPE="REFERENCE">Guyatt 2011b</LINK>). We evaluated consistency by examining similarity of point estimates, extent of overlap of confidence intervals and statistical criteria including measurement of heterogeneity (I<SUP>2</SUP>). We downgraded the quality of evidence when large and unexplained inconsistency across study results was present (i.e. some studies suggest important benefit and others no effect or harm without a clinical explanation) (<LINK REF="REF-Guyatt-2011d" TYPE="REFERENCE">Guyatt 2011d</LINK>). We assessed precision on the basis of the width of the 95% confidence interval (CI) and calculation of the optimal information size (OIS). If the total number of participants included in the pooled effect estimation was less than the number of participants generated by a conventional sample size calculation for a single adequately powered trial, we considered rating down for imprecision (<LINK REF="REF-Guyatt-2011c" TYPE="REFERENCE">Guyatt 2011c</LINK>). When trials were conducted in populations other than the target population, we downgraded the quality of evidence because of indirectness (<LINK REF="REF-Guyatt-2011e" TYPE="REFERENCE">Guyatt 2011e</LINK>).<BR/>
<BR/>We entered data (i.e. pooled estimates of effects and corresponding 95% confidence Intervals) and explicit judgements for each of the above aspects assessed into the Guideline Development Tool - the software used to create &#8216;Summary of findings&#8217; tables (<LINK REF="REF-GRADEpro-2008" TYPE="REFERENCE">GRADEpro 2008</LINK>). We explained in footnotes or comments in the &#8216;Summary of findings&#8217; table all judgements involving assessment of the study characteristics described above.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2017-01-17 22:01:26 -0500" MODIFIED_BY="[Empty name]">
<P>We analysed categorical data (proportion requiring re-intubation) using risk ratio (RR), risk difference (RD) and number needed to treat for an additional beneficial outcome (NNTB) or an additional harmful outcome (NNTH). We reported 95% confidence intervals (CIs) on all estimates. We analysed continuous data (frequency of apnoea) using mean difference (MD). We applied the fixed-effect model.</P>
</EFFECT_MEASURES>
<HETEROGENEITY_ASSESSMENT MODIFIED="2017-01-15 20:16:10 -0500" MODIFIED_BY="[Empty name]">
<P>We examined heterogeneity between trials by inspecting forest plots and quantifying the impact of heterogeneity using the I<SUP>2</SUP> statistic. If noted, we planned to explore possible causes of statistical heterogeneity by performing prespecified subgroup analyses (e.g. differences in study quality, participants, intervention regimens or outcome assessments).</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2017-01-15 20:16:23 -0500" MODIFIED_BY="[Empty name]">
<P>We used the Mantel-Haenszel method for estimates of typical RR and RD. We analysed continuous outcomes using the inverse variance method. We applied the fixed-effect model for all meta-analyses.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2017-01-22 16:23:30 -0500" MODIFIED_BY="[Empty name]">
<P>We planned to perform subgroup analyses using the same methods to determine whether responses differed according to methods of NIPPV delivery and whether or not methylxanthines were used concurrently. We planned subgroup analyses on the basis of characteristics of participants, including birth weight (e.g. infants weighing less than 1000 grams) and corrected age at the time of intervention (e.g. infants less than 28 weeks' gestation).</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2017-01-15 20:22:28 -0500" MODIFIED_BY="[Empty name]">
<P>We planned sensitivity analyses for situations for which this might affect interpretation of significant results (e.g. when risk of bias was associated with the quality of some included trials or missing outcome data). We judged none to be necessary in this review.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2017-01-25 10:18:42 -0500" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2017-01-17 21:47:31 -0500" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES_DESCR MODIFIED="2017-01-17 21:46:01 -0500" MODIFIED_BY="[Empty name]">
<P>We identified ten trials that met the inclusion criteria of this review (1431 infants) (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>) (<LINK REF="STD-Barrington-2001" TYPE="STUDY">Barrington 2001</LINK>; <LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK>; <LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010</LINK>; <LINK REF="STD-Jasani-2016" TYPE="STUDY">Jasani 2016</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>; <LINK REF="STD-Khalaf--2001" TYPE="STUDY">Khalaf 2001</LINK>; <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK>; <LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK>; <LINK REF="STD-Moretti-2008" TYPE="STUDY">Moretti 2008</LINK>; <LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK>). We provided details in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
<P>Inclusion criteria varied somewhat between trials; seven trials enrolled very low birth weight (VLBW) infants (i.e. infants at moderate risk of requiring endotracheal re-intubation), one trial exclusively enrolled extremely low birth weight infants (ELBW) and two trials enrolled premature infants at less than 35 or 36 weeks' gestation. In six trials, use of methylxanthines was mandatory (<LINK REF="STD-Barrington-2001" TYPE="STUDY">Barrington 2001</LINK>; <LINK REF="STD-Jasani-2016" TYPE="STUDY">Jasani 2016</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>; <LINK REF="STD-Khalaf--2001" TYPE="STUDY">Khalaf 2001</LINK>; <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK>; <LINK REF="STD-Moretti-2008" TYPE="STUDY">Moretti 2008</LINK>), and in three other trials, it was extensively prescribed (<LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK>; <LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK>; <LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK>). Infants were extubated from generally low levels of ventilator support (ventilator rates less than 25 breaths per minute and oxygen concentrations less than 40%). Differences in settings between studies were small. An interesting variation in ventilatory strategies was noted between centres, in spite of little variation in enrolment criteria. <LINK REF="STD-Barrington-2001" TYPE="STUDY">Barrington 2001,</LINK> <LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010,</LINK> <LINK REF="STD-Jasani-2016" TYPE="STUDY">Jasani 2016</LINK>, <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014,</LINK> <LINK REF="STD-Khalaf--2001" TYPE="STUDY">Khalaf 2001,</LINK> <LINK REF="STD-Moretti-2008" TYPE="STUDY">Moretti 2008</LINK> and <LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK> extubated infants at a median age of less than one week, whereas <LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK> and <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK> extubated infants later (median age of 18.5 days and 21 days in the two groups in <LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK>; mean age of 12.9 days and 6.9 days in the two groups in <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK>).</P>
<P>Five trials synchronised NIPPV delivery; three trials used the Infant Star ventilator with Star Synch abdominal capsule (<LINK REF="STD-Barrington-2001" TYPE="STUDY">Barrington 2001</LINK>; <LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK>; <LINK REF="STD-Khalaf--2001" TYPE="STUDY">Khalaf 2001</LINK>), and two used more recent ventilators (<LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010</LINK>; <LINK REF="STD-Moretti-2008" TYPE="STUDY">Moretti 2008</LINK>). One trial used bilevel devices (SiPAP) to deliver non-synchronised intermittent positive pressure ventilation (<LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK>), two trials used ventilators to deliver non-synchronised NIPPV (<LINK REF="STD-Jasani-2016" TYPE="STUDY">Jasani 2016</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>) and another permitted use of ventilator-driven NIPPV (synchronised or not) or bilevel devices (synchronised or not) (<LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK>).</P>
<P>Ventilator settings applied after extubation varied between studies. Intermittent mechanical ventilation rates varied between 10 per minute and 40 per minute, and PIP from that used before extubation to 2 cmH<SUB>2</SUB>O to 4 cmH<SUB>2</SUB>O above that used before extubation. Levels used in NCPAP groups also varied between studies (between 3 cmH<SUB>2</SUB>O and 8 cmH<SUB>2</SUB>O). No attempt was made to match NIPPV and NCPAP groups with respect to mean airway pressure delivered. Different prongs were used to deliver NCPAP and NIPPV; three studies used nasopharyngeal prongs (single or binasal) (<LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>; <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK>), and the others used short nasal prongs. <LINK REF="STD-Barrington-2001" TYPE="STUDY">Barrington 2001</LINK>, <LINK REF="STD-Jasani-2016" TYPE="STUDY">Jasani 2016</LINK>, <LINK REF="STD-Khalaf--2001" TYPE="STUDY">Khalaf 2001</LINK> and <LINK REF="STD-Moretti-2008" TYPE="STUDY">Moretti 2008</LINK> assessed the primary outcome (respiratory failure) over 72 hours post extubation, <LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK> and <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK> over 48 hours and <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008,</LINK> <LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK> and <LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK> over seven days. The assessment period was unclear in <LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010</LINK>.</P>
<P>Three studies (<LINK REF="STD-Barrington-2001" TYPE="STUDY">Barrington 2001</LINK>; <LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK>; <LINK REF="STD-Khalaf--2001" TYPE="STUDY">Khalaf 2001</LINK>) permitted rescue NIPPV for infants not responding to NCPAP but analysed the primary outcome on an intention-to-treat basis. Criteria for offering rescue treatment varied; some trials proposed more stringent guidelines for extubation, and duration of follow-up to endpoints for re-intubation differed from 48 hours to discharge from the neonatal intensive care unit. Therefore, the term 'need for endotracheal re-intubation', although available for each of the trials, assumed a clinically different meaning for each.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2017-01-17 21:47:31 -0500" MODIFIED_BY="[Empty name]">
<P>We excluded 14 studies (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table) for the following reasons.</P>
<UL>
<LI>Enrolled non-intubated or very shortly intubated (&lt; 6 hours) infants with respiratory distress (<LINK REF="STD-Bhandari-2007" TYPE="STUDY">Bhandari 2007</LINK>; <LINK REF="STD-Bisceglia-2007" TYPE="STUDY">Bisceglia 2007</LINK>; <LINK REF="STD-Kishore-2009" TYPE="STUDY">Kishore 2009</LINK>; <LINK REF="STD-Kugelman-2007" TYPE="STUDY">Kugelman 2007</LINK>; <LINK REF="STD-Meneses-2011" TYPE="STUDY">Meneses 2011</LINK>; <LINK REF="STD-Ramanathan-2012" TYPE="STUDY">Ramanathan 2012</LINK>).</LI>
<LI>Enrolled infants with apnoea of prematurity (<LINK REF="STD-Lin-1998" TYPE="STUDY">Lin 1998</LINK>; <LINK REF="STD-Pantalitschka-2009" TYPE="STUDY">Pantalitschka 2009</LINK>; <LINK REF="STD-Ryan-1989" TYPE="STUDY">Ryan 1989</LINK>).</LI>
<LI>Compared NIPPV versus oxygen via head box after extubation (<LINK REF="STD-Kumar-2011" TYPE="STUDY">Kumar 2011</LINK>).</LI>
<LI>Was not listed on Clinicaltrials.gov (<LINK REF="STD-DeSimone-2010" TYPE="STUDY">DeSimone 2010</LINK>).</LI>
<LI>Included term infants and infants with respiratory distress and post extubation (<LINK REF="STD-Shi-2010" TYPE="STUDY">Shi 2010</LINK>).</LI>
<LI>Reported none of the clinical outcomes listed in the inclusion criteria of this review (<LINK REF="STD-Ali-2007" TYPE="STUDY">Ali 2007</LINK>; <LINK REF="STD-Moretti-1999" TYPE="STUDY">Moretti 1999</LINK>).</LI>
</UL>
<P>Ongoing studies and studies awaiting clarification include <LINK REF="STD-El_x002d_Farash-2013" TYPE="STUDY">El-Farash 2013,</LINK> <LINK REF="STD-Estay-2013" TYPE="STUDY">Estay 2013,</LINK> <LINK REF="STD-Shi-2013" TYPE="STUDY">Shi 2013,</LINK> <LINK REF="STD-Silveira-2015" TYPE="STUDY">Silveira 2015</LINK> and <LINK REF="STD-Victor-2011" TYPE="STUDY">Victor 2011</LINK>.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2017-01-17 10:43:13 -0500" MODIFIED_BY="[Empty name]">
<P>We assessed methodological quality using the criteria of the Cochrane Neonatal Review Group (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
<UL>
<LI>Random sequence generation: Eight of the included trials met this criterion. This was unclear in two trials (<LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>).</LI>
<LI>Allocation concealment: This was adequate in eight trials and unclear in two (<LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010</LINK>; <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK>).</LI>
<LI>Blinding of participants and personnel: No study attempted to blind participants and personnel.</LI>
<LI>Blinding of outcome assessments: No study attempted this.</LI>
<LI>Incomplete outcome data: Risk was low in eight trials and unclear in two (<LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>).</LI>
<LI>Selective reporting: Five trials did not have clearly specified outcomes (<LINK REF="STD-Barrington-2001" TYPE="STUDY">Barrington 2001</LINK>; <LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK>; <LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>; <LINK REF="STD-Khalaf--2001" TYPE="STUDY">Khalaf 2001</LINK>).</LI>
<LI>Other sources of bias: We found no major sources of other bias in the included trials.</LI>
</UL>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2017-01-25 10:18:42 -0500" MODIFIED_BY="[Empty name]">
<P>Discussion between review authors resulted in no disagreement regarding quality assessment and data extraction from the ten identified trials.</P>
<SUBSECTION>
<HEADING LEVEL="3">Nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure to prevent extubation failure</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Respiratory failure post extubation (outcomes 1.1, 1.2 and 1.3)</HEADING>
<P>Six of the ten trials showed statistically significant benefit in terms of respiratory failure 48 hours to seven days post extubation for infants extubated to NIPPV: typical risk ratio (RR) 0.70, 95% confidence interval (CI) 0.60 to 0.80; typical risk difference (RD) -0.13, 95% CI -0.17 to -0.08, with eight infants (95% CI 6 to 13) needing to be treated with NIPPV to prevent one extubation failure (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). Only one study followed the number of re-intubations to discharge (<LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK>) and found no differences between groups. We graded the quality of evidence for this outcome as moderate (unblinded intervention).</P>
<P>Seven trials used short binasal prongs (<LINK REF="STD-Barrington-2001" TYPE="STUDY">Barrington 2001</LINK>; <LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010</LINK>; <LINK REF="STD-Jasani-2016" TYPE="STUDY">Jasani 2016</LINK>; <LINK REF="STD-Khalaf--2001" TYPE="STUDY">Khalaf 2001</LINK>; <LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK>; <LINK REF="STD-Moretti-2008" TYPE="STUDY">Moretti 2008</LINK>; <LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK>), two used bi-nasopharyngeal prongs (<LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK>; <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK>) and one used a shortened endotracheal tube in one nostril (<LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>). Both prongs and tube were effective (post hoc analysis).</P>
<P>Owing to methodological limitations (risk of selection bias) in three studies (<LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>; <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK>), we performed a post hoc analysis for the outcome respiratory failure post extubation, including only higher-quality studies in the analysis (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). Results were largely unchanged: typical RR 0.73, 95% CI 0.63 to 0.85; typical RD -0.11, 95% CI -0.16 to -0.06.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Endotracheal re-intubation (outcome 1.2)</HEADING>
<P>Not all NCPAP infants reaching extubation failure criteria were re-intubated, because a varying proportion of infants in each trial were offered rescue therapy with NIPPV. The pooled estimate of rates of endotracheal re-intubation favoured NIPPV (typical RR 0.76, 95% CI 0.65 to 0.88; typical RD -0.10, 95% CI -0.15 to -0.05; number needed to treat for an additional beneficial outcome (NNTB) 10, 95% CI 7 to 20; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). We graded the quality of evidence for this outcome as moderate (unblinded intervention).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Gastrointestinal side effects (outcomes 2.1, 2.2 and 2.3)</HEADING>
<P>
<LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK>, <LINK REF="STD-Barrington-2001" TYPE="STUDY">Barrington 2001</LINK> and <LINK REF="STD-Jasani-2016" TYPE="STUDY">Jasani 2016</LINK> reported rates of feeding cessation, and <LINK REF="STD-Khalaf--2001" TYPE="STUDY">Khalaf 2001</LINK> provided unpublished data for this outcome. Other studies reported feeding intolerance. Investigators reported no significant differences between groups (typical RR 1.27, 95% CI 0.64 to 2.53; typical RD 0.03, 95% CI -0.06 to 0.12; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). We graded the quality of evidence for this outcome as low (unblinded intervention and imprecision of results).</P>
<P>Results showed no significant differences between groups in the incidence of gastrointestinal perforation (typical RR 0.94, 95% CI 0.60 to 1.48; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). Six trials reported rates of NEC (<LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>; <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK>; <LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK>; <LINK REF="STD-Moretti-2008" TYPE="STUDY">Moretti 2008</LINK>; <LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK>) and revealed no differences between groups (typical RR 0.87, 95% CI 0.64 to 1.19; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>). We graded the quality of evidence for these outcomes as moderate (unblinded intervention).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Pulmonary outcomes (outcomes 3.1, 3.2 and 3.3)</HEADING>
<P>Six trials reported oxygen need at 36 weeks' corrected gestational age (<LINK REF="STD-Barrington-2001" TYPE="STUDY">Barrington 2001</LINK>; <LINK REF="STD-Jasani-2016" TYPE="STUDY">Jasani 2016</LINK>; <LINK REF="STD-Khalaf--2001" TYPE="STUDY">Khalaf 2001</LINK>; <LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK>; <LINK REF="STD-Moretti-2008" TYPE="STUDY">Moretti 2008</LINK>; <LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK>). Infants randomised to NIPPV did not have significantly lower rates of CLD compared with infants randomised to NCPAP (typical RR 0.94, 95% CI 0.80 to 1.10; typical RD -0.02, 95% CI -0.08 to 0.03; <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>). We graded the quality of evidence for this outcome as moderate (unblinded intervention). Heterogeneity between trials was also moderate (I<SUP>2</SUP>= 51%).</P>
<P>In view of new trials added to the review since its first publication, we added the outcome of air leaks to the review. Six trials reported this outcome (<LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010</LINK>; <LINK REF="STD-Jasani-2016" TYPE="STUDY">Jasani 2016</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>; <LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK>; <LINK REF="STD-Moretti-2008" TYPE="STUDY">Moretti 2008</LINK>; <LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK>) and described reduced air leaks among infants randomised to NIPPV (typical RR 0.48, 95% CI 0.28 to 0.82; typical RD -0.03, 95% CI -0.05 to -0.01; NNTB 33, 95% CI 20 to 100; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>). We rated the quality of evidence for this outcome as moderate (unblinded intervention).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Mortality (outcome 4.1)</HEADING>
<P>Six trials (1237 infants) reported mortality (<LINK REF="STD-Jasani-2016" TYPE="STUDY">Jasani 2016</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>; <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK>; <LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK>; <LINK REF="STD-Moretti-2008" TYPE="STUDY">Moretti 2008</LINK>; <LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK>). <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK> reported no deaths, and meta-analysis revealed a small difference between treatment groups (typical RR 0.69, 95% CI 0.48 to 0.99; typical RD -0.03, 95% CI -0.06 to 0.00; <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). We graded evidence for this outcome as moderate (unblinded intervention).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Duration of hospitalisation (outcome 5.1)</HEADING>
<P>Meta-analysis of the four studies that reported this outcome showed that duration of hospitalisation was longer in infants who were randomised to NIPPV (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>). However, these results should be viewed with caution because liberal use of rescue NIPPV for infants not responding to NCPAP within the first days of extubation makes a difference, and longer-term outcomes, should they exist, are more difficult to establish. We graded the quality of evidence for this outcome as low (unblinded intervention and imprecision of results).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Rates of apnoea (outcome 6.1)</HEADING>
<P>
<LINK REF="STD-Barrington-2001" TYPE="STUDY">Barrington 2001</LINK> used continuous multi-channel recording to detect apnoeic events and noted a trend towards fewer apnoeic episodes per day in the NIPPV group, which did not reach statistical significance (mean difference (MD) -3.10, 95% CI -7.92 to 1.72; <LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Subgroup analyses</HEADING>
<P>We planned to perform subgroup analyses to determine whether responses differed according to the modality used to deliver NIPPV (synchronised or not, bilevel devices or NIPPV provided by a ventilator).</P>
<SUBSECTION>
<HEADING LEVEL="5">Synchronised versus non-synchronised NIPPV</HEADING>
<P>Five studies used synchronised NIPPV (<LINK REF="STD-Barrington-2001" TYPE="STUDY">Barrington 2001</LINK>; <LINK REF="STD-Friedlich-1999" TYPE="STUDY">Friedlich 1999</LINK>; <LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010</LINK>; <LINK REF="STD-Khalaf--2001" TYPE="STUDY">Khalaf 2001</LINK>; <LINK REF="STD-Moretti-2008" TYPE="STUDY">Moretti 2008</LINK>), and four did not (<LINK REF="STD-Jasani-2016" TYPE="STUDY">Jasani 2016</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>; <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK>; <LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK>); one study did not prescribe use of either synchronised or non-synchronised NIPPV (<LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK>). Both synchronised (typical RR 0.25, 95% CI 0.15 to 0.41) and non-synchronised studies (typical RR 0.65, 95% CI 0.46 to 0.93) showed overall benefit, and the trial using both methods (typical RR 0.86, 95% CI 0.72 to 1.01) showed no benefit of NIPPV for preventing extubation failure (<LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>). Heterogeneity was high in this subgroup analysis.</P>
<P>When CLD was examined by method of delivery of NIPPV, synchronised NIPPV was associated with a reduction in CLD in three trials (181 infants) that could be pooled for this analysis (typical RR 0.64, 95% CI 0.44 to 0.95; typical RD -0.15, 95% CI -0.28 to 0.02; <LINK REF="CMP-007.06" TYPE="ANALYSIS">Analysis 7.6</LINK>). Air leaks were also reduced in the two trials that used synchronised NIPPV and reported this outcome (typical RR 0.35, 95% CI 0.14 to 0.90; <LINK REF="CMP-007.07" TYPE="ANALYSIS">Analysis 7.7</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">NIPPV provided by a ventilator versus bilevel devices</HEADING>
<P>Eight trials used NIPPV delivered via a ventilator, one used bilevel devices (<LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK>) and another used both a ventilator and bilevel devices (<LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK>). Six of the eight trials using a ventilator to generate NIPPV showed benefit of NIPPV in preventing respiratory failure post extubation (typical RR 0.32, 95% CI 0.22 to 0.47); the two trials that used bilevel (typical RR 0.78, 95% CI 0.50 to 1.21) or both ventilator and bilevel (typical RR 0.86, 95% CI 0.72 to 1.01) showed no benefit (<LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>). Heterogeneity was high in this subgroup analysis.</P>
<P>When CLD was examined by device delivering NIPPV, NIPPV delivered by a ventilator was associated with a reduction in CLD in the five trials (298 infants) that could be pooled for this analysis (typical RR 0.69, 95% CI 0.50 to 0.95; typical RD -0.12, 95% CI -0.22 to -0.02; <LINK REF="CMP-008.06" TYPE="ANALYSIS">Analysis 8.6</LINK>). Air leaks were also reduced in the four trials that reported this outcome (typical RR 0.35, 95% CI 0.16 to 0.79; <LINK REF="CMP-008.07" TYPE="ANALYSIS">Analysis 8.7</LINK>).</P>
<P>We had planned to perform subgroup analysis to determine whether use of methylxanthines alters response. Almost all infants received methylxanthines before extubation, so we did not perform the planned subgroup analysis. We could not perform planned subgroup analyses based on birth weight and age at randomisation, as trial authors did not present data in ways that would allow us to ascertain this information.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2017-01-22 16:26:26 -0500" MODIFIED_BY="[Empty name]">
<P>Meta-analysis performed for this updated review showed a strong effect of non-invasive positive pressure ventilation (NIPPV) on extubation failure but no overall effect on chronic lung disease (CLD). Asymmetrical funnel plots for the primary outcome suggest possible small study bias. When outcomes were examined by subgroups, synchronised NIPPV and NIPPV delivered by a ventilator demonstrated short-term benefit for extubation failure and long-term pulmonary effects for CLD and pulmonary air leaks. These subgroup analyses included a smaller number of infants and high heterogeneity; thus results should be interpreted with caution. Individual neonatal intensive care units may interpret these results differently.</P>
<P>Most trials included in this review were small, single-centre studies, and some used devices no longer available on the market. Additional data from one large pragmatic study increased heterogeneity in the meta-analysis, likely as the result of broader inclusion criteria, multi-centre status and examination of many devices providing NIPPV. Generalisation of these results to many currently available devices may not be appropriate.</P>
<P>Six of the ten trials identified in this review had no major methodological limitations. Three trials had potential selection bias (<LINK REF="STD-Gao-2010" TYPE="STUDY">Gao 2010</LINK>; <LINK REF="STD-Kahramaner-2014" TYPE="STUDY">Kahramaner 2014</LINK>; <LINK REF="STD-Khorana-2008" TYPE="STUDY">Khorana 2008</LINK>), and one was terminated early owing to enrolment difficulties (<LINK REF="STD-O_x0027_Brien-2012" TYPE="STUDY">O'Brien 2012</LINK>). Because of the nature of the interventions, it has been impossible to blind carers, and bias may have arisen through uneven use of co-interventions. Investigators dealt with potential confounders, such as methylxanthine usage and weaning strategies, by having management protocols in place; use of objective failure criteria in these extubation trials enhances our confidence in their findings.</P>
<P>Provision of synchronised NIPPV requires a ventilator capable of delivering this mode of support. Few such ventilators are available on the market. Further research should define whether this modality is definitely superior to non-synchronised NIPPV, and which type of synchronisation is optimal. Similarly, the effect of bilevel or bilevel positive airway pressure devices deserves more study. In preparing this review, we could not determine benefits for a subgroup of infants (smaller and more immature). A newly available method (neurally adjusted ventilatory assist, or NAVA) has shown promise in small case series (<LINK REF="REF-Lee-2015" TYPE="REFERENCE">Lee 2015</LINK>; <LINK REF="REF-Stein-2012" TYPE="REFERENCE">Stein 2012</LINK>), but further assessment is needed.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2017-01-17 21:56:24 -0500" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2017-01-17 21:55:48 -0500" MODIFIED_BY="[Empty name]">
<P>Use of nasal intermittent positive pressure ventilation (NIPPV) and nasal continuous positive airway pressure (NCPAP) after extubation reduces the incidence of extubation failure within 48 hours to seven days. Studies using synchronised NIPPV and delivering NIPPV to infants by a ventilator observed benefits more consistently. Investigators noted no overall reduction in chronic lung disease among infants randomised to NIPPV and reported a reassuring absence of the gastrointestinal side effects that had been reported in previous case series.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2017-01-17 21:56:24 -0500" MODIFIED_BY="[Empty name]">
<P>Future trials should enrol sufficient infants to detect differences in important outcomes such as death or chronic lung disease and should compare different categories of devices. These trials should establish the impact of synchronisation of NIPPV on safety and efficacy of the technique as well as the best combination of settings for NIPPV (rate, peak pressure and positive end expiratory pressure).</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2017-01-17 21:56:29 -0500" MODIFIED_BY="[Empty name]">
<P>The review authors acknowledge the generosity of Drs Friedlich, Barrington and Bhandari, who supplied 'preprints' of their manuscripts and additional information for this review. Review authors also acknowledge the generosity of the steering committee of <LINK REF="STD-Kirpalani-2013" TYPE="STUDY">Kirpalani 2013</LINK>, which provided further data for analysis.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2017-01-17 17:21:09 -0500" MODIFIED_BY="[Empty name]">
<P>Review authors have declared no conflicts of interest.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2017-01-22 16:26:02 -0500" MODIFIED_BY="[Empty name]">
<P>PGD and BL prepared the protocol for this review.</P>
<P>AGD and HK provided additional material for the Background section.</P>
<P>BL updated the literature search, made independent quality assessments and extracted data before comparing results and resolving differences for this update.</P>
<P>All review authors participated in data analysis and interpretation of results for this updated review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2017-01-17 21:56:56 -0500" MODIFIED_BY="[Empty name]">
<P>We added the methods and plan for 'Summary of findings' tables and GRADE recommendations, which were not included in the original protocol, nor in the previously published review.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2017-01-31 17:00:04 +0000" MODIFIED_BY="Colleen Ovelman">
<STUDIES MODIFIED="2017-01-17 18:49:05 -0500" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2017-01-17 18:46:27 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Barrington-2001" MODIFIED="2016-07-20 11:14:53 -0400" MODIFIED_BY="[Empty name]" NAME="Barrington 2001" YEAR="2001">
<REFERENCE MODIFIED="2016-07-20 11:14:53 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barrington KJ, Finer NN, Bull D</AU>
<TI>Randomised controlled trial of nasal synchronized intermittent mandatory ventilation compared with continuous positive airway pressure after extubation of very low birth weight infants</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>107</VL>
<NO>4</NO>
<PG>638-41</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872520"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872519"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Friedlich-1999" MODIFIED="2016-07-20 11:17:32 -0400" MODIFIED_BY="[Empty name]" NAME="Friedlich 1999" YEAR="1999">
<REFERENCE MODIFIED="2016-07-20 11:17:32 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Friedlich P, Lecart C, Posen R, Ramicone E, Chan L, Ramanathan R</AU>
<TI>A randomized trial of nasopharyngeal-synchronised intermittent mandatory ventilation versus nasopharyngeal continuous positive airway pressure in very low birth weight infants following extubation</TI>
<SO>Journal of Perinatology</SO>
<YR>1999</YR>
<VL>19</VL>
<NO>6 Pt 1</NO>
<PG>413-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872522"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872521"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gao-2010" MODIFIED="2014-06-21 10:20:03 -0400" MODIFIED_BY="Anne Lawson" NAME="Gao 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-06-21 10:20:03 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gao WW, Tan SZ, Chen YB, Zhang Y, Wang Y</AU>
<TI>Randomized trial of nasal synchronized intermittent mandatory ventilation compared with nasal continuous positive airway pressure in preterm infants with respiratory distress syndrome</TI>
<SO>Chinese Journal of Contemporary Pediatrics</SO>
<YR>2010</YR>
<VL>12</VL>
<NO>7</NO>
<PG>524-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872524"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872523"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jasani-2016" MODIFIED="2017-01-17 18:42:01 -0500" MODIFIED_BY="[Empty name]" NAME="Jasani 2016" YEAR="2015">
<REFERENCE MODIFIED="2017-01-17 18:42:01 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jasani B, Nanavati R, Kabra N, Rajdeo S, Bhandari V</AU>
<TI>Comparison of non-synchronized nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as post-extubation respiratory support in preterm infants with respiratory distress syndrome: a randomized controlled trial</TI>
<SO>Journal of Maternal-Fetal &amp; Neonatal Medicine</SO>
<YR>2016</YR>
<VL>29</VL>
<NO>10</NO>
<PG>1546-51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872526"/><IDENTIFIER TYPE="PUBMED" VALUE="26135774"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872525"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kahramaner-2014" MODIFIED="2017-01-17 18:42:17 -0500" MODIFIED_BY="[Empty name]" NAME="Kahramaner 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-01-17 18:42:17 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kahramaner Z, Erdemir A, Turkoglu E, Cosar H, Sutcuoglu S, Ozer EA</AU>
<TI>Unsynchronized nasal intermittent positive pressure versus nasal continuous positive airway pressure in preterm infants after extubation</TI>
<SO>Journal of Maternal-Fetal &amp; Neonatal Medicine</SO>
<YR>2014</YR>
<VL>27</VL>
<NO>9</NO>
<PG>926-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872528"/><IDENTIFIER TYPE="DOI" VALUE="10.3109/14767058.2013.846316"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872527"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khalaf--2001" MODIFIED="2016-07-20 11:23:22 -0400" MODIFIED_BY="[Empty name]" NAME="Khalaf  2001" YEAR="2001">
<REFERENCE MODIFIED="2016-07-20 11:23:05 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;check for full publication&lt;/p&gt;" NOTES_MODIFIED="2016-07-20 11:23:05 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khalaf MN, Brodsky N, Hurley J, Bhandari V</AU>
<TI>A prospective randomised controlled trial comparing synchronized nasal intermittent positive pressure ventilation (SNIPPV) versus nasal continuous positive airway pressure (NCPAP) as mode of extubation</TI>
<SO>Pediatric Research</SO>
<YR>1999</YR>
<VL>45</VL>
<PG>204a</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872530"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-07-20 11:23:22 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Khalaf MN, Brodsky N, Hurley J, Bhandari V</AU>
<TI>A prospective randomized, controlled trial comparing synchronized nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as modes of extubation</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>108</VL>
<NO>1</NO>
<PG>13-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872531"/><IDENTIFIER TYPE="MEDLINE" VALUE="11433048"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872529"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khorana-2008" MODIFIED="2014-06-21 10:21:22 -0400" MODIFIED_BY="Anne Lawson" NAME="Khorana 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-06-21 10:21:22 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Khorana M, Paradeevisut H, Sangtawesin V, Kanjanapatanakul W, Chotigeat U, Ayutthaya JKN</AU>
<TI>A randomized trial of non-synchronized nasopharyngeal intermittent mandatory ventilation (nsNIMV) vs. nasal continuous positive airway pressure (nCPAP) in the prevention of extubation failure in preterm under 1500 grams</TI>
<SO>Journal of the Medical Association of Thailand</SO>
<YR>2008</YR>
<VL>91</VL>
<NO>3</NO>
<PG>S136-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872533"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872532"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Kirpalani-2013" MODIFIED="2017-01-17 18:45:49 -0500" MODIFIED_BY="[Empty name]" NAME="Kirpalani 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-01-17 18:45:49 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kirpalani H, Millar D, Lemyre B, Yoder BA, Chiu A, Roberts RS; NIPPV Study Group</AU>
<TI>A trial comparing noninvasive ventilation strategies in preterm infants</TI>
<SO>New England Journal of Medicine</SO>
<YR>2013</YR>
<VL>369</VL>
<NO>7</NO>
<PG>611-20</PG>
<IDENTIFIERS MODIFIED="2015-01-14 19:49:31 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872535"/><IDENTIFIER MODIFIED="2015-01-14 19:49:31 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1056/NEJMoa1214533"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872534"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moretti-2008" MODIFIED="2014-06-21 10:22:14 -0400" MODIFIED_BY="Anne Lawson" NAME="Moretti 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-06-21 10:22:14 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Moretti C, Giannini L, Fassi C, Gizzi C, Papoff P, Colarizi P</AU>
<TI>Nasal flow-synchronized intermittent positive pressure ventilation to facilitate weaning in very low-birthweight infants: unmasked randomized controlled trial</TI>
<SO>Pediatrics International</SO>
<YR>2008</YR>
<VL>50</VL>
<PG>85-91</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872537"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872536"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Brien-2012" MODIFIED="2017-01-17 18:46:27 -0500" MODIFIED_BY="[Empty name]" NAME="O'Brien 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-01-17 18:46:27 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>O'Brien K, Campbell C, Havlin L, Wenger L, Shah V</AU>
<TI>Infant flow biphasic nasal continuous positive airway pressure (BP-nCPAP) vs. infant flow nCPAP for the facilitation of extubation in infants less than or = 1250 grams: a randomized controlled trial</TI>
<SO>BMC Pediatrics</SO>
<YR>2012</YR>
<VL>12</VL>
<PG>43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872539"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872538"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2017-01-17 18:47:48 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Ali-2007" MODIFIED="2014-06-21 10:22:39 -0400" MODIFIED_BY="Anne Lawson" NAME="Ali 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-06-21 10:22:39 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ali N, Claure N, Alegria X, D'Ugard C, Organero R, Bancalari E</AU>
<TI>Effects of non-invasive pressure support ventilation (NI-PSV) on ventilation and respiratory effort in very low birth weight infants</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2007</YR>
<VL>42</VL>
<PG>704-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872541"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872540"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bhandari-2007" MODIFIED="2014-06-21 10:45:46 -0400" MODIFIED_BY="Anne Lawson" NAME="Bhandari 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-06-21 10:45:46 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bhandari V, Gavino RG, Nedrelow JH, Pallela P, Salvadore A, Ehrenkranz RA, et al</AU>
<TI>A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS</TI>
<SO>Journal of Perinatology</SO>
<YR>2007</YR>
<VL>11</VL>
<PG>697-703</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872543"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2008-06-24 15:08:43 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872542"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bisceglia-2007" MODIFIED="2014-06-21 10:45:57 -0400" MODIFIED_BY="Anne Lawson" NAME="Bisceglia 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-06-21 10:45:57 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bisceglia M, Belcastro A, Poerio V, Raimondi F, Mesuraca L, Crugliano C, et al</AU>
<TI>A comparison of nasal intermittent versus continuous positive pressure delivery for the treatment of moderate respiratory syndrome in preterm infants</TI>
<SO>Minerva Pediatrica</SO>
<YR>2007</YR>
<VL>59</VL>
<PG>91-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872545"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872544"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-DeSimone-2010" MODIFIED="2014-06-21 10:46:09 -0400" MODIFIED_BY="Anne Lawson" NAME="DeSimone 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-06-21 10:46:09 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>DeSimone OA, Sommers R, Destin K, Mance M, Matook S, Stonestreet B, et al</AU>
<TI>Nasal intermittent positive pressure ventilation (NIPPV) does not facilitate earlier extubation in infants less than 28 weeks gestation: a pilot study</TI>
<SO>Pediatric Academic Society</SO>
<YR>2010</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872547"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872546"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kishore-2009" MODIFIED="2014-06-21 10:29:17 -0400" MODIFIED_BY="Anne Lawson" NAME="Kishore 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-06-21 10:29:17 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kishore MSS, Dutta S, Kumar P</AU>
<TI>Early nasal intermittent positive pressure ventilation versus continuous positive airway pressure for respiratory distress syndrome</TI>
<SO>Acta Paediatrica</SO>
<YR>2009</YR>
<VL>98</VL>
<PG>1412-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872549"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872548"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kugelman-2007" MODIFIED="2014-06-21 10:36:18 -0400" MODIFIED_BY="Anne Lawson" NAME="Kugelman 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-06-21 10:36:18 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D</AU>
<TI>Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized controlled prospective study</TI>
<SO>Journal of Pediatrics</SO>
<YR>2007</YR>
<VL>150</VL>
<PG>521-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872551"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872550"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kumar-2011" MODIFIED="2017-01-17 18:47:48 -0500" MODIFIED_BY="[Empty name]" NAME="Kumar 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-01-17 18:47:48 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kumar M, Avasthi S, Ahuja S, Malik GK, Singh SN</AU>
<TI>Unsynchronized nasal intermittent positive pressure ventilation to prevent extubation failure in neonates: a randomized controlled trial</TI>
<SO>Indian Journal of Pediatrics</SO>
<YR>2011</YR>
<VL>78</VL>
<NO>7</NO>
<PG>801-6</PG>
<IDENTIFIERS MODIFIED="2015-01-14 18:33:04 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872553"/><IDENTIFIER MODIFIED="2015-01-14 18:33:04 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1007/s12098-010-0357-x"/><IDENTIFIER MODIFIED="2015-01-14 18:32:35 -0500" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21287368"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872552"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lin-1998" MODIFIED="2014-06-21 10:36:28 -0400" MODIFIED_BY="Anne Lawson" NAME="Lin 1998" YEAR="1998">
<REFERENCE MODIFIED="2014-06-21 10:36:28 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lin CH, Wang ST, Lin YJ, Yeh TF</AU>
<TI>Efficacy of nasal intermittent positive pressure ventilation in treating apnea of prematurity</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1998</YR>
<VL>26</VL>
<NO>5</NO>
<PG>349-53</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872555"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872554"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meneses-2011" MODIFIED="2014-06-21 10:36:40 -0400" MODIFIED_BY="Anne Lawson" NAME="Meneses 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-06-21 10:36:40 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meneses J, Bhandari V, Guilherme AJ, Herrmann D</AU>
<TI>Noninvasive ventilation for respiratory distress syndrome: a randomized controlled trial</TI>
<SO>Pediatrics</SO>
<YR>2011</YR>
<VL>127</VL>
<NO>2</NO>
<PG>300-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872557"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872556"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moretti-1999" MODIFIED="2014-06-21 10:46:17 -0400" MODIFIED_BY="Anne Lawson" NAME="Moretti 1999" YEAR="1999">
<REFERENCE MODIFIED="2014-06-21 10:46:17 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moretti C, Gizzi C, Papoff P, Lampariello S, Capoferri M, Calcagnini G, et al</AU>
<TI>Comparing the effects of nasal synchronized intermittent positive pressure ventilation (nSIPPV) and nasal continuous positive airway pressure (nCPAP) after extubation in very low birth weight infants</TI>
<SO>Early Human Development</SO>
<YR>1999</YR>
<VL>56</VL>
<PG>166-77</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872559"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872558"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pantalitschka-2009" MODIFIED="2014-06-21 10:37:10 -0400" MODIFIED_BY="Anne Lawson" NAME="Pantalitschka 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-06-21 10:37:10 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pantalitschka T, Sievers J, Urschitz MS, Herberts T, Reher C, Poets CF</AU>
<TI>Randomised crossover trial of four nasal respiratory support systems for apnoea of prematurity in very low birthweight infants</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2009</YR>
<VL>94</VL>
<NO>4</NO>
<PG>F245-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872561"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872560"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramanathan-2012" MODIFIED="2014-06-21 10:37:27 -0400" MODIFIED_BY="Anne Lawson" NAME="Ramanathan 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-06-21 10:37:27 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ramanathan R, Sekar KC, Rasmussen M, Bhatia J, Soll RF</AU>
<TI>Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants under 30 weeks gestation: a randomized, controlled trial</TI>
<SO>Journal of Perinatology</SO>
<YR>2012</YR>
<VL>32</VL>
<NO>5</NO>
<PG>336-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872563"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872562"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ryan-1989" MODIFIED="2014-06-21 10:37:38 -0400" MODIFIED_BY="Anne Lawson" NAME="Ryan 1989" YEAR="1989">
<REFERENCE MODIFIED="2014-06-21 10:37:38 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ryan CA, Finer NN, Peters KL</AU>
<TI>Nasal intermittent positive-pressure ventilation offers no advantages over nasal continuous positive airway pressure in apnea of prematurity</TI>
<SO>American Journal of Diseases in Childhood</SO>
<YR>1989</YR>
<VL>143</VL>
<NO>10</NO>
<PG>1196-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872565"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872564"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shi-2010" MODIFIED="2014-06-21 10:40:58 -0400" MODIFIED_BY="Anne Lawson" NAME="Shi 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-06-21 10:40:58 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shi Y, Tang S, Zhao J, Hu Z, Li T</AU>
<TI>Efficiency of nasal intermittent positive pressure ventilation vs nasal continuous positive airway pressure on neonatal respiratory distress syndrome: a prospective, randomized, controlled study</TI>
<SO>Acta Academiae Medicinae Militaris Tertiae</SO>
<YR>2010</YR>
<VL>32</VL>
<NO>18</NO>
<PG>1991-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872567"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872566"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2017-01-17 18:49:05 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Silveira-2015" MODIFIED="2017-01-17 18:49:05 -0500" MODIFIED_BY="[Empty name]" NAME="Silveira 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-01-17 18:49:05 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Silveira CS, Leonardi KM, Melo AP, Zaia JE, Brunherotti MA</AU>
<TI>Response of preterm infants to 2 noninvasive ventilatory support systems: nasal CPAP and nasal intermittent positive-pressure ventilation</TI>
<SO>Respiratory Care</SO>
<YR>2015</YR>
<VL>60</VL>
<NO>12</NO>
<PG>1772-6</PG>
<IDENTIFIERS MODIFIED="2015-12-14 15:51:32 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872569"/><IDENTIFIER MODIFIED="2015-12-14 15:51:32 -0500" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="26374907"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872568"/></IDENTIFIERS>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2016-07-20 11:31:29 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="UNPUB" ID="STD-El_x002d_Farash-2013" MODIFIED="2013-03-08 15:18:04 -0500" MODIFIED_BY="[Empty name]" NAME="El-Farash 2013" YEAR="2013">
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872570"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Estay-2013" MODIFIED="2013-03-08 15:17:33 -0500" MODIFIED_BY="[Empty name]" NAME="Estay 2013" YEAR="2013">
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872571"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02396693" MODIFIED="2016-07-20 11:30:43 -0400" MODIFIED_BY="[Empty name]" NAME="NCT02396693" YEAR="2012">
<REFERENCE MODIFIED="2016-07-20 11:30:43 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02396693</AU>
<TI>Successful Extubation and Noninvasive Ventilation in Preterm &#8804; 1500g Terms</TI>
<SO>clinicaltrials.gov/show/NCT02396693</SO>
<YR>(accessed 7 December 2015)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872573"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872572"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Shi-2013" MODIFIED="2013-09-05 13:43:49 -0400" MODIFIED_BY="[Empty name]" NAME="Shi 2013" YEAR="2013">
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872574"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Victor-2011" MODIFIED="2016-07-20 11:31:29 -0400" MODIFIED_BY="[Empty name]" NAME="Victor 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-07-20 11:31:29 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Victor S; Extubate Trial Group</AU>
<TI>EXTUBATE: a randomised controlled trial of nasal biphasic positive airway pressure vs. nasal continuous positive airway pressure following extubation in infants less than 30 weeks' gestation: study protocol for a randomised controlled trial</TI>
<SO>Trials</SO>
<YR>2011</YR>
<VL>12</VL>
<PG>257</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2872576"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2872575"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2017-01-17 18:53:34 -0500" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2017-01-17 18:53:34 -0500" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Bancalari-2013" MODIFIED="2014-06-21 10:41:35 -0400" MODIFIED_BY="Anne Lawson" NAME="Bancalari 2013" TYPE="JOURNAL_ARTICLE">
<AU>Bancalari E, Claure N</AU>
<TI>The evidence for non-invasive ventilation in the preterm infant</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2013</YR>
<VL>98</VL>
<NO>2</NO>
<PG>F98-102</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bott-1993" MODIFIED="2014-06-21 10:41:53 -0400" MODIFIED_BY="Anne Lawson" NAME="Bott 1993" TYPE="JOURNAL_ARTICLE">
<AU>Bott J, Carroll MP, Conway JH, Keilty SE, Ward EM, Brown AM, et al</AU>
<TI>Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease</TI>
<SO>Lancet</SO>
<YR>1993</YR>
<VL>341</VL>
<PG>1555-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davis-2003b" MODIFIED="2014-06-22 11:35:19 -0400" MODIFIED_BY="Anne Lawson" NAME="Davis 2003b" TYPE="COCHRANE_REVIEW">
<AU>Davis PG, Henderson-Smart DJ</AU>
<TI>Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>2</NO>
<PG>Update Software</PG>
<IDENTIFIERS MODIFIED="2008-04-29 12:01:33 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2008-04-29 12:01:33 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000143"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Davis-2009" MODIFIED="2012-01-27 14:34:07 -0500" MODIFIED_BY="[Empty name]" NAME="Davis 2009" TYPE="JOURNAL_ARTICLE">
<AU>Davis PG, Morley CJ, Owen LS</AU>
<TI>Non-invasive respiratory support of preterm neonates with respiratory distress: continuous positive airway pressure and nasal intermittent positive pressure ventilation</TI>
<SO>Seminars in Fetal and Neonatal Medicine</SO>
<YR>2009</YR>
<VL>14</VL>
<PG>14-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ellis-1988" MODIFIED="2014-06-21 10:42:24 -0400" MODIFIED_BY="Anne Lawson" NAME="Ellis 1988" TYPE="JOURNAL_ARTICLE">
<AU>Ellis ER, Grunstein RR, Chan S, Bye PT, Sullivan CE</AU>
<TI>Noninvasive ventilatory support during sleep improves respiratory failure in kyphoscoliosis</TI>
<SO>Chest</SO>
<YR>1988</YR>
<VL>94</VL>
<PG>811-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Garland-1985" MODIFIED="2014-06-21 10:42:39 -0400" MODIFIED_BY="Anne Lawson" NAME="Garland 1985" TYPE="JOURNAL_ARTICLE">
<AU>Garland JS, Nelson DB, Rice T, Neu J</AU>
<TI>Increased risk of gastrointestinal perforations in neonates mechanically ventilated with either face mask or nasal prongs</TI>
<SO>Pediatrics</SO>
<YR>1985</YR>
<VL>76</VL>
<PG>406-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GRADEpro-2008" MODIFIED="2016-07-20 11:32:18 -0400" MODIFIED_BY="[Empty name]" NAME="GRADEpro 2008" TYPE="COMPUTER_PROGRAM">
<AU>Brozek J, Oxman A, Schünemann H</AU>
<TI>GRADEpro</TI>
<YR>2008</YR>
<EN>3.2 for Windows</EN>
<PB>The GRADE Working Group</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011a" MODIFIED="2017-01-17 18:51:13 -0500" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011a" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al</AU>
<TI>GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>4</NO>
<PG>383-94</PG>
<IDENTIFIERS MODIFIED="2015-12-14 13:18:38 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="21195583"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011b" MODIFIED="2017-01-17 18:51:32 -0500" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011b" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al</AU>
<TI>GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>4</NO>
<PG>407-15</PG>
<IDENTIFIERS MODIFIED="2015-12-14 13:18:38 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="21247734"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011c" MODIFIED="2017-01-17 18:51:43 -0500" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011c" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al</AU>
<TI>GRADE guidelines 6. Rating the quality of evidence - imprecision</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>12</NO>
<PG>1283-93</PG>
<IDENTIFIERS MODIFIED="2015-12-14 13:18:38 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="21839614"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011d" MODIFIED="2017-01-17 18:51:54 -0500" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011d" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al</AU>
<TI>GRADE guidelines: 7. Rating the quality of evidence - inconsistency</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>12</NO>
<PG>1294-302</PG>
<IDENTIFIERS MODIFIED="2015-12-14 13:18:38 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="21803546"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011e" MODIFIED="2017-01-17 18:52:05 -0500" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011e" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al</AU>
<TI>GRADE guidelines: 8. Rating the quality of evidence - indirectness</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>12</NO>
<PG>1303-10</PG>
<IDENTIFIERS MODIFIED="2015-12-14 13:18:38 -0500" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="21802903"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2017-01-17 18:52:16 -0500" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kiciman-1998" MODIFIED="2014-06-21 10:43:37 -0400" MODIFIED_BY="Anne Lawson" NAME="Kiciman 1998" TYPE="JOURNAL_ARTICLE">
<AU>Kiciman NM, Andréasson B, Bernstein G, Mannino FL, Rich W, Henderson C, et al</AU>
<TI>Thoracoabdominal motion in newborns during ventilation delivered by endotracheal tube or nasal prongs</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1998</YR>
<VL>25</VL>
<PG>175-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lee-2015" MODIFIED="2016-07-20 11:33:27 -0400" MODIFIED_BY="[Empty name]" NAME="Lee 2015" TYPE="JOURNAL_ARTICLE">
<AU>Lee J, Kim HS, Jung YH, Shin SH, Choi CW, Kim EK, et al</AU>
<TI>Non-invasive neurally adjusted ventilatory assist in preterm infants: a randomised phase II crossover trial</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2015</YR>
<VL>100</VL>
<NO>6</NO>
<PG>F507-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Owen-2007" MODIFIED="2014-06-21 10:44:08 -0400" MODIFIED_BY="Anne Lawson" NAME="Owen 2007" TYPE="JOURNAL_ARTICLE">
<AU>Owen LS, Morley CJ, Davis PG</AU>
<TI>Nasal intermittent positive pressure ventilation: what do we know in 2007?</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2007</YR>
<VL>92</VL>
<NO>5</NO>
<PG>F414-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Owen-2008" MODIFIED="2014-06-21 10:44:23 -0400" MODIFIED_BY="Anne Lawson" NAME="Owen 2008" TYPE="JOURNAL_ARTICLE">
<AU>Owen LS, Morley CJ, Davis PG</AU>
<TI>Neonatal nasal intermittent positive pressure ventilation: a survey of practice in England</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2008</YR>
<VL>93</VL>
<NO>2</NO>
<PG>F148-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Owen-2016" MODIFIED="2016-08-08 13:55:24 -0400" MODIFIED_BY="[Empty name]" NAME="Owen 2016" TYPE="JOURNAL_ARTICLE">
<AU>Owen LS; Manley BJ</AU>
<TI>Nasal intermittent positive pressure ventilation in preterm infants: equipment, evidence and synchronization</TI>
<SO>Seminars in Fetal and Neonatal Medicine</SO>
<YR>2016</YR>
<VL>21</VL>
<NO>3</NO>
<PG>146-153</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Piper-1992" MODIFIED="2008-04-29 12:22:13 -0400" MODIFIED_BY="[Empty name]" NAME="Piper 1992" TYPE="JOURNAL_ARTICLE">
<AU>Piper AJ, Parker S, Torzillo PJ, Sullivan CE, Bye PT</AU>
<TI>Nocturnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure</TI>
<SO>Chest</SO>
<YR>1992</YR>
<VL>102</VL>
<PG>846-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sch_x00fc_nemann-2013" MODIFIED="2017-01-17 18:53:34 -0500" MODIFIED_BY="[Empty name]" NAME="Schünemann 2013" TYPE="OTHER">
<AU>Schünemann H, Bro&#380;ek J, Guyatt G, Oxman A, editors; GWG</AU>
<TI>GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations</TI>
<SO>www.guidelinedevelopment.org/handbook.</SO>
<YR>Updated October 2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stein-2012" MODIFIED="2016-07-20 11:34:14 -0400" MODIFIED_BY="[Empty name]" NAME="Stein 2012" TYPE="JOURNAL_ARTICLE">
<AU>Stein D, Howard D</AU>
<TI>Neurally adjusted ventilatory assist in neonates weighing &lt;1500 grams: a retrospective analysis</TI>
<SO>Journal of Pediatrics</SO>
<YR>2012</YR>
<VL>160</VL>
<NO>5</NO>
<PG>786-9</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2014-06-22 11:40:26 -0400" MODIFIED_BY="Anne Lawson">
<REFERENCE ID="REF-Davis-2001" MODIFIED="2008-04-29 11:56:26 -0400" MODIFIED_BY="[Empty name]" NAME="Davis 2001" TYPE="COCHRANE_REVIEW">
<AU>Davis PG, Lemyre B, De Paoli AG</AU>
<TI>Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>3</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2008-04-29 11:56:26 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2008-04-29 11:56:26 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003212"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Davis-2003a" MODIFIED="2014-06-22 11:40:26 -0400" MODIFIED_BY="Anne Lawson" NAME="Davis 2003a" TYPE="COCHRANE_REVIEW">
<AU>Davis PG, Lemyre B, De Paoli AG</AU>
<TI>Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2008-04-29 11:56:49 -0400" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2008-04-29 11:56:49 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003212"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2017-01-17 22:01:57 -0500" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2017-01-17 22:01:57 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2017-01-17 21:57:16 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barrington-2001">
<CHAR_METHODS MODIFIED="2017-01-17 17:33:05 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial comparing effects of synchronised NIPPV vs NCPAP in preterm infants after extubation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 21:57:16 -0500" MODIFIED_BY="[Empty name]">
<P>Infants with birth weight &lt; 1250 grams (mean 831 ± 193 grams), &lt; 6 weeks of age (mean 7.6 ± 9.7 days), requiring &lt; 35% O<SUB>2</SUB> and &lt; 18 breaths/min on SIMV. All infants were loaded with aminophylline before extubation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-17 17:26:59 -0500" MODIFIED_BY="[Empty name]">
<P>Experimental group: synchronised NIPPV = nSIMV; ventilator rate 12 breaths/min and PIP 16 cmH<SUB>2</SUB>O, PEEP 6 cmH<SUB>2</SUB>O, PIP increased to achieve measured pressure &#8805; 12 cmH<SUB>2</SUB>O. Graseby capsule, Infant Star ventilator and Hudson nasal prongs were used.<BR/>Control group: NCPAP 6 cmH<SUB>2</SUB>O</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 17:33:56 -0500" MODIFIED_BY="[Empty name]">
<P>Primary: failure of extubation by 72 hours because pCO<SUB>2</SUB> &gt; 70 mmHg, oxygen requirement &gt; 70% or apnoea was severe or recurrent (defined)<BR/>Secondary: rates of re-intubation, abdominal distension, feeding intolerance and CLD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 17:34:10 -0500" MODIFIED_BY="[Empty name]">
<P>Power calculation performed<BR/>54 infants enrolled - 27 in each group<BR/>Most infants not responding to NCPAP were tried on NIPPV before re-intubation</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 18:02:43 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Friedlich-1999">
<CHAR_METHODS MODIFIED="2017-01-17 17:34:40 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial comparing effects of synchronised NIPPV vs NCPAP in preterm infants after extubation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 18:02:43 -0500" MODIFIED_BY="[Empty name]">
<P>Infants with birth weight 500 to 1500 grams (mean 963 ± 57 grams in experimental group and 944 ± 43 grams in control group) considered ready for extubation (SIMV rate &lt; 12 breaths/min, peak pressure &lt; 23 cmH<SUB>2</SUB>O, end expiratory pressure &lt; 6 cmH<SUB>2</SUB>O, oxygen requirement &lt; 40%. Aminophylline not mandated but given to about 85% of infants. Extubated at 26.3 ± 6.1 days of life in experimental group and at 19.9 ± 3.8 days of life in control group<BR/>Excluded were infants with sepsis, NEC, symptomatic PDA, congenital anomalies.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-17 17:35:47 -0500" MODIFIED_BY="[Empty name]">
<P>Experimental group: nasopharyngeal 3-Fr gauge tube, Infant Star ventilator, synchronised NIPPV = nSIMV with rate of 10 breaths/min, PIP = that before extubation, PEEP 4-6 cmH<SUB>2</SUB>O, IT 0.6 seconds<BR/>Control group: nasopharyngeal CPAP to desired level of attending</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 17:36:06 -0500" MODIFIED_BY="[Empty name]">
<P>Primary: failure of extubation by 48 hours because pH &lt; 7.25, pCO<SUB>2</SUB> increased by 25%, oxygen requirement &gt; 60%, SIMV rate &gt; 20 (in NIPPV group), PIP &gt; 26 cmH<SUB>2</SUB>O or PEEP &gt; 8 cmH<SUB>2</SUB>O in NIPPV group, or apnoea requiring bag and mask ventilation<BR/>Secondary: endotracheal re-intubation, abdominal distension, perforation or NEC, feeding delay (not defined) and nasal bleeding</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 17:36:52 -0500" MODIFIED_BY="[Empty name]">
<P>Power calculation performed. Study was closed early after interim analysis (stopping rule not specified).<BR/>41 infants were enrolled: 22 in NIPPV group and 19 in NCPAP group.<BR/>Most infants not responding to NCPAP were tried on NIPPV before re-intubation.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 21:57:33 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gao-2010">
<CHAR_METHODS MODIFIED="2017-01-17 17:37:15 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial comparing effects of synchronised NIPPV vs NCPAP in preterm infants after extubation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 18:02:48 -0500" MODIFIED_BY="[Empty name]">
<P>Infants at gestational age &lt; 36 weeks (mean 32.3 ± 1.6 weeks in experimental group and 32.6 ± 1.4 weeks in control group) with birth weight &lt; 2000 grams (mean 1264 ± 153 grams in experimental group and 1246 ± 161 grams in control group) with RDS after surfactant</P>
<P>Excluded were infants with severe abnormalities, not specified.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-17 17:38:03 -0500" MODIFIED_BY="[Empty name]">
<P>Experimental group: synchronised NIPPV via different devices (NEWPORT 150 and 200; Teama; Stephan; Millennium). Rate 40 breaths/min, PIP 20 cmH<SUB>2</SUB>O, PEEP 5 cmH<SUB>2</SUB>O</P>
<P>Control group: NCPAP via Infant Flow Driver (EME); CPAP 4 to 8 cmH<SUB>2</SUB>O</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 21:57:33 -0500" MODIFIED_BY="[Empty name]">
<P>Failed extubation, defined as pCO<SUB>2</SUB> &gt; 70 mmHg or FiO<SUB>2</SUB> &gt; 0.6 to maintain SaO<SUB>2</SUB> &gt; 88% or mean pressure &gt; 8 cmH<SUB>2</SUB>O (in NIPPV group) or severe apnoea (in NCPAP group), defined as &gt; 6 episodes in 24 hours or &gt; 2 episodes requiring PPV. Air leak, hypercapnia, hypoxia</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-01-12 10:26:35 -0500" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 18:02:53 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jasani-2016">
<CHAR_METHODS MODIFIED="2017-01-17 17:39:23 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial comparing effects of non-synchronised NIPPV vs NCPAP in preterm infants after extubation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 18:02:53 -0500" MODIFIED_BY="[Empty name]">
<P>Preterm infants &#8804; 1500 grams at birth (mean 1187 grams at 30.8 weeks in the intervention group; mean 1153 grams at 30.6 weeks in the control group)</P>
<P>Excluded were infants with suspected upper airway obstruction, airway anomaly, major cardiopulmonary malformation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-17 17:43:23 -0500" MODIFIED_BY="[Empty name]">
<P>Experimental group: NIPPV provided by Bear Cub ventilator, non-synchronised. Rate same as pre-extubation, PIP 4 over pre-extubation settings, PEEP &#8804; 5</P>
<P>Control group: CPAP 5 to 6 cmH<SUB>2</SUB>O via Bear Cub or Viasys Infant Flow CPAP</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 17:43:36 -0500" MODIFIED_BY="[Empty name]">
<P>Failed extubation within 72 hours, defined as meeting 1 or more of the following: pH &lt; 7.26 and pCO<SUB>2 </SUB>&gt; 59 mmHg; recurrent apnoea (&gt; 2 episodes per hour); 1 apnoea needing PPV or paO<SUB>2</SUB> &lt; 51 mmHg with FiO<SUB>2</SUB> &gt; .59</P>
<P>Secondary outcomes: duration of non-invasive ventilation, total duration of ventilation, days on oxygen, air leaks, BPD, PDA, IVH grade 3-4, NEC, ROP &#8805; grade 3, length of stay, mortality, GI perforation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-16 21:36:45 -0500" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 17:48:06 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kahramaner-2014">
<CHAR_METHODS MODIFIED="2017-01-17 17:46:00 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial comparing effects of non-synchronised nasal intermittent positive pressure ventilation vs continuous positive airway pressure in preterm infants after extubation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 17:46:33 -0500" MODIFIED_BY="[Empty name]">
<P>A total of 67 premature infants at &lt; 35 weeks' gestation with birth weight &lt; 2000&#8201;grams receiving mechanical ventilation because of respiratory distress syndrome (RDS)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-17 17:46:54 -0500" MODIFIED_BY="[Empty name]">
<P>Intervention group: non-synchronised nasal NIPPV with shortened endotracheal tube via Babylog 8000. Rate 25, PIP 2 cmH<SUB>2</SUB>O above pre-extubation setting, PEEP 6 cmH<SUB>2</SUB>O. Control group: NCPAP 6 cmH<SUB>2</SUB>O with binasal prongs via Sindi driver</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 17:47:42 -0500" MODIFIED_BY="[Empty name]">
<P>Extubation failure at 48 hours, defined as pH &lt; 7.25 and pCO<SUB>2</SUB> &gt; 60 or severe or frequent apnoea, or FiO<SUB>2</SUB> &gt; 60% to keep SaO<SUB>2</SUB> 88% to 93% or frequent desaturations not responding to increasing settings</P>
<P>Secondary outcomes: air leak, death, NEC, IVH, severe IVH, ROP, sepsis, nasal injury, BPD</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 17:48:06 -0500" MODIFIED_BY="[Empty name]">
<P>Outcomes not specified in the Methods section. No sample size calculation</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 17:50:57 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khalaf--2001">
<CHAR_METHODS MODIFIED="2017-01-17 17:48:45 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial comparing effects of synchronised NIPPV vs NCPAP in preterm infants after extubation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 17:49:21 -0500" MODIFIED_BY="[Empty name]">
<P>Infants at gestational age &lt; 34 weeks with RDS ventilated by endotracheal tube. Mean birth weight 1088 grams in experimental group and 1032 grams in control group with mean gestational age 28 weeks. Ventilator settings PIP &#8804; 16 cmH<SUB>2</SUB>O, PEEP &#8804; 5 cmH<SUB>2</SUB>O, ventilator rate 15 to 25 breaths/min and O<SUB>2</SUB> &lt; 35%. All had a therapeutic blood level of aminophylline and hematocrit &gt; 40%.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-17 17:49:51 -0500" MODIFIED_BY="[Empty name]">
<P>Experimental group: synchronised NIPPV via Argyle prongs, Infant Star ventilator at PEEP &#8804; 5 cmH<SUB>2</SUB>O, with ventilator rate 15 to 25 breaths/min and PIP set at 2 to 4 cmH<SUB>2</SUB>O above that used pre-extubation. Gas flow set at 8 to 10 L/min in both groups<BR/>Control group: NCPAP delivered by Argyle prongs from a Bear Cub or Infant Star ventilator at 4 to 6 cmH<SUB>2</SUB>O</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-06-15 17:37:23 -0400" MODIFIED_BY="[Empty name]">
<P>Primary: failure of extubation by 72 hours because pH &lt; 7.25 or pCO<SUB>2</SUB> &gt; 60 mmHg, single episode of severe apnoea requiring bag and mask ventilation or frequent apnoea or desaturations (defined)<BR/>Secondary: included CLD defined as supplemental O<SUB>2</SUB> requirement at 36 weeks' corrected age, days of ventilation and hospitalisation. Data on rates of feeding intolerance provided by study authors</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 17:50:57 -0500" MODIFIED_BY="[Empty name]">
<P>Power calculation was performed. 64 infants were enrolled: 34 in NIPPV group and 30 in NCPAP group.<BR/>2 infants not responding to NCPAP were tried on NIPPV (successfully) before re-intubation.<BR/>For the outcome "abdominal distension causing cessation of feeds", denominators were number of infants offered enteral feeds during the 72-hour study period, i.e. 21 in NIPPV group and 20 in NCPAP group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 18:02:58 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khorana-2008">
<CHAR_METHODS MODIFIED="2017-01-17 17:51:45 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial comparing effects of non-synchronised NIPPV vs NCPAP in preterm infants after extubation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 18:02:58 -0500" MODIFIED_BY="[Empty name]">
<P>Infants &#8804; 34 weeks (mean 28 ± 2.6 weeks and 29 ± 2.1 weeks) or birth weight &#8804; 1500 grams (mean 984 ± 218 grams and 1185 ± 219 grams) considered ready for extubation (SIMV rate &#8804; 15 breaths/min, peak pressure &#8804; 15 cmH<SUB>2</SUB>O, end expiratory pressure &lt; 6 cmH<SUB>2</SUB>O, O<SUB>2</SUB> requirement &lt; 41%. Aminophylline pre-extubation. Extubated at 12.9 ± 9.9 days of life in experimental group and at 6.9 ± 6.0 days of life in control group<BR/>Excluded were infants with major congenital malformations, cleft lip or palate, symptomatic PDA, NEC, sepsis, IVH grade 3-4.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-17 17:52:41 -0500" MODIFIED_BY="[Empty name]">
<P>Experimental group: non-synchronised NIPPV via bi-nasopharyngeal prongs on Bear 750 ventilator; same settings as pre-extubation on the ventilator</P>
<P>Control group: NCPAP delivered by bi-nasopharyngeal prongs from a Bear 750 ventilator; CPAP level same as pre-extubation level</P>
<P>Aminophylline load before extubation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 17:53:08 -0500" MODIFIED_BY="[Empty name]">
<P>Primary: re-intubation or failure of extubation within 1 week because of:</P>
<UL>
<LI>pH &#8804; 7.25 or pCO<SUB>2</SUB> &#8805; 60 mmHg or pCO<SUB>2</SUB> &#8805; 25% higher than pre-extubation or FiO<SUB>2</SUB> &#8805; 0.6 for SaO<SUB>2</SUB> 92 to 95%; or</LI>
<LI>increased settings: intermittent mandatory ventilation rate &#8805; 20, PIP &#8805; 20 cmH<SUB>2</SUB>O, mean airway pressure &#8805; 8 cmH<SUB>2</SUB>O; or</LI>
<LI>single episode of severe apnoea requiring bag and mask ventilation; or</LI>
<LI>need for re-intubation as deemed necessary</LI>
</UL>
<P>Secondary: respiratory failure, death, abdominal distension, NEC, gastrointestinal perforation, apnoea, atelectasis and sepsis</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 17:53:19 -0500" MODIFIED_BY="[Empty name]">
<P>Imbalance between groups at randomisation (NIPPV group: lower birth weight, fewer boys, higher antenatal steroids)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 17:59:29 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kirpalani-2013">
<CHAR_METHODS MODIFIED="2017-01-17 17:58:15 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised multi-centre controlled trial comparing effects of NIPPV vs NCPAP in preterm infants after extubation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 17:58:49 -0500" MODIFIED_BY="[Empty name]">
<P>Infants with birth weight &lt; 1000 grams at &lt; 30 weeks</P>
<P>2 subgroups: intubated for &gt; 24 hours and &lt; 28 days at extubation; intubated &lt; 24 hours or never intubated. Infants never intubated were not included in this review.</P>
<P>Criteria for extubation and for re-intubation were provided.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-17 17:58:54 -0500" MODIFIED_BY="[Empty name]">
<P>NIPPV (any device) vs NCPAP; guidelines provided for both</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 17:59:05 -0500" MODIFIED_BY="[Empty name]">
<P>Death or moderate to severe BPD according to physiological definition</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 17:59:29 -0500" MODIFIED_BY="[Empty name]">
<P>2 subgroups of infants; only subgroup intubated for at least 24 hours and extubated before 28 days included in this review</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 22:01:57 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moretti-2008">
<CHAR_METHODS MODIFIED="2017-01-17 18:00:05 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial comparing effects of synchronised NIPPV vs NCPAP in preterm infants after extubation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 22:01:57 -0500" MODIFIED_BY="[Empty name]">
<P>Infants with birth weight &lt; 1251 grams (mean 908 ± 192 grams in experimental group and 957 ± 213 grams in control group) with RDS requiring ventilation within first 48 hours of life and who met criteria for extubation by day 14 of life. Criteria for extubation: stable or improving clinical condition; receiving assist/control or proportional assist ventilation; low ventilatory setting (FiO<SUB>2</SUB> &#8804; 0.35, PIP &#8804; 15 cmH<SUB>2</SUB>O and ventilator rate &#8804; 15 breaths/min or elastance &lt; 1 to maintain pCO<SUB>2</SUB> &#8804; 60 mmHg); no clinical or haematological sign of infection; haemoglobin &#8805; 10.0 grams/dL Extubated at a median of 4 days (range 1 to 14) and 6 days (range 1 to 14)<BR/>Excluded were infants with IVH grade 3 to 4, gastrointestinal surgery, congenital malformation and cardiovascular and neuromuscular abnormalities.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-17 18:01:17 -0500" MODIFIED_BY="[Empty name]">
<P>Experimental group: synchronised NIPPV via short nasal prongs on Giulia ventilator; same settings as pre-extubation on the ventilator. PEEP 3 to 5 cmH<SUB>2</SUB>O, PIP titrated according to infant from 10 to 20 cmH<SUB>2</SUB>O, flow rate 6 to 10 L/min<BR/>Control group: NCPAP delivered by short nasal prongs from a Giulia ventilator; CPAP level 3 to 5 cmH<SUB>2</SUB>O; flow rate 6 to 10 L/min</P>
<P>Caffeine load before extubation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 18:01:55 -0500" MODIFIED_BY="[Empty name]">
<P>Primary: need for re-intubation within 72 hours because of:</P>
<UL>
<LI>persistent severe acidosis (arterial pH &lt; 7.2 with pCO<SUB>2</SUB> &gt; 70 mmHg); or</LI>
<LI>severe recurrent apnoeic episodes not responding to increased ventilatory settings and then requiring bag ventilation; or</LI>
<LI>hypoxaemia (SaO<SUB>2 </SUB>&lt; 90% or pO<SUB>2 </SUB>&lt; 60 mmHg with FiO<SUB>2</SUB> consistently &#8805; 0.70)</LI>
</UL>
<P>Secondary: number of days on endotracheal mechanical ventilation, number of days on O<SUB>2</SUB>, CLD (O<SUB>2</SUB> at 36 weeks with abnormal chest x-ray), duration of hospital stay, air leaks, ROP, sepsis, feeding intolerance (presence of 4-hour gastric aspirate &gt; 25% of feed volume or containing bile)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-01-17 18:08:15 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-O_x0027_Brien-2012">
<CHAR_METHODS MODIFIED="2017-01-17 18:03:34 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial comparing effects of non-synchronised NIPPV delivered by a bilevel device vs NCPAP in preterm infants after extubation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 18:06:12 -0500" MODIFIED_BY="[Empty name]">
<P>Infants with birth weight &lt; 1251 grams (mean 901 &#771;± 200 grams in experimental group and 896 ± 156 grams in control group) who were intubated at birth for RDS (some were prophylactically intubated to received surfactant) and who met criteria for extubation (no time limit)</P>
<P>Criteria for extubation: ventilator rate &lt; 20 breaths/min, PIP &#8805; 16 cmH<SUB>2</SUB>O and FiO<SUB>2</SUB> &#8805; .35. If on high-frequency oscillatory ventilation: frequency of 9 to 13 Hz, amplitude &lt; 20%, MAP &#8804; 8 and FiO<SUB>2</SUB> &#8804; 35%. Extubated at a median of 3 days (range 1 to 67) in experimental group and 3 days (range 1 to 62) in control group. All received caffeine during first week of life. Unclear if load pre-extubation<BR/>Excluded were infants with congenital anomalies of the upper airway, acquired nasal septum injury and major congenital or chromosomal abnormalities.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-17 18:07:12 -0500" MODIFIED_BY="[Empty name]">
<P>Experimental group: NIPPV with SiPAP bilevel device, non-synchronised. Ventilator rate 20 breaths/min, IT 1.0 second. Predefined upper and lower CPAP based on FiO<SUB>2</SUB>: 8 over 5 for FiO<SUB>2</SUB> &lt; 30%; 9 over 6 for FiO<SUB>2</SUB> 30% to 50%; and 10 over 7 for FiO<SUB>2</SUB> &gt; 50%</P>
<P>Control group: CPAP with SiPAP. Level of CPAP predefined on the basis of FiO<SUB>2</SUB>: 5 cmH<SUB>2</SUB>O if FiO<SUB>2</SUB> &lt; .30; 6 mH<SUB>2</SUB>O if FiO<SUB>2</SUB> .30 to .50; and 7 mH<SUB>2</SUB>O if FiO<SUB>2</SUB> &gt; .50</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 18:07:36 -0500" MODIFIED_BY="[Empty name]">
<P>Primary: sustained extubation for 7 days. Re-intubation criteria: severe apnoea (needing PPV), &#8805; 4 apnoeic episodes per hour needing moderate stimulation, O<SUB>2</SUB> &gt; 60%, uncompensated respiratory acidosis (pH &lt; 7.25). Re-intubation also allowed at clinician discretion for other reasons (concerns regarding sepsis)</P>
<P>Secondary: adverse events (nasal septal injury or erythema, eyelid oedema, abdominal distension, feeding intolerance, pneumothorax). Feeding intolerance = aspirates &#8805; 30% of a feed. Abdominal distension &#8805; 10% increase in girth. Also: BPD, PDA treated, NEC, IVH 3 to 4, periventricular leukomalacia, ROP</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 18:08:15 -0500" MODIFIED_BY="[Empty name]">
<P>Study authors overestimated successful extubations in their control group. Recruitment was stopped at half the sample size, as clinical practice had changed and babies were no longer being intubated prophylactically.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>BPD: bronchopulmonary dysplasia; CLD: chronic lung disease; CPAP: continuous positive airway pressure; FiO<SUB>2</SUB>: fraction of inspired oxygen; IT: inspiratory time; IVH: intraventricular haemorrhage; NCPAP: nasal continuous positive airway pressure; NEC: necrotising enterocolitis; NIPPV: nasal intermittent positive pressure ventilation; nSIMV: nasal synchronised intermittent mechanical ventilation; pO<SUB>2</SUB>: partial pressure of oxygen; pCO<SUB>2</SUB>: partial pressure of carbon dioxide; PDA: patent ductus arteriosus; PEEP: positive end expiratory pressure; PIP: peak inspiratory pressure; PPV: positive pressure ventilation; RDS: respiratory distress syndrome; ROP: retinopathy of prematurity; SaO<SUB>2</SUB>: oxygen saturation measured by blood analysis; SIMV: synchronised intermittent mechanical ventilation; SiPAP: synchronised inspiratory positive airway pressure.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2017-01-17 21:31:30 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:13:07 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ali-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:13:07 -0500" MODIFIED_BY="[Empty name]">
<P>Study compared a form of NIPPV (non-invasive pressure support ventilation) vs NCPAP in a randomised cross-over study. Investigators compared short-term physiological outcomes (tidal volume, breathing effort, etc.). We excluded this study because investigators reported none of the clinical outcomes listed in the inclusion criteria for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:13:30 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bhandari-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:13:30 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised trial of NIPPV vs conventional ventilation for management of RDS (i.e. different groups compared for a different indication). Timing of extubation was different between groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:13:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bisceglia-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:13:45 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised trial of NIPPV vs NCPAP for moderate RDS (i.e. different inclusion criteria)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:14:06 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-DeSimone-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:14:06 -0500" MODIFIED_BY="[Empty name]">
<P>Extubation criteria were different for NIPPV and NCPAP groups, whereas infants randomised to NIPPV were extubated from higher ventilator settings.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:15:15 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kishore-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:15:15 -0500" MODIFIED_BY="[Empty name]">
<P>Infants were enrolled early during acute respiratory illness. Intervention was aimed at treating RDS, not upon extubation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:15:08 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kugelman-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:15:08 -0500" MODIFIED_BY="[Empty name]">
<P>Infants were enrolled early during acute respiratory illness. Intervention was aimed at treating RDS, not upon extubation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:15:40 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kumar-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:15:40 -0500" MODIFIED_BY="[Empty name]">
<P>RCT evaluating the role of unsynchronised NIPPV vs head box oxygen for prevention of extubation failure in mechanically ventilated preterm neonates weighing less than 2000 grams</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:16:01 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lin-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:16:01 -0500" MODIFIED_BY="[Empty name]">
<P>Infants enrolled had apnoea of prematurity; NIPPV or NCPAP was used for treatment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:16:23 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meneses-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:16:23 -0500" MODIFIED_BY="[Empty name]">
<P>Infants were enrolled early during acute respiratory illness. Intervention was aimed at treating RDS, not upon extubation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:16:52 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moretti-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:16:52 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised cross-over trial<BR/>Each of 11 infants (mean body weight 1141 grams) received NIPPV and NCPAP in random order for a period of 1 hour.<BR/>Outcomes included respiratory rates and pulmonary function tests (i.e. not outcome criteria specified in the protocol).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:17:09 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pantalitschka-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:17:09 -0500" MODIFIED_BY="[Empty name]">
<P>Infants enrolled had apnoea of prematurity; NIPPV or NCPAP was used for treatment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:17:44 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ramanathan-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:17:44 -0500" MODIFIED_BY="[Empty name]">
<P>Infants were randomised after INSURE procedure and extubation was planned within 2 hours of life. We included this study in the review: early NIPPV vs NCPAP for RDS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:17:59 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ryan-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:17:59 -0500" MODIFIED_BY="[Empty name]">
<P>Infants enrolled had apnoea of prematurity; NIPPV or NCPAP was used for treatment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-01-17 18:18:36 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shi-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-01-17 18:18:36 -0500" MODIFIED_BY="[Empty name]">
<P>RCT comparing NIPPV vs NCPAP. Not all enrolled infants were premature; mean birth weight of enrolled infants was 2380 grams (experimental group) vs 2416 grams (control group). Unclear if intervention was provided to treat RDS, or if RDS occurred after extubation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>INSURE: intubation, surfactant, extubation; NCPAP: nasal continuous positive airway pressure; NIPPV: nasal intermittent positive pressure ventilation; RCT: randomised controlled trial; RDS: respiratory distress syndrome.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2017-01-17 18:22:09 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2017-01-17 18:22:09 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Silveira-2015">
<CHAR_METHODS MODIFIED="2017-01-17 18:20:34 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised, prospective, clinical trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 18:21:26 -0500" MODIFIED_BY="[Empty name]">
<P>80 newborns (gestational age &lt; 37 weeks, birth weight &lt; 2500 grams). Infants could be randomised early (for initial management of respiratory distress syndrome (RDS)) or later, after extubation (mean of day 3).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-17 18:21:12 -0500" MODIFIED_BY="[Empty name]">
<P>40 infants were treated with nasal continuous positive airway pressure (CPAP) and 40 with nasal intermittent positive-pressure ventilation (NIPPV)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 18:21:53 -0500" MODIFIED_BY="[Empty name]">
<P>Occurrence of apnoea, progression of respiratory distress, nose bleeding and agitation were defined as ventilation failure. The need for intubation and re-intubation after failure was observed.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-01-17 18:22:09 -0500" MODIFIED_BY="[Empty name]">
<P>A portion of the study population may be eligible for inclusion in this review. Communication with a study investigator is ongoing.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2017-01-17 21:59:44 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2017-01-17 19:52:14 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-El_x002d_Farash-2013">
<CHAR_STUDY_NAME MODIFIED="2017-01-17 19:51:31 -0500" MODIFIED_BY="[Empty name]">
<P>Nasal Continuous Airway Pressure (n-CPAP) vs Nasal Bilevel Positive Airway Pressure (n-BiPAP) for RDS</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-04-09 11:50:18 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 19:52:00 -0500" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria:</P>
<UL>
<LI>preterm infants &lt; 34 weeks</LI>
</UL>
<P>Exclusion criteria:</P>
<UL>
<LI>preterm infants with birth weight &lt; 1000 grams </LI>
<LI>infants with Apgar score of 0 at 1 minute</LI>
<LI>presence of any other cause of respiratory distress such as congenital malformation affecting the cardiorespiratory system, neuromuscular disease, foetal hydrops, interventricular haemorrhage and chromosomal aberrations</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-22 10:46:06 -0400" MODIFIED_BY="Anne Lawson">
<P>Bilevel positive airway pressure and NCPAP</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 19:52:14 -0500" MODIFIED_BY="[Empty name]">
<P>Primary: failure of extubation during the first 48 hours post extubation, defined as uncompensated respiratory acidosis defined as pH &lt; 7.2 and PaCO<SUB>2</SUB> &gt; 60 mmHg (or) major apnoea requiring mask ventilation<BR/>Secondary: maintenance of successful extubation for 7 days from the hour of extubation</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-04-09 11:50:41 -0400" MODIFIED_BY="[Empty name]">
<P>January 2013</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-04-09 11:51:40 -0400" MODIFIED_BY="[Empty name]">
<P>Rania A. El-Farrash, MD</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-01-17 19:56:27 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Estay-2013">
<CHAR_STUDY_NAME MODIFIED="2017-01-17 19:54:17 -0500" MODIFIED_BY="[Empty name]">
<P>Non-Invasive Ventilation vs Continuous Positive Airway Pressure After Extubation in Very Low Birth Weight Infants</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-04-09 11:42:56 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 19:54:36 -0500" MODIFIED_BY="[Empty name]">
<P>Infants &lt; 1500 grams and &lt; 34 weeks with RDS and ready for extubation (&gt; 2 hours but &lt; 14 days)</P>
<P>Exclusion criteria: major congenital anomalies, presence of cardiovascular instability, intubation &lt; 2 hours, mechanical ventilation &gt; 14 days, using muscle relaxant, airway anomalies, consent not provided or refused</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-22 10:56:52 -0400" MODIFIED_BY="Anne Lawson">
<P>Non-synchronised NIPPV and NCPAP</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 19:56:27 -0500" MODIFIED_BY="[Empty name]">
<P>Primary: assessment of the need for re-intubation within the first 72 hours after extubation in the 2 groups</P>
<P>Criteria for failure were met by at least 1 of the following: pH &lt; 7.25 and pCO<SUB>2</SUB> &gt; 65 mmHg; more than 2 episodes of recurrent apnoea per hour associated with bradycardia during 4-hour continuous; 2 episodes of apnoea that required bag and mask ventilation any time during the study; PaO<SUB>2 </SUB>&lt; 50 mmHg with FiO<SUB>2</SUB> &gt; 0.6</P>
<P>Secondary: concerning respiratory support: total duration on endotracheal tube ventilation; total duration on NCPAP; total duration on supplemental O<SUB>2</SUB>, incidence of pneumothorax, BPD and death. Other outcomes included incidence of patent ductus arteriosus, necrotising enterocolitis, intraventricular haemorrhage grades 3 and 4, retinopathy of prematurity stage 3, time to full feeds and length of hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-04-09 11:45:33 -0400" MODIFIED_BY="[Empty name]">
<P>December 2011</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-04-09 11:45:49 -0400" MODIFIED_BY="[Empty name]">
<P>Alberto Estay, MD</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-04-09 11:46:14 -0400" MODIFIED_BY="[Empty name]">
<P>Expected completion date: June 2013</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-01-17 21:59:15 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT02396693">
<CHAR_STUDY_NAME MODIFIED="2017-01-17 19:58:16 -0500" MODIFIED_BY="[Empty name]">
<P>Successful Extubation and Non-invasive Ventilation in Preterm &#8804; 1500 grams</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-01-17 19:57:38 -0500" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 21:59:15 -0500" MODIFIED_BY="[Empty name]">
<P>Infants 26 to 34 weeks, 500 to 1500 grams, with diagnosis of RDS and first elective extubation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-18 12:30:54 -0500" MODIFIED_BY="[Empty name]">
<P>NIPPV (unspecified device) vs bubble CPAP</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 19:58:08 -0500" MODIFIED_BY="[Empty name]">
<P>Success rate of extubation, total duration of oxygen use, mechanical ventilation and bronchopulmonary dysplasia (BPD), days of oxygen use, mechanical ventilation</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-02-18 12:31:03 -0500" MODIFIED_BY="[Empty name]">
<P>August 2012</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-02-18 13:04:23 -0500" MODIFIED_BY="[Empty name]">
<P>Cintia Johnston</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-01-17 19:58:12 -0500" MODIFIED_BY="[Empty name]">
<P>Completed. No publication identified</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-01-17 21:59:44 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shi-2013">
<CHAR_STUDY_NAME MODIFIED="2017-01-17 19:58:42 -0500" MODIFIED_BY="[Empty name]">
<P>Nasal Intermittent Positive Pressure Ventilation in Newborn Infants With Respiratory Distress Syndrome</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-09-05 13:45:36 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 21:59:44 -0500" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria:</P>
<UL>
<LI>Newborn infants with birth weight &gt; 500 grams</LI>
<LI>Gestational age &gt; 24 completed weeks</LI>
<LI>Intention to manage the infant with non-invasive respiratory support (i.e. no endotracheal tube), when the infant is within the first 7 days of life and has never been intubated or has received &lt; 24 hours of total cumulative intubated respiratory support; or the infant is within the first 28 days of life, has been managed with intubated respiratory support for &#8805; 24 hours and is a candidate for extubation followed by non-invasive respiratory support</LI>
<LI>No known lethal congenital anomaly or genetic syndromes</LI>
<LI>Signed parental informed consent</LI>
</UL>
<P>Exclusion criteria:</P>
<UL>
<LI>Considered non-viable by clinician (decision not to administer effective therapies)</LI>
<LI>Life-threatening congenital abnormalities including congenital heart disease (excluding patent ductus arteriosus)</LI>
<LI>Infants known to require surgical treatment</LI>
<LI>Abnormalities of upper and lower airways</LI>
<LI>Neuromuscular disorders</LI>
<LI>Infants &gt; 28 days old who continue to require mechanical ventilation with an endotracheal tube</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-22 11:16:37 -0400" MODIFIED_BY="Anne Lawson">
<P>NIPPV via Bird ventilator or NCPAP (after extubation or as a primary mode of respiratory support)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 20:00:08 -0500" MODIFIED_BY="[Empty name]">
<P>Primary: incidence of mechanical ventilation via endotracheal tube after non-invasive respiratory support within 7 days</P>
<P>Secondary: overall clinical outcomes at 7 days', 28 days' and 36 weeks' postmenstrual age</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-09-05 13:49:01 -0400" MODIFIED_BY="[Empty name]">
<P>January 2008</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-09-05 13:49:27 -0400" MODIFIED_BY="[Empty name]">
<P>Yuan Shi, MD</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-01-17 20:00:21 -0500" MODIFIED_BY="[Empty name]">
<P>Expected completion date: December 2011; information last updated on Clinicaltrials.gov 17 December 2012. Part of the study population could be included in an updated version of this review.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-01-17 20:04:27 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Victor-2011">
<CHAR_STUDY_NAME MODIFIED="2017-01-17 20:01:24 -0500" MODIFIED_BY="[Empty name]">
<P>A Randomised Controlled Trial of Nasal Biphasic Positive Airway Pressure vs Nasal Continuous Positive Airway Pressure Following Extubation in Infants Less Than 30 Weeks&#8217; Gestation: Study Protocol for a Randomised Controlled Trial</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-01-17 20:01:31 -0500" MODIFIED_BY="[Empty name]">
<P>Unblinded multi-centre randomised trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-01-17 20:01:35 -0500" MODIFIED_BY="[Empty name]">
<P>Infants born before 30 weeks&#8217; gestation and less than 2 weeks old. Infants with congenital abnormalities and severe intraventricular haemorrhage will be excluded. 540 infants admitted to neonatal centres in England will be randomised at the time of first extubation attempt.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-01-17 20:02:36 -0500" MODIFIED_BY="[Empty name]">
<P>Unblinded multi-centre randomised trial comparing NCPAP vs n-BiPAP</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-01-17 20:04:13 -0500" MODIFIED_BY="[Empty name]">
<P>Primary aim of this study is to compare rate of extubation failure within 48 hours after first attempt at extubation.</P>
<P>Secondary aims are to compare effects of n-BiPAP and n-CPAP on the following outcomes.<BR/>&#8226; Maintenance of successful extubation for 7 days post extubation<BR/>&#8226; Oxygen requirement at 28 days of age and at 36 weeks&#8217; postmenstrual age<BR/>&#8226; Total days on ventilator, n-CPAP/n-BiPAP<BR/>&#8226; Number of ventilator days after first extubation attempt<BR/>&#8226; pH and partial pressure of carbon dioxide in the first postextubation blood gas<BR/>&#8226; Duration of hospital stay<BR/>&#8226; Rate of abdominal distension requiring cessation of feeds<BR/>&#8226; Rates of apnoea and bradycardia<BR/>&#8226; Age at transfer back to referral centre in days</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE/>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-01-17 20:04:27 -0500" MODIFIED_BY="[Empty name]">
<P>suresh.victor@manchester.ac.uk</P>
<P>1 Ward 68, 2nd Floor, St Mary&#8217;s Hospital for Women and Children, Manchester, UK M13 9WL</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2014-06-25 15:33:24 -0400" MODIFIED_BY="[Empty name]">
<P>Trial registration number: ISRCTN: ISRCTN18921778</P>
<P>http://www.trialsjournal.com/content/12/1/257 TRIALS</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>BPD: bronchopulmonary dysplasia; CPAP: continuous positive airway pressure; FiO<SUB>2</SUB>: fraction of inspired oxygen; n-BiPAP: noninvasive cycled respiratory support mechanism; n-CPAP/NCPAP: nasal continuous positive airway pressure; NIPPV: nasal intermittent positive pressure ventilation; PaCO<SUB>2</SUB>: partial pressure of carbon dioxide in arterial blood; pCO<SUB>2</SUB>: partial pressure of carbon dioxide; RDS: respiratory distress syndrome.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2017-01-17 18:08:40 -0500" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2017-01-17 18:08:33 -0500" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-18 10:03:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrington-2001">
<DESCRIPTION>
<P>Table of random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-18 10:04:37 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Friedlich-1999">
<DESCRIPTION>
<P>Unspecified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-18 10:05:44 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gao-2010">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-17 17:45:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jasani-2016">
<DESCRIPTION>
<P>Randomisation software</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-17 17:48:09 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kahramaner-2014">
<DESCRIPTION>
<P>Not specified in the text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-18 10:07:09 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khalaf--2001">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-18 10:07:55 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khorana-2008">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-24 18:47:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kirpalani-2013">
<DESCRIPTION>
<P>Web-based randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-17 18:03:17 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moretti-2008">
<DESCRIPTION>
<P>Not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-17 18:08:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Brien-2012">
<DESCRIPTION>
<P>Computer-generated random list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2017-01-17 17:48:12 -0500" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-14 18:52:48 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrington-2001">
<DESCRIPTION>
<P>Adequate: sequentially numbered sealed opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-14 18:54:00 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Friedlich-1999">
<DESCRIPTION>
<P>Adequate: sealed randomisation cards</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-17 17:39:06 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gao-2010">
<DESCRIPTION>
<P>No study flow diagram; unclear if exclusions; English translation imprecise and unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-24 18:49:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jasani-2016">
<DESCRIPTION>
<P>Opaque sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-17 17:48:12 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kahramaner-2014">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-14 18:54:36 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khalaf--2001">
<DESCRIPTION>
<P>Adequate: sealed randomisation cards</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-22 07:57:07 -0400" MODIFIED_BY="Anne Lawson" RESULT="UNKNOWN" STUDY_ID="STD-Khorana-2008">
<DESCRIPTION>
<P>Method of allocation concealment not specified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-24 18:47:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kirpalani-2013">
<DESCRIPTION>
<P>Randomisation immediately pre-extubation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-06-22 08:17:26 -0400" MODIFIED_BY="Anne Lawson" RESULT="YES" STUDY_ID="STD-Moretti-2008">
<DESCRIPTION>
<P>Sealed opaque envelopes to conceal allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-31 08:59:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Brien-2012">
<DESCRIPTION>
<P>Sealed opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2015-01-14 18:53:17 -0500" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2017-01-17 17:53:43 -0500" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-18 10:03:21 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Barrington-2001">
<DESCRIPTION>
<P>Unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-18 10:05:03 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Friedlich-1999">
<DESCRIPTION>
<P>Unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-05-24 11:01:57 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gao-2010">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-16 21:37:46 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jasani-2016">
<DESCRIPTION>
<P>Intervention could not be blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-01-17 17:48:14 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kahramaner-2014">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-01-17 17:51:05 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Khalaf--2001">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2017-01-17 17:53:43 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Khorana-2008">
<DESCRIPTION>
<P>Unblinded intervention </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-18 10:08:42 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kirpalani-2013">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-18 10:09:05 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moretti-2008">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-18 10:09:55 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-O_x0027_Brien-2012">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2017-01-17 17:55:57 -0500" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-18 10:03:23 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Barrington-2001">
<DESCRIPTION>
<P>Unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-02-18 10:05:06 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Friedlich-1999">
<DESCRIPTION>
<P>Unblinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-05-24 11:02:14 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gao-2010">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-01-17 17:55:57 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jasani-2016">
<DESCRIPTION>
<P>Despite criteria to define extubation failure, intervention was not blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-01-17 17:48:16 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kahramaner-2014">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-01-17 17:51:08 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Khalaf--2001">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-01-17 17:53:32 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Khorana-2008">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-05-24 18:46:21 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kirpalani-2013">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-05-24 18:46:30 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moretti-2008">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-05-24 18:46:44 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-O_x0027_Brien-2012">
<DESCRIPTION>
<P>Unblinded intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2017-01-17 18:08:37 -0500" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-17 17:34:23 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barrington-2001">
<DESCRIPTION>
<P>All participants accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-05-24 10:59:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Friedlich-1999">
<DESCRIPTION>
<P>All accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-05-24 11:02:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gao-2010">
<DESCRIPTION>
<P>No flow diagram</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-17 17:45:41 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jasani-2016">
<DESCRIPTION>
<P>All participants accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-17 17:48:18 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kahramaner-2014">
<DESCRIPTION>
<P>No flow diagram. No sample size calculation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-17 17:51:15 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khalaf--2001">
<DESCRIPTION>
<P>All participants accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-17 17:53:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khorana-2008">
<DESCRIPTION>
<P>All participants accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-17 17:59:44 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kirpalani-2013">
<DESCRIPTION>
<P>Flow diagram in full study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-05-24 11:11:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moretti-2008">
<DESCRIPTION>
<P>No flow diagram</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-01-17 18:08:37 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Brien-2012">
<DESCRIPTION>
<P>Flow diagram attached</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2017-01-17 18:08:40 -0500" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-17 17:34:26 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barrington-2001">
<DESCRIPTION>
<P>Secondary outcomes not listed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-18 10:04:51 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Friedlich-1999">
<DESCRIPTION>
<P>No outcomes listed, only objectives for the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-18 10:06:01 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gao-2010">
<DESCRIPTION>
<P>No outcomes listed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-16 21:37:14 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jasani-2016">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-17 17:48:34 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kahramaner-2014">
<DESCRIPTION>
<P>No outcomes specified in the Methods section</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-17 17:51:18 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khalaf--2001">
<DESCRIPTION>
<P>No outcomes stated besides objectives</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-17 17:54:09 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khorana-2008">
<DESCRIPTION>
<P>All specified secondary outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-14 18:55:53 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kirpalani-2013">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-05-24 11:11:28 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moretti-2008">
<DESCRIPTION>
<P>All outcomes accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-17 18:08:40 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-O_x0027_Brien-2012">
<DESCRIPTION>
<P>All outcomes accounted for and reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2017-01-22 16:25:35 -0500" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2017-01-22 16:25:35 -0500" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2017-01-17 18:32:52 -0500" MODIFIED_BY="[Empty name]">NIPPV versus NCPAP</TITLE>
<TABLE COLS="7" ROWS="23">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>NIPPV versus NCPAP</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>preterm neonates after extubation<BR/>
<B>Setting: </B>neonatal intensive care unit<BR/>
<B>Intervention: </B>NIPPV<BR/>
<B>Comparison: </B>NCPAP</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with NCPAP</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with NIPPV</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Respiratory failure post extubation</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.70<BR/>(0.60 to 0.80)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>1431<BR/>(10 studies)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Moderate<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Risk of bias: intervention unblinded</P>
<P/>
<P>OIS 554</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>413 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>289 per 1000<BR/>(248 to 330)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Endotracheal re-intubation during the week post extubation</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.76<BR/>(0.65 to 0.88)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>1301</P>
<P>(8 studies)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Moderate<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Risk of bias: intervention unblinded</P>
<P/>
<P>OIS 724</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>396 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>301 per 1000<BR/>(257 to 348)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Abdominal distension requiring cessation of feeds</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 1.27<BR/>(0.64 to 2.53)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>199</P>
<P>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Low<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Risk of bias: intervention unblinded Imprecision: wide confidence intervals</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>112 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>143 per 1000<BR/>(72 to 284)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Gastrointestinal perforation</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.94<BR/>(0.60 to 1.48)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>1066</P>
<P>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Moderate<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Risk of bias: intervention unblinded</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>66 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>62 per 1000<BR/>(40 to 98)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Necrotising enterocolitis</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.87<BR/>(0.64 to 1.19)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>1214<BR/>(6 studies)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Moderate<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Risk of bias: intervention unblinded</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>127 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>110 per 1000<BR/>(81 to 151)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Chronic lung disease (oxygen supplementation at 36 weeks)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.94<BR/>(0.80 to 1.10)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>1140</P>
<P>(6 studies)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Moderate<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Risk of bias: intervention unblinded</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>355 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>334 per 1000<BR/>(284 to 391)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Pulmonary air leak</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.48<BR/>(0.28 to 0.82)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>1229<BR/>(6 studies)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Moderate<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Risk of bias: intervention unblinded</P>
<P/>
<P>OIS 749</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>61 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>29 per 1000<BR/>(17 to 50)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Duration of hospitalisation (days)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Mean duration of hospitalisation (days) was 0</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Mean duration of hospitalisation (days) in the intervention group was 2.77 higher (0.04 to 5.51 higher)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>238<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Low<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk of bias: intervention unblinded Imprecision: wide confidence intervals</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Death before discharge</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.69<BR/>(0.48 to 0.99)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>1237<BR/>(6 studies)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Moderate<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Risk of bias: intervention unblinded</P>
<P/>
<P>Imprecision</P>
<P/>
<P>OIS 1844</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>104 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>72 per 1000<BR/>(50 to 103)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>CI: confidence interval; OR: odds ratio; RR: risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence.</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to the estimate of effect.<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different.<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect.<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Intervention unblinded.</P>
<P>
<SUP>b</SUP>Imprecise estimate (wide confidence intervals).</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2017-01-17 18:30:55 -0500" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2017-01-17 18:23:32 -0500" MODIFIED_BY="[Empty name]" NO="1">
<NAME>NIPPV versus NCPAP to prevent extubation failure</NAME>
<DICH_OUTCOME CHI2="23.876451025087515" CI_END="0.803318533879429" CI_START="0.6032769246470022" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6961490750052898" ESTIMABLE="YES" EVENTS_1="206" EVENTS_2="292" I2="62.30595581167611" I2_Q="79.61458544114763" ID="CMP-001.01" LOG_CI_END="-0.09511221303322195" LOG_CI_START="-0.21948328613748871" LOG_EFFECT_SIZE="-0.15729774958535533" METHOD="MH" MODIFIED="2017-01-17 18:23:15 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.004500981259299652" P_Q="0.026771931301905694" P_Z="7.132852668863347E-7" Q="4.905468059592389" RANDOM="NO" SCALE="100.0" SORT_BY="WEIGHT" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="724" TOTAL_2="707" WEIGHT="100.0" Z="4.957711087336755">
<NAME>Respiratory failure post extubation</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="17.656785492740692" CI_END="0.8439929381836128" CI_START="0.6302525406359061" DF="6" EFFECT_SIZE="0.7293344181985278" ESTIMABLE="YES" EVENTS_1="198" EVENTS_2="271" I2="66.01872972593564" ID="CMP-001.01.01" LOG_CI_END="-0.07366118716666697" LOG_CI_START="-0.20048539494635093" LOG_EFFECT_SIZE="-0.13707329105650898" MODIFIED="2016-02-17 15:41:43 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.007149681283420528" P_Z="2.268184777838004E-5" STUDIES="7" TAU2="0.0" TOTAL_1="639" TOTAL_2="636" WEIGHT="92.14428127279096" Z="4.236710300289697">
<NAME>Short (nasal) prongs</NAME>
<DICH_DATA CI_END="1.7049516306551555" CI_START="0.2777678570268953" EFFECT_SIZE="0.6881720430107527" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.2317120626026905" LOG_CI_START="-0.5563180117427864" LOG_EFFECT_SIZE="-0.16230297457004791" MODIFIED="2016-02-17 15:41:43 -0500" MODIFIED_BY="[Empty name]" ORDER="185" O_E="0.0" SE="0.4628927664823126" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="0.21426971326164876" WEIGHT="3.0050645496372206"/>
<DICH_DATA CI_END="0.9042517476033083" CI_START="0.12287630231913588" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.04371064322574003" LOG_CI_START="-0.9105318662135851" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="1" O_E="0.0" SE="0.5091750772173156" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.25925925925925924" WEIGHT="4.0713777769278465"/>
<DICH_DATA CI_END="0.6633878173154215" CI_START="0.039296460866996646" EFFECT_SIZE="0.16145833333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.17823250827820158" LOG_CI_START="-1.4056465614603522" LOG_EFFECT_SIZE="-0.7919395348692769" MODIFIED="2011-12-21 10:51:03 -0500" MODIFIED_BY="[Empty name]" ORDER="19" O_E="0.0" SE="0.7209890906367477" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.5198252688172044" WEIGHT="4.136002821006066"/>
<DICH_DATA CI_END="0.6048508966856184" CI_START="0.03575475823274725" EFFECT_SIZE="0.14705882352941177" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.2183516711780126" LOG_CI_START="-1.44666615423446" LOG_EFFECT_SIZE="-0.8325089127062363" ORDER="2" O_E="0.0" SE="0.7215180076021095" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.5205882352941177" WEIGHT="4.325838887985837"/>
<DICH_DATA CI_END="0.8617311511321657" CI_START="0.18567275859737423" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.06462820725139477" LOG_CI_START="-0.7312518100926805" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2011-12-21 10:54:52 -0500" MODIFIED_BY="[Empty name]" ORDER="20" O_E="0.0" SE="0.39157800414902433" STUDY_ID="STD-Gao-2010" TOTAL_1="25" TOTAL_2="25" VAR="0.15333333333333332" WEIGHT="5.089222221159808"/>
<DICH_DATA CI_END="1.213721495731571" CI_START="0.502896830270043" EFFECT_SIZE="0.7812660833762224" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="29" LOG_CI_END="0.08411904362308358" LOG_CI_START="-0.2985211017037254" LOG_EFFECT_SIZE="-0.10720102904032094" MODIFIED="2012-05-31 09:03:34 -0400" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.2247647154642346" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.05051917731771834" WEIGHT="9.69446938795442"/>
<DICH_DATA CI_END="1.0095008161362045" CI_START="0.7243424096435749" EFFECT_SIZE="0.8551165146909828" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" LOG_CI_END="0.004106674387440954" LOG_CI_START="-0.1400560864754043" LOG_EFFECT_SIZE="-0.06797470604398165" MODIFIED="2013-04-16 12:29:17 -0400" MODIFIED_BY="[Empty name]" ORDER="47" O_E="0.0" SE="0.08468191934801064" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="423" TOTAL_2="422" VAR="0.0071710274644629785" WEIGHT="61.822305628119764"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.2551226176433943" CI_END="0.65098043420162" CI_START="0.14468477497929494" DF="2" EFFECT_SIZE="0.30689893717376265" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="21" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="-0.1864320643441989" LOG_CI_START="-0.8395771668102032" LOG_EFFECT_SIZE="-0.513004615577201" MODIFIED="2016-02-17 15:42:29 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.53389255518448" P_Z="0.002077955750603659" STUDIES="3" TAU2="0.0" TOTAL_1="85" TOTAL_2="71" WEIGHT="7.855718727209039" Z="3.0788581791025944">
<NAME>Long (nasopharyngeal) prongs</NAME>
<DICH_DATA CI_END="2.4772689203208653" CI_START="0.1009175862778834" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3939731540513527" LOG_CI_START="-0.9960331453793151" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2011-12-21 10:55:25 -0500" MODIFIED_BY="[Empty name]" ORDER="21" O_E="0.0" SE="0.816496580927726" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.6666666666666667" WEIGHT="1.3571259256426156"/>
<DICH_DATA CI_END="0.9147035714412431" CI_START="0.016641228558704663" EFFECT_SIZE="0.12337662337662338" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="-0.03871962521779245" LOG_CI_START="-1.7788146145494759" LOG_EFFECT_SIZE="-0.9087671198836341" ORDER="3" O_E="0.0" SE="1.0221404103425464" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="1.044771018455229" WEIGHT="2.5487486896214975"/>
<DICH_DATA CI_END="0.9351606398054496" CI_START="0.13779727772531192" EFFECT_SIZE="0.358974358974359" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.029113780583416606" LOG_CI_START="-0.8607593621131058" LOG_EFFECT_SIZE="-0.4449365713482612" MODIFIED="2016-02-17 15:42:29 -0500" MODIFIED_BY="[Empty name]" ORDER="186" O_E="0.0" SE="0.4885127313025615" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="0.23864468864468869" WEIGHT="3.9498441119449264"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="13.714525996407081" CI_END="0.8763180797113745" CI_START="0.6512659034444888" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7554575341393902" ESTIMABLE="YES" EVENTS_1="194" EVENTS_2="256" I2="48.959227596827965" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.05733822809009767" LOG_CI_START="-0.1862416584043504" LOG_EFFECT_SIZE="-0.121789943247224" METHOD="MH" MODIFIED="2016-06-20 10:15:09 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.056498113631906266" P_Q="1.0" P_Z="2.12554438509844E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="654" TOTAL_2="647" WEIGHT="100.00000000000001" Z="3.703608226124034">
<NAME>Endotracheal re-intubation</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.521215975389076" CI_START="0.22117943611706017" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6552552534796293" LOG_CI_START="-0.6552552534796292" LOG_EFFECT_SIZE="0.0" ORDER="4" O_E="0.0" SE="0.769800358919501" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.5925925925925926" WEIGHT="1.1687815595973303"/>
<DICH_DATA CI_END="12.889084259427214" CI_START="0.057868173842490454" EFFECT_SIZE="0.8636363636363636" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1102220627990844" LOG_CI_START="-1.237560222537839" LOG_EFFECT_SIZE="-0.06366907986937727" ORDER="5" O_E="0.0" SE="1.3790989361166537" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="1.9019138755980862" WEIGHT="0.4181007205063621"/>
<DICH_DATA CI_END="0.8617311511321657" CI_START="0.18567275859737423" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.06462820725139477" LOG_CI_START="-0.7312518100926805" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2011-12-21 11:26:06 -0500" MODIFIED_BY="[Empty name]" ORDER="30" O_E="0.0" SE="0.39157800414902433" STUDY_ID="STD-Gao-2010" TOTAL_1="25" TOTAL_2="25" VAR="0.15333333333333332" WEIGHT="5.843907797986652"/>
<DICH_DATA CI_END="0.7423065041733587" CI_START="0.04195284338346285" EFFECT_SIZE="0.17647058823529413" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.12941673409338317" LOG_CI_START="-1.3772385992238398" LOG_EFFECT_SIZE="-0.7533276666586115" ORDER="6" O_E="0.0" SE="0.732976740395481" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.5372549019607843" WEIGHT="4.139434690240545"/>
<DICH_DATA CI_END="2.4772689203208653" CI_START="0.1009175862778834" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3939731540513527" LOG_CI_START="-0.9960331453793151" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2011-12-21 11:26:17 -0500" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.816496580927726" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.6666666666666667" WEIGHT="1.5583754127964404"/>
<DICH_DATA CI_END="1.0095008161362045" CI_START="0.7243424096435749" EFFECT_SIZE="0.8551165146909828" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" LOG_CI_END="0.004106674387440954" LOG_CI_START="-0.1400560864754043" LOG_EFFECT_SIZE="-0.06797470604398165" MODIFIED="2013-04-16 12:31:59 -0400" MODIFIED_BY="[Empty name]" ORDER="53" O_E="0.0" SE="0.08468191934801064" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="423" TOTAL_2="422" VAR="0.0071710274644629785" WEIGHT="70.98999380446554"/>
<DICH_DATA CI_END="0.6633878173154215" CI_START="0.039296460866996646" EFFECT_SIZE="0.16145833333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.17823250827820158" LOG_CI_START="-1.4056465614603522" LOG_EFFECT_SIZE="-0.7919395348692769" MODIFIED="2011-12-21 11:26:43 -0500" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.7209890906367477" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.5198252688172044" WEIGHT="4.749334591379628"/>
<DICH_DATA CI_END="1.213721495731571" CI_START="0.502896830270043" EFFECT_SIZE="0.7812660833762224" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="29" LOG_CI_END="0.08411904362308358" LOG_CI_START="-0.2985211017037254" LOG_EFFECT_SIZE="-0.10720102904032094" MODIFIED="2012-05-31 09:10:27 -0400" MODIFIED_BY="[Empty name]" ORDER="46" O_E="0.0" SE="0.2247647154642346" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.05051917731771834" WEIGHT="11.132071423027513"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="18.275845943030102" CI_END="0.8476743637541232" CI_START="0.6300456396360253" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7308033502348819" ESTIMABLE="YES" EVENTS_1="193" EVENTS_2="263" I2="67.16978235260167" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.07177095102751746" LOG_CI_START="-0.20062798971441817" LOG_EFFECT_SIZE="-0.1361994703709678" METHOD="MH" MODIFIED="2017-01-17 18:23:32 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.00557859044281539" P_Q="1.0" P_Z="3.423581819295353E-5" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="636" TOTAL_2="630" WEIGHT="100.00000000000003" Z="4.143290259667658">
<NAME>Post hoc analysis (high-quality studies): respiratory failure post extubation</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9042517476033083" CI_START="0.12287630231913588" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.04371064322574003" LOG_CI_START="-0.9105318662135851" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2016-05-24 18:38:31 -0400" MODIFIED_BY="[Empty name]" ORDER="1" O_E="0.0" SE="0.5091750772173156" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.25925925925925924" WEIGHT="4.543755315270411"/>
<DICH_DATA CI_END="0.9147035714412431" CI_START="0.016641228558704663" EFFECT_SIZE="0.12337662337662338" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="-0.03871962521779245" LOG_CI_START="-1.7788146145494759" LOG_EFFECT_SIZE="-0.9087671198836341" MODIFIED="2016-05-24 18:38:58 -0400" MODIFIED_BY="[Empty name]" ORDER="3" O_E="0.0" SE="1.0221404103425464" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="1.044771018455229" WEIGHT="2.8444647095595252"/>
<DICH_DATA CI_END="1.7049516306551555" CI_START="0.2777678570268953" EFFECT_SIZE="0.6881720430107527" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.2317120626026905" LOG_CI_START="-0.5563180117427864" LOG_EFFECT_SIZE="-0.16230297457004791" MODIFIED="2016-05-24 18:38:15 -0400" MODIFIED_BY="[Empty name]" ORDER="185" O_E="0.0" SE="0.4628927664823126" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="0.21426971326164876" WEIGHT="3.3537241612710176"/>
<DICH_DATA CI_END="0.6048508966856184" CI_START="0.03575475823274725" EFFECT_SIZE="0.14705882352941177" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.2183516711780126" LOG_CI_START="-1.44666615423446" LOG_EFFECT_SIZE="-0.8325089127062363" MODIFIED="2016-05-24 18:38:31 -0400" MODIFIED_BY="[Empty name]" ORDER="2" O_E="0.0" SE="0.7215180076021095" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.5205882352941177" WEIGHT="4.827740022474812"/>
<DICH_DATA CI_END="1.0095008161362045" CI_START="0.7243424096435749" EFFECT_SIZE="0.8551165146909828" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" LOG_CI_END="0.004106674387440954" LOG_CI_START="-0.1400560864754043" LOG_EFFECT_SIZE="-0.06797470604398165" MODIFIED="2016-05-24 18:38:46 -0400" MODIFIED_BY="[Empty name]" ORDER="47" O_E="0.0" SE="0.08468191934801064" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="423" TOTAL_2="422" VAR="0.0071710274644629785" WEIGHT="68.99517686418301"/>
<DICH_DATA CI_END="0.6633878173154215" CI_START="0.039296460866996646" EFFECT_SIZE="0.16145833333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.17823250827820158" LOG_CI_START="-1.4056465614603522" LOG_EFFECT_SIZE="-0.7919395348692769" MODIFIED="2016-05-24 18:38:31 -0400" MODIFIED_BY="[Empty name]" ORDER="19" O_E="0.0" SE="0.7209890906367477" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.5198252688172044" WEIGHT="4.615878415512798"/>
<DICH_DATA CI_END="1.213721495731571" CI_START="0.502896830270043" EFFECT_SIZE="0.7812660833762224" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="29" LOG_CI_END="0.08411904362308358" LOG_CI_START="-0.2985211017037254" LOG_EFFECT_SIZE="-0.10720102904032094" MODIFIED="2016-05-24 18:38:46 -0400" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.2247647154642346" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.05051917731771834" WEIGHT="10.81926051172844"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2016-11-22 18:12:42 -0500" MODIFIED_BY="[Empty name]" NO="2">
<NAME>NIPPV versus NCPAP and gastrointestinal complications</NAME>
<DICH_OUTCOME CHI2="1.7382091494906278" CI_END="2.5295485038829177" CI_START="0.6370758434898834" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2694543106231837" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.40304301138512433" LOG_CI_START="-0.19580886209413448" LOG_EFFECT_SIZE="0.10361707464549492" METHOD="MH" MODIFIED="2016-11-22 18:12:42 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4193272147992084" P_Q="1.0" P_Z="0.49761300291445953" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="101" TOTAL_2="98" WEIGHT="100.0" Z="0.6782503102433804">
<NAME>Abdominal distension leading to cessation of feeds</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours nCPAP</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.9391427389533935" CI_START="0.7051731713880003" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.5954017182086463" LOG_CI_START="-0.15170421897593347" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-04-08 11:20:23 -0400" MODIFIED_BY="[Empty name]" ORDER="55" O_E="0.0" SE="0.43885372573625553" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.1925925925925926" WEIGHT="52.483048111075234"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-08 11:20:05 -0400" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.0" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.3734791926643415" CI_START="0.16161945612107143" EFFECT_SIZE="0.6193548387096774" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.37538542878634884" LOG_CI_START="-0.791506359047795" LOG_EFFECT_SIZE="-0.20806046513072304" MODIFIED="2016-02-17 15:53:46 -0500" MODIFIED_BY="[Empty name]" ORDER="187" O_E="0.0" SE="0.6854380123812833" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="0.4698252688172043" WEIGHT="43.04165321278657"/>
<DICH_DATA CI_END="66.4433184667098" CI_START="0.12341968180365896" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2013-04-08 11:19:56 -0400" MODIFIED_BY="[Empty name]" ORDER="57" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-Khalaf--2001" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="4.475298676138198"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.5664679425717827E-31" CI_END="1.4846864042006065" CI_START="0.5959841811900155" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9406644518272427" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" I2="100.0" I2_Q="100.0" ID="CMP-002.02" LOG_CI_END="0.17163473156059658" LOG_CI_START="-0.22476526729509735" LOG_EFFECT_SIZE="-0.026565267867250365" METHOD="MH" MODIFIED="2015-12-15 17:05:50 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.792782484394046" Q="8.88051191201309E-34" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="537" TOTAL_2="529" WEIGHT="100.0" Z="0.26269913425718466">
<NAME>Gastrointestinal perforation</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours nCPAP</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-08 11:22:31 -0400" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="0.0" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-08 11:22:49 -0400" MODIFIED_BY="[Empty name]" ORDER="59" O_E="0.0" SE="0.0" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-08 11:23:08 -0400" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.0" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-08 11:23:22 -0400" MODIFIED_BY="[Empty name]" ORDER="61" O_E="0.0" SE="0.0" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.4846864042006063" CI_START="0.5959841811900155" EFFECT_SIZE="0.9406644518272426" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" LOG_CI_END="0.1716347315605965" LOG_CI_START="-0.22476526729509735" LOG_EFFECT_SIZE="-0.026565267867250417" MODIFIED="2013-04-16 12:33:12 -0400" MODIFIED_BY="[Empty name]" ORDER="62" O_E="0.0" SE="0.2328473215394751" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="430" TOTAL_2="429" VAR="0.054217875148107705" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9064277668229357" CI_END="1.1874094135070667" CI_START="0.6426761240386012" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8735672152271229" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="76" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.07460048758984546" LOG_CI_START="-0.19200783419710815" LOG_EFFECT_SIZE="-0.05870367330363132" METHOD="MH" MODIFIED="2016-02-17 15:55:14 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9236368755339137" P_Q="1.0" P_Z="0.3880731591851805" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="614" TOTAL_2="600" WEIGHT="100.0" Z="0.863116984977422">
<NAME>Necrotising enterocolitis</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours nCPAP</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-08 11:25:39 -0400" MODIFIED_BY="[Empty name]" ORDER="63" O_E="0.0" SE="0.0" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.794781034462849" CI_START="0.10750237766842106" EFFECT_SIZE="0.717948717948718" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.68076877882767" LOG_CI_START="-0.9685819301962298" LOG_EFFECT_SIZE="-0.14390657568427997" MODIFIED="2016-02-17 15:55:14 -0500" MODIFIED_BY="[Empty name]" ORDER="188" O_E="0.0" SE="0.9688367708983225" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="0.9386446886446886" WEIGHT="3.050410508623428"/>
<DICH_DATA CI_END="2.9822977569213727" CI_START="0.037256880488624015" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4745510018709087" LOG_CI_START="-1.4287935113102337" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2013-04-08 11:25:57 -0400" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="1.1180339887498947" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="1.2499999999999998" WEIGHT="3.930336616880186"/>
<DICH_DATA CI_END="1.240338626008517" CI_START="0.6315087969955417" EFFECT_SIZE="0.8850337584396099" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="62" LOG_CI_END="0.09354026849299439" LOG_CI_START="-0.19962059529073903" LOG_EFFECT_SIZE="-0.05304016339887233" MODIFIED="2013-04-16 12:34:58 -0400" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.17220414255624494" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="430" TOTAL_2="429" VAR="0.029654266713531528" WEIGHT="81.32151665194083"/>
<DICH_DATA CI_END="6.455662881691861" CI_START="0.1453726100167811" EFFECT_SIZE="0.96875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8099408432066292" LOG_CI_START="-0.8375174121778957" LOG_EFFECT_SIZE="-0.013788284485633297" MODIFIED="2013-04-08 11:26:38 -0400" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.967725134262757" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.936491935483871" WEIGHT="2.6618152749241473"/>
<DICH_DATA CI_END="2.7778003940885467" CI_START="0.38181021280260546" EFFECT_SIZE="1.0298507462686568" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4437010351883466" LOG_CI_START="-0.4181524591154887" LOG_EFFECT_SIZE="0.012774288036428919" MODIFIED="2013-04-08 11:26:56 -0400" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="0.5062570087976748" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.25629615895676894" WEIGHT="9.035920947631409"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2016-08-08 14:06:53 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>NIPPV versus NCPAP to improve pulmonary outcomes</NAME>
<DICH_OUTCOME CHI2="10.20091161921502" CI_END="1.096993517829687" CI_START="0.7980088734487587" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9356337752261081" ESTIMABLE="YES" EVENTS_1="193" EVENTS_2="199" I2="50.98477286498871" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.04020406132209934" LOG_CI_START="-0.09799227949086738" LOG_EFFECT_SIZE="-0.028894109084383994" METHOD="MH" MODIFIED="2016-06-20 10:15:31 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.06973864213278547" P_Q="1.0" P_Z="0.4124561258421433" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="580" TOTAL_2="560" WEIGHT="100.0" Z="0.819579054519374">
<NAME>Chronic lung disease (oxygen supplementation at 36 weeks)</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>nCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours nCPAP</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3728897852588204" CI_START="0.466169977278508" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="15" LOG_CI_END="0.13763567374427166" LOG_CI_START="-0.33145569976038447" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2013-04-08 11:30:53 -0400" MODIFIED_BY="[Empty name]" ORDER="68" O_E="0.0" SE="0.2755465948363832" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.07592592592592592" WEIGHT="7.40300482995809"/>
<DICH_DATA CI_END="0.9069420327208643" CI_START="0.050759286566747525" EFFECT_SIZE="0.21455938697318008" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.04242047002256124" LOG_CI_START="-1.2944844906415995" LOG_EFFECT_SIZE="-0.6684524803320805" MODIFIED="2016-02-17 15:55:55 -0500" MODIFIED_BY="[Empty name]" ORDER="189" O_E="0.0" SE="0.7354686035284823" STUDY_ID="STD-Jasani-2016" TOTAL_1="29" TOTAL_2="28" VAR="0.5409140667761358" WEIGHT="4.519729264605991"/>
<DICH_DATA CI_END="1.1642941116095282" CI_START="0.37613565299764" EFFECT_SIZE="0.6617647058823529" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" LOG_CI_END="0.06606270103095975" LOG_CI_START="-0.42465549889274506" LOG_EFFECT_SIZE="-0.17929639893089266" MODIFIED="2013-04-08 11:31:23 -0400" MODIFIED_BY="[Empty name]" ORDER="69" O_E="0.0" SE="0.28825029972944977" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.08308823529411763" WEIGHT="8.390072140619168"/>
<DICH_DATA CI_END="1.292788865416217" CI_START="0.8828469606506252" EFFECT_SIZE="1.0683326825458805" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="130" LOG_CI_END="0.11152760293768939" LOG_CI_START="-0.05411457377839148" LOG_EFFECT_SIZE="0.028706514579648932" MODIFIED="2013-04-16 12:37:27 -0400" MODIFIED_BY="[Empty name]" ORDER="70" O_E="0.0" SE="0.09729903454502449" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="394" TOTAL_2="380" VAR="0.009467102123393868" WEIGHT="65.3198806874166"/>
<DICH_DATA CI_END="1.2303695921450277" CI_START="0.06226611265570253" EFFECT_SIZE="0.2767857142857143" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.09003558925936458" LOG_CI_START="-1.2057482469311824" LOG_EFFECT_SIZE="-0.5578563288359089" MODIFIED="2013-04-08 11:32:05 -0400" MODIFIED_BY="[Empty name]" ORDER="71" O_E="0.0" SE="0.7611498396117639" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.5793490783410138" WEIGHT="3.5095726601282795"/>
<DICH_DATA CI_END="1.5539689967039805" CI_START="0.5863418296799888" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.1914423499251933" LOG_CI_START="-0.23184912210176722" LOG_EFFECT_SIZE="-0.02020338608828695" MODIFIED="2013-04-09 11:03:26 -0400" MODIFIED_BY="[Empty name]" ORDER="72" O_E="0.0" SE="0.24864350599521612" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="64" TOTAL_2="64" VAR="0.06182359307359307" WEIGHT="10.857740417271865"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.6581673638214063" CI_END="0.8214986618555935" CI_START="0.2786368639047275" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.478434750871394" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="37" I2="0.0" I2_Q="100.0" ID="CMP-003.02" LOG_CI_END="-0.08539313965339305" LOG_CI_START="-0.5549614265649515" LOG_EFFECT_SIZE="-0.32017728310917226" METHOD="MH" MODIFIED="2016-08-08 14:06:53 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7983018174074368" P_Q="0.0" P_Z="0.007521641712985021" Q="1.620122072047577E-31" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="618" TOTAL_2="611" WEIGHT="100.0" Z="2.6728208060611918">
<NAME>Air leaks</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>nCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours nCPAP</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4497421980485377" CI_START="0.17244445276996065" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.16129078022171156" LOG_CI_START="-0.763350771549674" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2013-04-08 11:34:51 -0400" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="0.5431390245600108" STUDY_ID="STD-Gao-2010" TOTAL_1="25" TOTAL_2="25" VAR="0.29500000000000004" WEIGHT="21.428404412106588"/>
<DICH_DATA CI_END="3.1322503103103903" CI_START="0.037798763976709754" EFFECT_SIZE="0.34408602150537637" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.495856460934691" LOG_CI_START="-1.422522401402749" LOG_EFFECT_SIZE="-0.4633329702340291" MODIFIED="2016-02-17 15:56:36 -0500" MODIFIED_BY="[Empty name]" ORDER="190" O_E="0.0" SE="1.1268652398655326" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="1.2698252688172043" WEIGHT="7.908101628277431"/>
<DICH_DATA CI_END="3.7672503571186633" CI_START="0.03420600655264412" EFFECT_SIZE="0.358974358974359" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5760244827204464" LOG_CI_START="-1.4658976254169689" LOG_EFFECT_SIZE="-0.4449365713482612" MODIFIED="2016-02-17 15:57:03 -0500" MODIFIED_BY="[Empty name]" ORDER="191" O_E="0.0" SE="1.1994351539973676" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="1.4386446886446886" WEIGHT="6.236625164717589"/>
<DICH_DATA CI_END="1.2842472300778474" CI_START="0.29354805518736693" EFFECT_SIZE="0.6139937106918238" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="18" LOG_CI_END="0.1086486376915249" LOG_CI_START="-0.5323207925617145" LOG_EFFECT_SIZE="-0.21183607743509478" MODIFIED="2013-04-16 12:39:30 -0400" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.37650861618060366" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="424" TOTAL_2="426" VAR="0.14175873805823314" WEIGHT="48.10046543329337"/>
<DICH_DATA CI_END="1.2649955552013255" CI_START="0.020607814229536094" EFFECT_SIZE="0.16145833333333334" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10208899953956095" LOG_CI_START="-1.6859680692781147" LOG_EFFECT_SIZE="-0.7919395348692769" MODIFIED="2013-04-08 11:35:34 -0400" MODIFIED_BY="[Empty name]" ORDER="75" O_E="0.0" SE="1.0503135732487408" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="1.1031586021505377" WEIGHT="16.326403361605017"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-08 11:35:48 -0400" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.0" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2017-01-17 18:23:57 -0500" MODIFIED_BY="[Empty name]" NO="4">
<NAME>NIPPV versus NCPAP and mortality</NAME>
<DICH_OUTCOME CHI2="5.640818028614893" CI_END="0.9904994047364962" CI_START="0.4847303464132133" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6929106144229595" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="64" I2="29.088299255379404" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-0.0041457811246594185" LOG_CI_START="-0.3144997905366737" LOG_EFFECT_SIZE="-0.15932278583066659" METHOD="MH" MODIFIED="2017-01-17 18:23:57 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.22762601413548467" P_Q="1.0" P_Z="0.04418544698339047" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="623" TOTAL_2="614" WEIGHT="100.0" Z="2.012327295118918">
<NAME>Death before discharge</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.6183017780452293" CI_START="0.10174120499529542" EFFECT_SIZE="0.5161290322580645" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4180197006512073" LOG_CI_START="-0.9925031230079031" LOG_EFFECT_SIZE="-0.2872417111783479" MODIFIED="2016-02-17 15:57:58 -0500" MODIFIED_BY="[Empty name]" ORDER="193" O_E="0.0" SE="0.8285480888179461" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="0.686491935483871" WEIGHT="5.9901301498025585"/>
<DICH_DATA CI_END="0.6376564534210859" CI_START="0.060125296135299884" EFFECT_SIZE="0.1958041958041958" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" LOG_CI_END="-0.19541324066474453" LOG_CI_START="-1.2209427715809407" LOG_EFFECT_SIZE="-0.7081780061228425" MODIFIED="2016-02-17 15:57:38 -0500" MODIFIED_BY="[Empty name]" ORDER="192" O_E="0.0" SE="0.6024011229132237" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="0.36288711288711284" WEIGHT="19.486669181356977"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-04-08 11:39:26 -0400" MODIFIED_BY="[Empty name]" ORDER="77" O_E="0.0" SE="0.0" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.3133344115120864" CI_START="0.5548723087564983" EFFECT_SIZE="0.8536585365853658" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="41" LOG_CI_END="0.11837532363907724" LOG_CI_START="-0.25580694837799695" LOG_EFFECT_SIZE="-0.06871581236945987" MODIFIED="2013-04-16 12:40:47 -0400" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="0.2197965188149483" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="430" TOTAL_2="430" VAR="0.048310509683169925" WEIGHT="62.38913781024197"/>
<DICH_DATA CI_END="4.4389760930612585" CI_START="0.21141735004317108" EFFECT_SIZE="0.96875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6472828060572356" LOG_CI_START="-0.6748593750285022" LOG_EFFECT_SIZE="-0.013788284485633297" MODIFIED="2013-04-08 11:40:07 -0400" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="0.7766328618791105" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.6031586021505376" WEIGHT="4.637520115976174"/>
<DICH_DATA CI_END="2.484093004489646" CI_START="0.1537033117368657" EFFECT_SIZE="0.6179104477611941" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.39516785180265446" LOG_CI_START="-0.8133167749625093" LOG_EFFECT_SIZE="-0.20907446157992746" MODIFIED="2013-04-08 11:40:47 -0400" MODIFIED_BY="[Empty name]" ORDER="80" O_E="0.0" SE="0.7098698518572377" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.5039152065758166" WEIGHT="7.4965427426223314"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2016-02-17 22:06:34 -0500" MODIFIED_BY="[Empty name]" NO="5">
<NAME>NIPPV versus NCPAP and duration of hospital admission</NAME>
<CONT_OUTCOME CHI2="4.5345932702144935" CI_END="5.509028222686153" CI_START="0.038609917685175965" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="2.7738190701856644" ESTIMABLE="YES" I2="33.84191654617581" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2016-02-17 22:06:34 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.20922537600510516" P_Q="1.0" P_Z="0.04685255670483679" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="122" TOTAL_2="116" UNITS="" WEIGHT="100.0" Z="1.9876306249649085">
<NAME>Duration of hospital admission (days)</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<CONT_DATA CI_END="7.093619988568964" CI_START="-19.093619988568964" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="86.0" MEAN_2="92.0" MODIFIED="2013-04-08 11:43:44 -0400" MODIFIED_BY="[Empty name]" ORDER="81" SD_1="23.0" SD_2="26.0" SE="6.680541118025518" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" WEIGHT="4.363767638350555"/>
<CONT_DATA CI_END="5.672126555569159" CI_START="-12.632126555569167" EFFECT_SIZE="-3.480000000000004" ESTIMABLE="YES" MEAN_1="33.3" MEAN_2="36.78" MODIFIED="2016-02-17 15:59:28 -0500" MODIFIED_BY="[Empty name]" ORDER="194" SD_1="18.43" SD_2="16.81" SE="4.669538128128869" STUDY_ID="STD-Jasani-2016" TOTAL_1="29" TOTAL_2="28" WEIGHT="8.93176006833737"/>
<CONT_DATA CI_END="18.175583522496325" CI_START="-26.175583522496325" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="72.0" MEAN_2="76.0" MODIFIED="2013-04-08 11:44:18 -0400" MODIFIED_BY="[Empty name]" ORDER="82" SD_1="46.65" SD_2="43.82" SE="11.314281128334244" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" WEIGHT="1.5213564108455593"/>
<CONT_DATA CI_END="6.9635603800741155" CI_START="1.036439619925884" EFFECT_SIZE="4.0" ESTIMABLE="YES" MEAN_1="62.0" MEAN_2="58.0" MODIFIED="2013-04-08 11:44:46 -0400" MODIFIED_BY="[Empty name]" ORDER="83" SD_1="6.0" SD_2="6.0" SE="1.5120483863225558" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" WEIGHT="85.18311588246652"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2017-01-17 18:24:17 -0500" MODIFIED_BY="[Empty name]" NO="6">
<NAME>NIPPV versus NCPAP and apnoea</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.7210215336301546" CI_START="-7.921021533630154" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.01" MODIFIED="2017-01-17 18:24:17 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.20756455723994438" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="27" TOTAL_2="27" UNITS="" WEIGHT="100.0" Z="1.2602906478824867">
<NAME>Rates of apnoea (episodes/24 h)</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>nCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours nCPAP</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.7210215336301546" CI_START="-7.921021533630154" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="8.2" MODIFIED="2013-04-08 11:48:49 -0400" MODIFIED_BY="[Empty name]" ORDER="84" SD_1="4.4" SD_2="12.0" SE="2.4597500625816378" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2017-01-17 18:28:01 -0500" MODIFIED_BY="[Empty name]" NO="7">
<NAME>NIPPV versus NCPAP (synchronised vs non-synchronised)</NAME>
<DICH_OUTCOME CHI2="23.876451025087523" CI_END="0.8033185338794289" CI_START="0.6032769246470021" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6961490750052897" ESTIMABLE="YES" EVENTS_1="206" EVENTS_2="292" I2="62.30595581167612" I2_Q="90.61152912500278" ID="CMP-007.01" LOG_CI_END="-0.09511221303322202" LOG_CI_START="-0.2194832861374888" LOG_EFFECT_SIZE="-0.15729774958535542" METHOD="MH" MODIFIED="2017-01-17 18:25:00 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.004500981259300096" P_Q="2.3668833698975433E-5" P_Z="7.132852668863307E-7" Q="21.302723591828684" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="724" TOTAL_2="707" WEIGHT="100.0" Z="4.957711087336756">
<NAME>Respiratory failure post extubation</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.1670489254087726" CI_END="0.4119022648200418" CI_START="0.14984041239418547" DF="4" EFFECT_SIZE="0.24843430766851438" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="58" I2="0.0" ID="CMP-007.01.01" LOG_CI_END="-0.3852058200947053" LOG_CI_START="-0.8243710403560395" LOG_EFFECT_SIZE="-0.6047884302253723" MODIFIED="2017-01-17 18:24:52 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.530269613675493" P_Z="6.72911234690063E-8" STUDIES="5" TAU2="0.0" TOTAL_1="140" TOTAL_2="132" WEIGHT="20.171190396701057" Z="5.398257816513206">
<NAME>Synchronised NIPPV</NAME>
<DICH_DATA CI_END="0.9042517476033083" CI_START="0.12287630231913588" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.04371064322574003" LOG_CI_START="-0.9105318662135851" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2015-12-15 17:45:37 -0500" MODIFIED_BY="[Empty name]" ORDER="586" O_E="0.0" SE="0.5091750772173156" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.25925925925925924" WEIGHT="4.0713777769278465"/>
<DICH_DATA CI_END="0.9147035714412431" CI_START="0.016641228558704663" EFFECT_SIZE="0.12337662337662338" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="-0.03871962521779245" LOG_CI_START="-1.7788146145494759" LOG_EFFECT_SIZE="-0.9087671198836341" MODIFIED="2015-12-15 17:45:37 -0500" MODIFIED_BY="[Empty name]" ORDER="587" O_E="0.0" SE="1.0221404103425464" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="1.044771018455229" WEIGHT="2.5487486896214975"/>
<DICH_DATA CI_END="0.8617311511321657" CI_START="0.18567275859737423" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.06462820725139477" LOG_CI_START="-0.7312518100926805" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2015-12-15 17:45:37 -0500" MODIFIED_BY="[Empty name]" ORDER="588" O_E="0.0" SE="0.39157800414902433" STUDY_ID="STD-Gao-2010" TOTAL_1="25" TOTAL_2="25" VAR="0.15333333333333332" WEIGHT="5.089222221159808"/>
<DICH_DATA CI_END="0.6048508966856184" CI_START="0.03575475823274725" EFFECT_SIZE="0.14705882352941177" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.2183516711780126" LOG_CI_START="-1.44666615423446" LOG_EFFECT_SIZE="-0.8325089127062363" MODIFIED="2015-12-15 17:45:37 -0500" MODIFIED_BY="[Empty name]" ORDER="589" O_E="0.0" SE="0.7215180076021095" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.5205882352941177" WEIGHT="4.325838887985837"/>
<DICH_DATA CI_END="0.6633878173154215" CI_START="0.039296460866996646" EFFECT_SIZE="0.16145833333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.17823250827820158" LOG_CI_START="-1.4056465614603522" LOG_EFFECT_SIZE="-0.7919395348692769" MODIFIED="2015-12-15 17:45:37 -0500" MODIFIED_BY="[Empty name]" ORDER="590" O_E="0.0" SE="0.7209890906367477" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.5198252688172044" WEIGHT="4.136002821006066"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.259584399436412" CI_END="0.9310841693850087" CI_START="0.456427014571698" DF="3" EFFECT_SIZE="0.6518987404094049" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="52" I2="0.0" ID="CMP-007.01.02" LOG_CI_END="-0.03101105731386404" LOG_CI_START="-0.34062865888087596" LOG_EFFECT_SIZE="-0.18581985809737" MODIFIED="2017-01-17 18:25:00 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5203077545918282" P_Z="0.01864363324027137" STUDIES="4" TAU2="0.0" TOTAL_1="161" TOTAL_2="153" WEIGHT="18.006503975179182" Z="2.352580910387056">
<NAME>Non-synchronised NIPPV</NAME>
<DICH_DATA CI_END="1.7049516306551555" CI_START="0.2777678570268953" EFFECT_SIZE="0.6881720430107527" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.2317120626026905" LOG_CI_START="-0.5563180117427864" LOG_EFFECT_SIZE="-0.16230297457004791" MODIFIED="2015-12-16 11:15:42 -0500" MODIFIED_BY="[Empty name]" ORDER="84" O_E="0.0" SE="0.4628927664823126" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="0.21426971326164876" WEIGHT="3.0050645496372206"/>
<DICH_DATA CI_END="0.9351606398054496" CI_START="0.13779727772531192" EFFECT_SIZE="0.358974358974359" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.029113780583416606" LOG_CI_START="-0.8607593621131058" LOG_EFFECT_SIZE="-0.4449365713482612" MODIFIED="2015-12-16 11:26:56 -0500" MODIFIED_BY="[Empty name]" ORDER="98" O_E="0.0" SE="0.4885127313025615" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="0.23864468864468869" WEIGHT="3.9498441119449264"/>
<DICH_DATA CI_END="2.4772689203208653" CI_START="0.1009175862778834" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3939731540513527" LOG_CI_START="-0.9960331453793151" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2015-12-15 17:46:58 -0500" MODIFIED_BY="[Empty name]" ORDER="591" O_E="0.0" SE="0.816496580927726" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.6666666666666667" WEIGHT="1.3571259256426156"/>
<DICH_DATA CI_END="1.213721495731571" CI_START="0.502896830270043" EFFECT_SIZE="0.7812660833762224" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="29" LOG_CI_END="0.08411904362308358" LOG_CI_START="-0.2985211017037254" LOG_EFFECT_SIZE="-0.10720102904032094" MODIFIED="2015-12-15 17:46:58 -0500" MODIFIED_BY="[Empty name]" ORDER="592" O_E="0.0" SE="0.2247647154642346" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.05051917731771834" WEIGHT="9.69446938795442"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.6857098985207475E-30" CI_END="1.0095008161362047" CI_START="0.7243424096435751" DF="0" EFFECT_SIZE="0.8551165146909829" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" I2="100.0" ID="CMP-007.01.03" LOG_CI_END="0.004106674387441049" LOG_CI_START="-0.14005608647540416" LOG_EFFECT_SIZE="-0.06797470604398159" MODIFIED="2015-12-15 17:47:31 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.06455903546956124" STUDIES="1" TAU2="0.0" TOTAL_1="423" TOTAL_2="422" WEIGHT="61.822305628119764" Z="1.8482994486024389">
<NAME>Mixed NIPPV devices</NAME>
<DICH_DATA CI_END="1.0095008161362045" CI_START="0.7243424096435749" EFFECT_SIZE="0.8551165146909828" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" LOG_CI_END="0.004106674387440954" LOG_CI_START="-0.1400560864754043" LOG_EFFECT_SIZE="-0.06797470604398165" MODIFIED="2015-12-15 17:47:31 -0500" MODIFIED_BY="[Empty name]" ORDER="593" O_E="0.0" SE="0.08468191934801064" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="423" TOTAL_2="422" VAR="0.0071710274644629785" WEIGHT="61.822305628119764"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="16.41732279522069" CI_END="0.8513589893356078" CI_START="0.6374044391699122" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7366545996121427" ESTIMABLE="YES" EVENTS_1="205" EVENTS_2="275" I2="45.17985598346142" I2_Q="83.06872298593515" ID="CMP-007.02" LOG_CI_END="-0.0698872739782575" LOG_CI_START="-0.19558491623052637" LOG_EFFECT_SIZE="-0.13273609510439194" METHOD="MH" MODIFIED="2017-01-17 18:25:18 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.05866201604075494" P_Q="0.0027224523291320413" P_Z="3.481777782401647E-5" Q="11.81245808180089" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="724" TOTAL_2="707" WEIGHT="100.0" Z="4.139424752788402">
<NAME>Endotracheal re-intubation during the week post extubation</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="4.523043736175231" CI_END="0.5655494829075167" CI_START="0.19107763489787208" DF="4" EFFECT_SIZE="0.3287306764080329" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="41" I2="11.563976973999521" ID="CMP-007.02.01" LOG_CI_END="-0.2475293903609624" LOG_CI_START="-0.7187901429233298" LOG_EFFECT_SIZE="-0.48315976664214605" MODIFIED="2017-01-17 18:25:10 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.33982395579078306" P_Z="5.846961286490069E-5" STUDIES="5" TAU2="0.0" TOTAL_1="140" TOTAL_2="132" WEIGHT="15.11262596226396" Z="4.0189034891975615">
<NAME>Synchronised NIPPV</NAME>
<DICH_DATA CI_END="4.521215975389076" CI_START="0.22117943611706017" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6552552534796293" LOG_CI_START="-0.6552552534796292" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:31:05 -0500" MODIFIED_BY="[Empty name]" ORDER="4" O_E="0.0" SE="0.769800358919501" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.5925925925925926" WEIGHT="1.0823428594152493"/>
<DICH_DATA CI_END="12.889084259427214" CI_START="0.057868173842490454" EFFECT_SIZE="0.8636363636363636" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1102220627990844" LOG_CI_START="-1.237560222537839" LOG_EFFECT_SIZE="-0.06366907986937727" MODIFIED="2015-12-16 11:31:05 -0500" MODIFIED_BY="[Empty name]" ORDER="5" O_E="0.0" SE="1.3790989361166537" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="1.9019138755980862" WEIGHT="0.38717955946561766"/>
<DICH_DATA CI_END="0.8617311511321657" CI_START="0.18567275859737423" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.06462820725139477" LOG_CI_START="-0.7312518100926805" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2015-12-16 11:31:05 -0500" MODIFIED_BY="[Empty name]" ORDER="30" O_E="0.0" SE="0.39157800414902433" STUDY_ID="STD-Gao-2010" TOTAL_1="25" TOTAL_2="25" VAR="0.15333333333333332" WEIGHT="5.411714297076247"/>
<DICH_DATA CI_END="0.7423065041733587" CI_START="0.04195284338346285" EFFECT_SIZE="0.17647058823529413" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.12941673409338317" LOG_CI_START="-1.3772385992238398" LOG_EFFECT_SIZE="-0.7533276666586115" MODIFIED="2015-12-16 11:31:05 -0500" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.732976740395481" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.5372549019607843" WEIGHT="3.833297627095675"/>
<DICH_DATA CI_END="0.6633878173154215" CI_START="0.039296460866996646" EFFECT_SIZE="0.16145833333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.17823250827820158" LOG_CI_START="-1.4056465614603522" LOG_EFFECT_SIZE="-0.7919395348692769" MODIFIED="2015-12-16 11:31:05 -0500" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.7209890906367477" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.5198252688172044" WEIGHT="4.398091619211172"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.2595843994364126" CI_END="0.9310841693850087" CI_START="0.456427014571698" DF="3" EFFECT_SIZE="0.6518987404094049" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="52" I2="0.0" ID="CMP-007.02.02" LOG_CI_END="-0.03101105731386404" LOG_CI_START="-0.34062865888087596" LOG_EFFECT_SIZE="-0.18581985809737" MODIFIED="2017-01-17 18:25:18 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5203077545918282" P_Z="0.01864363324027137" STUDIES="4" TAU2="0.0" TOTAL_1="161" TOTAL_2="153" WEIGHT="19.14753389971444" Z="2.352580910387056">
<NAME>Non-synchronised NIPPV</NAME>
<DICH_DATA CI_END="1.7049516306551555" CI_START="0.2777678570268953" EFFECT_SIZE="0.6881720430107527" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.2317120626026905" LOG_CI_START="-0.5563180117427864" LOG_EFFECT_SIZE="-0.16230297457004791" MODIFIED="2015-12-16 16:25:45 -0500" MODIFIED_BY="[Empty name]" ORDER="200" O_E="0.0" SE="0.4628927664823126" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="0.21426971326164876" WEIGHT="3.1954884420831173"/>
<DICH_DATA CI_END="0.9351606398054496" CI_START="0.13779727772531192" EFFECT_SIZE="0.358974358974359" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.029113780583416606" LOG_CI_START="-0.8607593621131058" LOG_EFFECT_SIZE="-0.4449365713482612" MODIFIED="2015-12-16 15:53:36 -0500" MODIFIED_BY="[Empty name]" ORDER="166" O_E="0.0" SE="0.4885127313025615" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="0.23864468864468869" WEIGHT="4.20013646937261"/>
<DICH_DATA CI_END="2.4772689203208653" CI_START="0.1009175862778834" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3939731540513527" LOG_CI_START="-0.9960331453793151" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2015-12-16 16:04:40 -0500" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.816496580927726" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.6666666666666667" WEIGHT="1.4431238125536658"/>
<DICH_DATA CI_END="1.213721495731571" CI_START="0.502896830270043" EFFECT_SIZE="0.7812660833762224" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="29" LOG_CI_END="0.08411904362308358" LOG_CI_START="-0.2985211017037254" LOG_EFFECT_SIZE="-0.10720102904032094" MODIFIED="2015-12-16 16:04:28 -0500" MODIFIED_BY="[Empty name]" ORDER="46" O_E="0.0" SE="0.2247647154642346" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.05051917731771834" WEIGHT="10.308785175705047"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.6857098985207475E-30" CI_END="1.0095008161362047" CI_START="0.7243424096435751" DF="0" EFFECT_SIZE="0.8551165146909829" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" I2="100.0" ID="CMP-007.02.03" LOG_CI_END="0.004106674387441049" LOG_CI_START="-0.14005608647540416" LOG_EFFECT_SIZE="-0.06797470604398159" MODIFIED="2015-12-16 16:06:05 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.06455903546956124" STUDIES="1" TAU2="0.0" TOTAL_1="423" TOTAL_2="422" WEIGHT="65.7398401380216" Z="1.8482994486024389">
<NAME>Mixed NIPPV devices</NAME>
<DICH_DATA CI_END="1.0095008161362045" CI_START="0.7243424096435749" EFFECT_SIZE="0.8551165146909828" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" LOG_CI_END="0.004106674387440954" LOG_CI_START="-0.1400560864754043" LOG_EFFECT_SIZE="-0.06797470604398165" MODIFIED="2015-12-16 16:05:54 -0500" MODIFIED_BY="[Empty name]" ORDER="593" O_E="0.0" SE="0.08468191934801064" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="423" TOTAL_2="422" VAR="0.0071710274644629785" WEIGHT="65.7398401380216"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.10756378039984922" CI_END="4.049931801561148" CI_START="0.7654733333344899" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.760714285714286" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-007.03" LOG_CI_END="0.6074477100158925" LOG_CI_START="-0.11606993414587088" LOG_EFFECT_SIZE="0.24568888793501084" METHOD="MH" MODIFIED="2017-01-17 18:25:37 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7429350042088615" P_Q="1.0" P_Z="0.18315228602960432" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="70" TOTAL_2="66" WEIGHT="100.0" Z="1.3311116201242388">
<NAME>Abdominal distension requiring cessation of feeds</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.10756378039984922" CI_END="4.049931801561148" CI_START="0.7654733333344899" DF="1" EFFECT_SIZE="1.760714285714286" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" I2="0.0" ID="CMP-007.03.01" LOG_CI_END="0.6074477100158925" LOG_CI_START="-0.11606993414587088" LOG_EFFECT_SIZE="0.24568888793501084" MODIFIED="2017-01-17 18:25:28 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7429350042088615" P_Z="0.18315228602960432" STUDIES="3" TAU2="0.0" TOTAL_1="70" TOTAL_2="66" WEIGHT="100.0" Z="1.3311116201242388">
<NAME>Synchronised NIPPV</NAME>
<DICH_DATA CI_END="3.9391427389533935" CI_START="0.7051731713880003" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.5954017182086463" LOG_CI_START="-0.15170421897593347" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2015-12-16 11:32:35 -0500" MODIFIED_BY="[Empty name]" ORDER="55" O_E="0.0" SE="0.43885372573625553" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.1925925925925926" WEIGHT="92.14285714285714"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:32:35 -0500" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.0" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="66.4433184667098" CI_START="0.12341968180365896" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2015-12-16 11:32:35 -0500" MODIFIED_BY="[Empty name]" ORDER="57" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-Khalaf--2001" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="7.857142857142858"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-01-17 18:25:37 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Non-synchronised NIPPV</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.03.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-12-15 17:33:21 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Mixed NIPPV devices</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.6857098985207475E-30" CI_END="1.0095008161362047" CI_START="0.7243424096435751" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8551165146909829" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" I2="100.0" I2_Q="0.0" ID="CMP-007.04" LOG_CI_END="0.004106674387441049" LOG_CI_START="-0.14005608647540416" LOG_EFFECT_SIZE="-0.06797470604398159" METHOD="MH" MODIFIED="2017-01-17 18:25:53 -0500" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="1.0" P_Z="0.06455903546956124" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="530" TOTAL_2="522" WEIGHT="100.0" Z="1.8482994486024389">
<NAME>Gastrointestinal perforation</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-01-17 18:25:46 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="3" TAU2="0.0" TOTAL_1="83" TOTAL_2="76" WEIGHT="0.0" Z="0.0">
<NAME>Synchronised NIPPV</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:33:13 -0500" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="0.0" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:33:13 -0500" MODIFIED_BY="[Empty name]" ORDER="59" O_E="0.0" SE="0.0" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:33:13 -0500" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.0" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-01-17 18:25:53 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="24" WEIGHT="0.0" Z="0.0">
<NAME>Non-synchronised NIPPV</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 16:07:09 -0500" MODIFIED_BY="[Empty name]" ORDER="61" O_E="0.0" SE="0.0" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.6857098985207475E-30" CI_END="1.0095008161362047" CI_START="0.7243424096435751" DF="0" EFFECT_SIZE="0.8551165146909829" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" I2="100.0" ID="CMP-007.04.03" LOG_CI_END="0.004106674387441049" LOG_CI_START="-0.14005608647540416" LOG_EFFECT_SIZE="-0.06797470604398159" MODIFIED="2015-12-16 16:06:59 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.06455903546956124" STUDIES="1" TAU2="0.0" TOTAL_1="423" TOTAL_2="422" WEIGHT="100.0" Z="1.8482994486024389">
<NAME>Mixed NIPPV devices</NAME>
<DICH_DATA CI_END="1.0095008161362045" CI_START="0.7243424096435749" EFFECT_SIZE="0.8551165146909828" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" LOG_CI_END="0.004106674387440954" LOG_CI_START="-0.1400560864754043" LOG_EFFECT_SIZE="-0.06797470604398165" MODIFIED="2015-12-16 16:06:59 -0500" MODIFIED_BY="[Empty name]" ORDER="593" O_E="0.0" SE="0.08468191934801064" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="423" TOTAL_2="422" VAR="0.0071710274644629785" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9064277668229358" CI_END="1.1874094135070667" CI_START="0.6426761240386012" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8735672152271229" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="76" I2="0.0" I2_Q="0.0" ID="CMP-007.05" LOG_CI_END="0.07460048758984546" LOG_CI_START="-0.19200783419710815" LOG_EFFECT_SIZE="-0.05870367330363132" METHOD="MH" MODIFIED="2017-01-17 18:26:14 -0500" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.9236368755339137" P_Q="0.8371603966419336" P_Z="0.3880731591851805" Q="0.04224141326001535" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="614" TOTAL_2="600" WEIGHT="99.99999999999999" Z="0.863116984977422">
<NAME>Necrotising enterocolitis</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.8619433281117878" CI_END="1.1989940416440976" CI_START="0.6436214275942054" DF="3" EFFECT_SIZE="0.8784635773667114" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="74" I2="0.0" ID="CMP-007.05.01" LOG_CI_END="0.07881702489407862" LOG_CI_START="-0.1913695056994604" LOG_EFFECT_SIZE="-0.0562762404026909" MODIFIED="2017-01-17 18:26:06 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8346007520332704" P_Z="0.41423220338536226" STUDIES="5" TAU2="0.0" TOTAL_1="575" TOTAL_2="572" WEIGHT="96.94958949137656" Z="0.8164685643824585">
<NAME>Synchronised NIPPV</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:33:58 -0500" MODIFIED_BY="[Empty name]" ORDER="63" O_E="0.0" SE="0.0" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.9822977569213727" CI_START="0.037256880488624015" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4745510018709087" LOG_CI_START="-1.4287935113102337" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2015-12-16 11:33:58 -0500" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="1.1180339887498947" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="1.2499999999999998" WEIGHT="3.930336616880186"/>
<DICH_DATA CI_END="1.240338626008517" CI_START="0.6315087969955417" EFFECT_SIZE="0.8850337584396099" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="62" LOG_CI_END="0.09354026849299439" LOG_CI_START="-0.19962059529073903" LOG_EFFECT_SIZE="-0.05304016339887233" MODIFIED="2015-12-16 11:33:58 -0500" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.17220414255624494" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="430" TOTAL_2="429" VAR="0.029654266713531528" WEIGHT="81.32151665194083"/>
<DICH_DATA CI_END="6.455662881691861" CI_START="0.1453726100167811" EFFECT_SIZE="0.96875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8099408432066292" LOG_CI_START="-0.8375174121778957" LOG_EFFECT_SIZE="-0.013788284485633297" MODIFIED="2015-12-16 11:33:58 -0500" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.967725134262757" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.936491935483871" WEIGHT="2.6618152749241473"/>
<DICH_DATA CI_END="2.7778003940885467" CI_START="0.38181021280260546" EFFECT_SIZE="1.0298507462686568" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4437010351883466" LOG_CI_START="-0.4181524591154887" LOG_EFFECT_SIZE="0.012774288036428919" MODIFIED="2015-12-16 11:33:58 -0500" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="0.5062570087976748" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.25629615895676894" WEIGHT="9.035920947631409"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.794781034462848" CI_START="0.10750237766842106" DF="0" EFFECT_SIZE="0.717948717948718" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-007.05.02" LOG_CI_END="0.6807687788276698" LOG_CI_START="-0.9685819301962298" LOG_EFFECT_SIZE="-0.14390657568427997" MODIFIED="2017-01-17 18:26:14 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7323392722196396" STUDIES="1" TAU2="0.0" TOTAL_1="39" TOTAL_2="28" WEIGHT="3.050410508623428" Z="0.3420154415146757">
<NAME>Non-synchronised NIPPV</NAME>
<DICH_DATA CI_END="4.794781034462849" CI_START="0.10750237766842106" EFFECT_SIZE="0.717948717948718" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.68076877882767" LOG_CI_START="-0.9685819301962298" LOG_EFFECT_SIZE="-0.14390657568427997" MODIFIED="2015-12-16 15:54:54 -0500" MODIFIED_BY="[Empty name]" ORDER="169" O_E="0.0" SE="0.9688367708983225" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="0.9386446886446886" WEIGHT="3.050410508623428"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.05.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-12-15 17:33:33 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Mixed NIPPV devices</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.212781381257235" CI_END="1.0970463298715576" CI_START="0.7949831539181632" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9338808014493266" ESTIMABLE="YES" EVENTS_1="188" EVENTS_2="194" I2="51.04174060578511" I2_Q="69.46496963379307" ID="CMP-007.06" LOG_CI_END="0.04022496885337403" LOG_CI_START="-0.09964207415849748" LOG_EFFECT_SIZE="-0.029708552652561702" METHOD="MH" MODIFIED="2017-01-17 18:26:31 -0500" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.06942590571475837" P_Q="0.03781969859291001" P_Z="0.4050619512095668" Q="6.549854301810019" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="564" TOTAL_2="544" WEIGHT="100.0" Z="0.8326149173953813">
<NAME>Chronic lung disease (oxygen supplementation at 36 weeks)</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.8553161562933465" CI_END="0.9457062488262425" CI_START="0.4396159707451911" DF="2" EFFECT_SIZE="0.6447849025974025" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="38" I2="0.0" ID="CMP-007.06.01" LOG_CI_END="-0.024243741320284885" LOG_CI_START="-0.3569265385403617" LOG_EFFECT_SIZE="-0.1905851399303233" MODIFIED="2017-01-17 18:26:24 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.39547886328870085" P_Z="0.024728189240187926" STUDIES="3" TAU2="0.0" TOTAL_1="93" TOTAL_2="88" WEIGHT="19.790318564366665" Z="2.2456226373788453">
<NAME>Synchronised NIPPV</NAME>
<DICH_DATA CI_END="1.3728897852588204" CI_START="0.466169977278508" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="15" LOG_CI_END="0.13763567374427166" LOG_CI_START="-0.33145569976038447" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2015-12-16 11:18:26 -0500" MODIFIED_BY="[Empty name]" ORDER="86" O_E="0.0" SE="0.2755465948363832" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.07592592592592592" WEIGHT="7.590036949401988"/>
<DICH_DATA CI_END="1.1642941116095282" CI_START="0.37613565299764" EFFECT_SIZE="0.6617647058823529" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" LOG_CI_END="0.06606270103095975" LOG_CI_START="-0.42465549889274506" LOG_EFFECT_SIZE="-0.17929639893089266" MODIFIED="2015-12-16 11:18:26 -0500" MODIFIED_BY="[Empty name]" ORDER="88" O_E="0.0" SE="0.28825029972944977" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.08308823529411763" WEIGHT="8.60204187598892"/>
<DICH_DATA CI_END="1.2303695921450277" CI_START="0.06226611265570253" EFFECT_SIZE="0.2767857142857143" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.09003558925936458" LOG_CI_START="-1.2057482469311824" LOG_EFFECT_SIZE="-0.5578563288359089" MODIFIED="2015-12-16 11:18:26 -0500" MODIFIED_BY="[Empty name]" ORDER="87" O_E="0.0" SE="0.7611498396117639" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.5793490783410138" WEIGHT="3.598239738975757"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.8969899227228857" CI_END="1.159892815045774" CI_START="0.46835537856983406" DF="1" EFFECT_SIZE="0.7370495495495496" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="31" I2="74.33916895270582" ID="CMP-007.06.02" LOG_CI_END="0.06441785820543794" LOG_CI_START="-0.32942448798909074" LOG_EFFECT_SIZE="-0.13250331489182637" MODIFIED="2017-01-17 18:26:31 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.048372760467138454" P_Z="0.18723244884144288" STUDIES="2" TAU2="0.0" TOTAL_1="93" TOTAL_2="92" WEIGHT="15.76597148788062" Z="1.3188105724511212">
<NAME>Non-synchronised NIPPV</NAME>
<DICH_DATA CI_END="0.9069420327208643" CI_START="0.050759286566747525" EFFECT_SIZE="0.21455938697318008" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.04242047002256124" LOG_CI_START="-1.2944844906415995" LOG_EFFECT_SIZE="-0.6684524803320805" MODIFIED="2015-12-16 11:22:09 -0500" MODIFIED_BY="[Empty name]" ORDER="91" O_E="0.0" SE="0.7354686035284823" STUDY_ID="STD-Jasani-2016" TOTAL_1="29" TOTAL_2="28" VAR="0.5409140667761358" WEIGHT="4.6339172954243715"/>
<DICH_DATA CI_END="1.5539689967039805" CI_START="0.5863418296799888" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.1914423499251933" LOG_CI_START="-0.23184912210176722" LOG_EFFECT_SIZE="-0.02020338608828695" MODIFIED="2015-12-16 11:19:51 -0500" MODIFIED_BY="[Empty name]" ORDER="89" O_E="0.0" SE="0.24864350599521612" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="64" TOTAL_2="64" VAR="0.06182359307359307" WEIGHT="11.132054192456248"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3001259506189036" CI_START="0.8819486812651074" DF="0" EFFECT_SIZE="1.0708148148148149" ESTIMABLE="YES" EVENTS_1="139" EVENTS_2="125" I2="0.0" ID="CMP-007.06.03" LOG_CI_END="0.1139854269292695" LOG_CI_START="-0.054556684813530855" LOG_EFFECT_SIZE="0.029714371057869348" MODIFIED="2015-12-16 11:21:12 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.4895073999335465" STUDIES="1" TAU2="0.0" TOTAL_1="378" TOTAL_2="364" WEIGHT="64.44370994775272" Z="0.6910925286798073">
<NAME>Mixed NIPPV devices</NAME>
<DICH_DATA CI_END="1.3001259506189036" CI_START="0.8819486812651074" EFFECT_SIZE="1.0708148148148149" ESTIMABLE="YES" EVENTS_1="139" EVENTS_2="125" LOG_CI_END="0.1139854269292695" LOG_CI_START="-0.054556684813530855" LOG_EFFECT_SIZE="0.029714371057869348" MODIFIED="2015-12-16 11:21:12 -0500" MODIFIED_BY="[Empty name]" ORDER="90" O_E="0.0" SE="0.09900247073462942" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="378" TOTAL_2="364" VAR="0.009801489211561154" WEIGHT="64.44370994775272"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.5505346192171094" CI_END="1.0223828987001693" CI_START="0.4373214256341528" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6686628050097715" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="43" I2="38.936281807208246" I2_Q="51.15336849551408" ID="CMP-007.07" LOG_CI_END="0.009613576473299064" LOG_CI_START="-0.3591992447984315" LOG_EFFECT_SIZE="-0.17479283416256625" METHOD="MH" MODIFIED="2017-01-17 18:26:47 -0500" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.16163408711422844" P_Q="0.12909302739818607" P_Z="0.0631994009867678" Q="4.094448150055806" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="615" TOTAL_2="607" WEIGHT="100.0" Z="1.857786063581036">
<NAME>Pulmonary air leak</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.963907895749943" CI_END="0.9025339133980954" CI_START="0.1385382938250908" DF="1" EFFECT_SIZE="0.3536036036036036" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="14" I2="0.0" ID="CMP-007.07.01" LOG_CI_END="-0.04453647017029725" LOG_CI_START="-0.858430165240475" LOG_EFFECT_SIZE="-0.4514833177053861" MODIFIED="2017-01-17 18:26:40 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3262044418178883" P_Z="0.02967034813708576" STUDIES="2" TAU2="0.0" TOTAL_1="57" TOTAL_2="56" WEIGHT="31.599941723477905" Z="2.1744634408229744">
<NAME>Synchronised NIPPV</NAME>
<DICH_DATA CI_END="1.4497421980485377" CI_START="0.17244445276996065" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.16129078022171156" LOG_CI_START="-0.763350771549674" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2015-12-16 11:36:27 -0500" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="0.5431390245600108" STUDY_ID="STD-Gao-2010" TOTAL_1="25" TOTAL_2="25" VAR="0.29500000000000004" WEIGHT="17.935102059271244"/>
<DICH_DATA CI_END="1.2649955552013255" CI_START="0.020607814229536094" EFFECT_SIZE="0.16145833333333334" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10208899953956095" LOG_CI_START="-1.6859680692781147" LOG_EFFECT_SIZE="-0.7919395348692769" MODIFIED="2015-12-16 11:36:27 -0500" MODIFIED_BY="[Empty name]" ORDER="75" O_E="0.0" SE="1.0503135732487408" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="1.1031586021505377" WEIGHT="13.664839664206662"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.376268787791569" CI_END="2.081007485610697" CI_START="0.582144503122666" DF="1" EFFECT_SIZE="1.1006575619625696" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="11" I2="27.339774841173938" ID="CMP-007.07.02" LOG_CI_END="0.31827364241901396" LOG_CI_START="-0.23496919899407392" LOG_EFFECT_SIZE="0.04165222171247001" MODIFIED="2017-01-17 18:26:47 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2407379216429919" P_Z="0.767901271405671" STUDIES="3" TAU2="0.0" TOTAL_1="134" TOTAL_2="125" WEIGHT="28.141029183475595" Z="0.2951212318409846">
<NAME>Non-synchronised NIPPV</NAME>
<DICH_DATA CI_END="3.1322503103103903" CI_START="0.037798763976709754" EFFECT_SIZE="0.34408602150537637" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.495856460934691" LOG_CI_START="-1.422522401402749" LOG_EFFECT_SIZE="-0.4633329702340291" MODIFIED="2015-12-16 16:26:36 -0500" MODIFIED_BY="[Empty name]" ORDER="201" O_E="0.0" SE="1.1268652398655326" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="1.2698252688172043" WEIGHT="6.618906712350102"/>
<DICH_DATA CI_END="2.6145978068611493" CI_START="0.6799431151944617" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="8" LOG_CI_END="0.41740489255526714" LOG_CI_START="-0.16752741933866733" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2015-12-16 16:03:04 -0500" MODIFIED_BY="[Empty name]" ORDER="167" O_E="0.0" SE="0.3435921354681384" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="36" TOTAL_2="24" VAR="0.11805555555555555" WEIGHT="21.522122471125492"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-18 09:39:19 -0500" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.0" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2842472300778476" CI_START="0.2935480551873669" DF="0" EFFECT_SIZE="0.6139937106918238" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="18" I2="0.0" ID="CMP-007.07.03" LOG_CI_END="0.10864863769152498" LOG_CI_START="-0.5323207925617146" LOG_EFFECT_SIZE="-0.21183607743509478" MODIFIED="2015-12-16 16:09:06 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.19514443019547711" STUDIES="1" TAU2="0.0" TOTAL_1="424" TOTAL_2="426" WEIGHT="40.25902909304651" Z="1.2955097787892527">
<NAME>Mixed NIPPV devices</NAME>
<DICH_DATA CI_END="1.2842472300778474" CI_START="0.29354805518736693" EFFECT_SIZE="0.6139937106918238" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="18" LOG_CI_END="0.1086486376915249" LOG_CI_START="-0.5323207925617145" LOG_EFFECT_SIZE="-0.21183607743509478" MODIFIED="2015-12-16 16:09:06 -0500" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.37650861618060366" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="424" TOTAL_2="426" VAR="0.14175873805823314" WEIGHT="40.25902909304651"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.7210215336301546" CI_START="-7.921021533630154" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.08" MODIFIED="2017-01-17 18:27:17 -0500" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.20756455723994438" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="27" TOTAL_2="27" UNITS="" WEIGHT="100.0" Z="1.2602906478824867">
<NAME>Rates of apnoea (episodes/24 h)</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.7210215336301546" CI_START="-7.921021533630154" DF="0" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-007.08.01" MODIFIED="2017-01-17 18:27:05 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.20756455723994438" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="27" WEIGHT="100.0" Z="1.2602906478824867">
<NAME>Synchronised NIPPV</NAME>
<CONT_DATA CI_END="1.7210215336301546" CI_START="-7.921021533630154" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="8.2" MODIFIED="2015-12-16 11:37:26 -0500" MODIFIED_BY="[Empty name]" ORDER="84" SD_1="4.4" SD_2="12.0" SE="2.4597500625816378" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.02" MODIFIED="2017-01-17 18:27:17 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Non-synchronised NIPPV</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.03" MODIFIED="2015-12-15 17:35:22 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Mixed NIPPV devices</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.715792042124006" CI_END="5.440232382113518" CI_START="-0.005450288447442109" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="2.717391046833038" ESTIMABLE="YES" I2="36.38396321970145" I2_Q="53.50542953635329" ID="CMP-007.09" MODIFIED="2017-01-17 18:27:35 -0500" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.1938311149280978" P_Q="0.14249673412898067" P_Z="0.050460354943834204" Q="2.15078876958737" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="124" TOTAL_2="120" UNITS="" WEIGHT="99.99999999999999" Z="1.9560407412265615">
<NAME>Duration of hospitalisation (days)</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.5650032725366354" CI_END="6.253382837433837" CI_START="0.5209752107254646" DF="2" EFFECT_SIZE="3.387179024079651" ESTIMABLE="YES" I2="22.02738992913178" ID="CMP-007.09.01" MODIFIED="2017-01-17 18:27:27 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2773427415219325" P_Z="0.020546444417540177" STUDIES="3" TAU2="0.0" TOTAL_1="93" TOTAL_2="88" WEIGHT="90.24653391300834" Z="2.316216615669289">
<NAME>Synchronised NIPPV</NAME>
<CONT_DATA CI_END="7.093619988568964" CI_START="-19.093619988568964" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="86.0" MEAN_2="92.0" MODIFIED="2015-12-16 11:35:14 -0500" MODIFIED_BY="[Empty name]" ORDER="81" SD_1="23.0" SD_2="26.0" SE="6.680541118025518" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" WEIGHT="4.324393492818235"/>
<CONT_DATA CI_END="18.175583522496325" CI_START="-26.175583522496325" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="72.0" MEAN_2="76.0" MODIFIED="2015-12-16 11:35:14 -0500" MODIFIED_BY="[Empty name]" ORDER="82" SD_1="46.65" SD_2="43.82" SE="11.314281128334244" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" WEIGHT="1.5076292572270404"/>
<CONT_DATA CI_END="6.9635603800741155" CI_START="1.036439619925884" EFFECT_SIZE="4.0" ESTIMABLE="YES" MEAN_1="62.0" MEAN_2="58.0" MODIFIED="2015-12-16 11:35:14 -0500" MODIFIED_BY="[Empty name]" ORDER="83" SD_1="6.0" SD_2="6.0" SE="1.5120483863225558" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" WEIGHT="84.41451116296307"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.238521559942841" CI_START="-12.198521559942849" DF="0" EFFECT_SIZE="-3.480000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-007.09.02" MODIFIED="2017-01-17 18:27:35 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.4340264833918053" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="32" WEIGHT="9.753466086991649" Z="0.7823201008685824">
<NAME>Non-synchronised NIPPV</NAME>
<CONT_DATA CI_END="5.238521559942841" CI_START="-12.198521559942849" EFFECT_SIZE="-3.480000000000004" ESTIMABLE="YES" MEAN_1="33.3" MEAN_2="36.78" MODIFIED="2015-12-16 16:27:19 -0500" MODIFIED_BY="[Empty name]" ORDER="202" SD_1="18.43" SD_2="16.81" SE="4.448307024370565" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" WEIGHT="9.753466086991649"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.09.03" MODIFIED="2015-12-15 17:35:41 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Mixed NIPPV devices</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.640818028614893" CI_END="0.9904994047364962" CI_START="0.4847303464132133" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6929106144229595" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="64" I2="29.088299255379404" I2_Q="52.2387258522838" ID="CMP-007.10" LOG_CI_END="-0.0041457811246594185" LOG_CI_START="-0.3144997905366737" LOG_EFFECT_SIZE="-0.15932278583066659" METHOD="MH" MODIFIED="2017-01-17 18:28:01 -0500" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.22762601413548467" P_Q="0.123224661465682" P_Z="0.04418544698339047" Q="4.187492975615338" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="623" TOTAL_2="614" WEIGHT="100.0" Z="2.012327295118918">
<NAME>Death before discharge</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.4389760930612585" CI_START="0.21141735004317108" DF="0" EFFECT_SIZE="0.96875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" I2="0.0" ID="CMP-007.10.01" LOG_CI_END="0.6472828060572356" LOG_CI_START="-0.6748593750285022" LOG_EFFECT_SIZE="-0.013788284485633297" MODIFIED="2017-01-17 18:27:54 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9673916162887245" STUDIES="2" TAU2="0.0" TOTAL_1="56" TOTAL_2="55" WEIGHT="4.637520115976174" Z="0.04087993165491657">
<NAME>Synchronised NIPPV</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:34:28 -0500" MODIFIED_BY="[Empty name]" ORDER="77" O_E="0.0" SE="0.0" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.4389760930612585" CI_START="0.21141735004317108" EFFECT_SIZE="0.96875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6472828060572356" LOG_CI_START="-0.6748593750285022" LOG_EFFECT_SIZE="-0.013788284485633297" MODIFIED="2015-12-16 11:34:28 -0500" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="0.7766328618791105" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.6031586021505376" WEIGHT="4.637520115976174"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.790580530755809" CI_END="0.7482324795419322" CI_START="0.16368438702784344" DF="2" EFFECT_SIZE="0.349962819122467" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="20" I2="0.0" ID="CMP-007.10.02" LOG_CI_END="-0.12596344371910334" LOG_CI_START="-0.7859927436242663" LOG_EFFECT_SIZE="-0.4559780936716848" MODIFIED="2017-01-17 18:28:01 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4084890517316079" P_Z="0.006767706390992453" STUDIES="3" TAU2="0.0" TOTAL_1="137" TOTAL_2="129" WEIGHT="32.973342073781865" Z="2.7080635404038755">
<NAME>Non-synchronised NIPPV</NAME>
<DICH_DATA CI_END="2.6183017780452293" CI_START="0.10174120499529542" EFFECT_SIZE="0.5161290322580645" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4180197006512073" LOG_CI_START="-0.9925031230079031" LOG_EFFECT_SIZE="-0.2872417111783479" MODIFIED="2015-12-16 16:27:56 -0500" MODIFIED_BY="[Empty name]" ORDER="204" O_E="0.0" SE="0.8285480888179461" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="0.686491935483871" WEIGHT="5.9901301498025585"/>
<DICH_DATA CI_END="0.6376564534210859" CI_START="0.060125296135299884" EFFECT_SIZE="0.1958041958041958" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" LOG_CI_END="-0.19541324066474453" LOG_CI_START="-1.2209427715809407" LOG_EFFECT_SIZE="-0.7081780061228425" MODIFIED="2015-12-16 15:54:31 -0500" MODIFIED_BY="[Empty name]" ORDER="168" O_E="0.0" SE="0.6024011229132237" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="0.36288711288711284" WEIGHT="19.486669181356977"/>
<DICH_DATA CI_END="2.484093004489646" CI_START="0.1537033117368657" EFFECT_SIZE="0.6179104477611941" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.39516785180265446" LOG_CI_START="-0.8133167749625093" LOG_EFFECT_SIZE="-0.20907446157992746" MODIFIED="2015-12-16 16:27:35 -0500" MODIFIED_BY="[Empty name]" ORDER="80" O_E="0.0" SE="0.7098698518572377" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.5039152065758166" WEIGHT="7.4965427426223314"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3133344115120864" CI_START="0.5548723087564983" DF="0" EFFECT_SIZE="0.8536585365853658" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="41" I2="0.0" ID="CMP-007.10.03" LOG_CI_END="0.11837532363907724" LOG_CI_START="-0.25580694837799695" LOG_EFFECT_SIZE="-0.06871581236945987" MODIFIED="2015-12-16 16:09:48 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.4716076087493303" STUDIES="1" TAU2="0.0" TOTAL_1="430" TOTAL_2="430" WEIGHT="62.38913781024197" Z="0.7198658380395303">
<NAME>Mixed NIPPV devices</NAME>
<DICH_DATA CI_END="1.3133344115120864" CI_START="0.5548723087564983" EFFECT_SIZE="0.8536585365853658" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="41" LOG_CI_END="0.11837532363907724" LOG_CI_START="-0.25580694837799695" LOG_EFFECT_SIZE="-0.06871581236945987" MODIFIED="2015-12-16 16:09:48 -0500" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="0.2197965188149483" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="430" TOTAL_2="430" VAR="0.048310509683169925" WEIGHT="62.38913781024197"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2017-01-17 18:30:55 -0500" MODIFIED_BY="[Empty name]" NO="8">
<NAME>NIPPV versus NCPAP (ventilator-generated NIPPV vs bilevel NIPPV)</NAME>
<DICH_OUTCOME CHI2="23.87645102508752" CI_END="0.8033185338794289" CI_START="0.6032769246470021" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6961490750052897" ESTIMABLE="YES" EVENTS_1="206" EVENTS_2="292" I2="62.30595581167612" I2_Q="90.49109459295312" ID="CMP-008.01" LOG_CI_END="-0.09511221303322202" LOG_CI_START="-0.2194832861374888" LOG_EFFECT_SIZE="-0.15729774958535542" METHOD="MH" MODIFIED="2017-01-17 18:28:37 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.004500981259300207" P_Q="2.708715051347177E-5" P_Z="7.132852668863307E-7" Q="21.03291508734365" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="724" TOTAL_2="707" WEIGHT="100.0" Z="4.957711087336756">
<NAME>Respiratory failure post extubation</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.318693297426145" CI_END="0.47274137299565383" CI_START="0.21951990650739012" DF="7" EFFECT_SIZE="0.3221430458696589" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="81" I2="0.0" ID="CMP-008.01.01" LOG_CI_END="-0.3253763878019473" LOG_CI_START="-0.658526090937506" LOG_EFFECT_SIZE="-0.4919512393697267" MODIFIED="2017-01-17 18:28:37 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5030686935328548" P_Z="7.104774261454729E-9" STUDIES="8" TAU2="0.0" TOTAL_1="234" TOTAL_2="216" WEIGHT="28.48322498392582" Z="5.7884290590057725">
<NAME>Ventilator-generated NIPPV</NAME>
<DICH_DATA CI_END="0.9042517476033083" CI_START="0.12287630231913588" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.04371064322574003" LOG_CI_START="-0.9105318662135851" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2015-12-16 11:11:42 -0500" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.5091750772173156" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.25925925925925924" WEIGHT="4.0713777769278465"/>
<DICH_DATA CI_END="0.9147035714412431" CI_START="0.016641228558704663" EFFECT_SIZE="0.12337662337662338" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="-0.03871962521779245" LOG_CI_START="-1.7788146145494759" LOG_EFFECT_SIZE="-0.9087671198836341" MODIFIED="2015-12-16 11:11:42 -0500" MODIFIED_BY="[Empty name]" ORDER="77" O_E="0.0" SE="1.0221404103425464" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="1.044771018455229" WEIGHT="2.5487486896214975"/>
<DICH_DATA CI_END="0.8617311511321657" CI_START="0.18567275859737423" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.06462820725139477" LOG_CI_START="-0.7312518100926805" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2015-12-16 11:11:42 -0500" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="0.39157800414902433" STUDY_ID="STD-Gao-2010" TOTAL_1="25" TOTAL_2="25" VAR="0.15333333333333332" WEIGHT="5.089222221159808"/>
<DICH_DATA CI_END="1.7049516306551555" CI_START="0.2777678570268953" EFFECT_SIZE="0.6881720430107527" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.2317120626026905" LOG_CI_START="-0.5563180117427864" LOG_EFFECT_SIZE="-0.16230297457004791" MODIFIED="2015-12-16 11:16:14 -0500" MODIFIED_BY="[Empty name]" ORDER="85" O_E="0.0" SE="0.4628927664823126" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="0.21426971326164876" WEIGHT="3.0050645496372206"/>
<DICH_DATA CI_END="0.9351606398054496" CI_START="0.13779727772531192" EFFECT_SIZE="0.358974358974359" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.029113780583416606" LOG_CI_START="-0.8607593621131058" LOG_EFFECT_SIZE="-0.4449365713482612" MODIFIED="2015-12-16 11:27:23 -0500" MODIFIED_BY="[Empty name]" ORDER="99" O_E="0.0" SE="0.4885127313025615" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="0.23864468864468869" WEIGHT="3.9498441119449264"/>
<DICH_DATA CI_END="0.6048508966856184" CI_START="0.03575475823274725" EFFECT_SIZE="0.14705882352941177" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.2183516711780126" LOG_CI_START="-1.44666615423446" LOG_EFFECT_SIZE="-0.8325089127062363" MODIFIED="2015-12-16 11:11:42 -0500" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="0.7215180076021095" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.5205882352941177" WEIGHT="4.325838887985837"/>
<DICH_DATA CI_END="2.4772689203208653" CI_START="0.1009175862778834" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3939731540513527" LOG_CI_START="-0.9960331453793151" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2015-12-16 11:12:58 -0500" MODIFIED_BY="[Empty name]" ORDER="81" O_E="0.0" SE="0.816496580927726" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.6666666666666667" WEIGHT="1.3571259256426156"/>
<DICH_DATA CI_END="0.6633878173154215" CI_START="0.039296460866996646" EFFECT_SIZE="0.16145833333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.17823250827820158" LOG_CI_START="-1.4056465614603522" LOG_EFFECT_SIZE="-0.7919395348692769" MODIFIED="2015-12-16 11:11:42 -0500" MODIFIED_BY="[Empty name]" ORDER="80" O_E="0.0" SE="0.7209890906367477" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.5198252688172044" WEIGHT="4.136002821006066"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.213721495731571" CI_START="0.502896830270043" DF="0" EFFECT_SIZE="0.7812660833762224" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="29" I2="0.0" ID="CMP-008.01.02" LOG_CI_END="0.08411904362308358" LOG_CI_START="-0.2985211017037254" LOG_EFFECT_SIZE="-0.10720102904032094" MODIFIED="2015-12-16 11:13:34 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.2721115878843854" STUDIES="1" TAU2="0.0" TOTAL_1="67" TOTAL_2="69" WEIGHT="9.69446938795442" Z="1.098212817399014">
<NAME>Bilevel NIPPV</NAME>
<DICH_DATA CI_END="1.213721495731571" CI_START="0.502896830270043" EFFECT_SIZE="0.7812660833762224" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="29" LOG_CI_END="0.08411904362308358" LOG_CI_START="-0.2985211017037254" LOG_EFFECT_SIZE="-0.10720102904032094" MODIFIED="2015-12-16 11:13:34 -0500" MODIFIED_BY="[Empty name]" ORDER="82" O_E="0.0" SE="0.2247647154642346" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.05051917731771834" WEIGHT="9.69446938795442"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.6857098985207475E-30" CI_END="1.0095008161362047" CI_START="0.7243424096435751" DF="0" EFFECT_SIZE="0.8551165146909829" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" I2="100.0" ID="CMP-008.01.03" LOG_CI_END="0.004106674387441049" LOG_CI_START="-0.14005608647540416" LOG_EFFECT_SIZE="-0.06797470604398159" MODIFIED="2015-12-16 11:14:15 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.06455903546956124" STUDIES="1" TAU2="0.0" TOTAL_1="423" TOTAL_2="422" WEIGHT="61.822305628119764" Z="1.8482994486024389">
<NAME>Mixed NIPPV devices</NAME>
<DICH_DATA CI_END="1.0095008161362045" CI_START="0.7243424096435749" EFFECT_SIZE="0.8551165146909828" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" LOG_CI_END="0.004106674387440954" LOG_CI_START="-0.1400560864754043" LOG_EFFECT_SIZE="-0.06797470604398165" MODIFIED="2015-12-16 11:14:15 -0500" MODIFIED_BY="[Empty name]" ORDER="83" O_E="0.0" SE="0.08468191934801064" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="423" TOTAL_2="422" VAR="0.0071710274644629785" WEIGHT="61.822305628119764"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="16.41732279522069" CI_END="0.8513589893356078" CI_START="0.6374044391699122" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7366545996121427" ESTIMABLE="YES" EVENTS_1="205" EVENTS_2="275" I2="45.17985598346142" I2_Q="83.79696579148332" ID="CMP-008.02" LOG_CI_END="-0.0698872739782575" LOG_CI_START="-0.19558491623052637" LOG_EFFECT_SIZE="-0.13273609510439194" METHOD="MH" MODIFIED="2017-01-17 18:28:50 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.05866201604075494" P_Q="0.002087728344824069" P_Z="3.481777782401647E-5" Q="12.34336713890756" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="724" TOTAL_2="707" WEIGHT="100.0" Z="4.139424752788402">
<NAME>Endotracheal re-intubation during the week post extubation</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.106845341842388" CI_END="0.5863871044374948" CI_START="0.2624650478190939" DF="7" EFFECT_SIZE="0.39230870421988734" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="64" I2="0.0" ID="CMP-008.02.01" LOG_CI_END="-0.23181558907159788" LOG_CI_START="-0.5809285229245934" LOG_EFFECT_SIZE="-0.40637205599809567" MODIFIED="2017-01-17 18:28:50 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5273305967588918" P_Z="5.046439444040172E-6" STUDIES="8" TAU2="0.0" TOTAL_1="234" TOTAL_2="216" WEIGHT="23.951374686273354" Z="4.562847817120069">
<NAME>Ventilator-generated NIPPV</NAME>
<DICH_DATA CI_END="4.521215975389076" CI_START="0.22117943611706017" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6552552534796293" LOG_CI_START="-0.6552552534796292" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:31:24 -0500" MODIFIED_BY="[Empty name]" ORDER="4" O_E="0.0" SE="0.769800358919501" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.5925925925925926" WEIGHT="1.0823428594152493"/>
<DICH_DATA CI_END="12.889084259427214" CI_START="0.057868173842490454" EFFECT_SIZE="0.8636363636363636" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1102220627990844" LOG_CI_START="-1.237560222537839" LOG_EFFECT_SIZE="-0.06366907986937727" MODIFIED="2015-12-16 11:31:24 -0500" MODIFIED_BY="[Empty name]" ORDER="5" O_E="0.0" SE="1.3790989361166537" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="1.9019138755980862" WEIGHT="0.38717955946561766"/>
<DICH_DATA CI_END="0.8617311511321657" CI_START="0.18567275859737423" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.06462820725139477" LOG_CI_START="-0.7312518100926805" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2015-12-16 11:31:24 -0500" MODIFIED_BY="[Empty name]" ORDER="30" O_E="0.0" SE="0.39157800414902433" STUDY_ID="STD-Gao-2010" TOTAL_1="25" TOTAL_2="25" VAR="0.15333333333333332" WEIGHT="5.411714297076247"/>
<DICH_DATA CI_END="1.7049516306551555" CI_START="0.2777678570268953" EFFECT_SIZE="0.6881720430107527" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.2317120626026905" LOG_CI_START="-0.5563180117427864" LOG_EFFECT_SIZE="-0.16230297457004791" MODIFIED="2015-12-16 16:19:37 -0500" MODIFIED_BY="[Empty name]" ORDER="194" O_E="0.0" SE="0.4628927664823126" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="0.21426971326164876" WEIGHT="3.1954884420831173"/>
<DICH_DATA CI_END="0.9351606398054496" CI_START="0.13779727772531192" EFFECT_SIZE="0.358974358974359" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.029113780583416606" LOG_CI_START="-0.8607593621131058" LOG_EFFECT_SIZE="-0.4449365713482612" MODIFIED="2015-12-16 16:11:52 -0500" MODIFIED_BY="[Empty name]" ORDER="182" O_E="0.0" SE="0.4885127313025615" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="0.23864468864468869" WEIGHT="4.20013646937261"/>
<DICH_DATA CI_END="0.7423065041733587" CI_START="0.04195284338346285" EFFECT_SIZE="0.17647058823529413" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.12941673409338317" LOG_CI_START="-1.3772385992238398" LOG_EFFECT_SIZE="-0.7533276666586115" MODIFIED="2015-12-16 11:31:24 -0500" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.732976740395481" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.5372549019607843" WEIGHT="3.833297627095675"/>
<DICH_DATA CI_END="2.4772689203208653" CI_START="0.1009175862778834" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3939731540513527" LOG_CI_START="-0.9960331453793151" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2015-12-16 11:31:24 -0500" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.816496580927726" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.6666666666666667" WEIGHT="1.4431238125536658"/>
<DICH_DATA CI_END="0.6633878173154215" CI_START="0.039296460866996646" EFFECT_SIZE="0.16145833333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" LOG_CI_END="-0.17823250827820158" LOG_CI_START="-1.4056465614603522" LOG_EFFECT_SIZE="-0.7919395348692769" MODIFIED="2015-12-16 11:31:24 -0500" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.7209890906367477" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.5198252688172044" WEIGHT="4.398091619211172"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.213721495731571" CI_START="0.502896830270043" DF="0" EFFECT_SIZE="0.7812660833762224" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="29" I2="0.0" ID="CMP-008.02.02" LOG_CI_END="0.08411904362308358" LOG_CI_START="-0.2985211017037254" LOG_EFFECT_SIZE="-0.10720102904032094" MODIFIED="2015-12-16 16:11:07 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.2721115878843854" STUDIES="1" TAU2="0.0" TOTAL_1="67" TOTAL_2="69" WEIGHT="10.308785175705047" Z="1.098212817399014">
<NAME>Bilevel NIPPV</NAME>
<DICH_DATA CI_END="1.213721495731571" CI_START="0.502896830270043" EFFECT_SIZE="0.7812660833762224" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="29" LOG_CI_END="0.08411904362308358" LOG_CI_START="-0.2985211017037254" LOG_EFFECT_SIZE="-0.10720102904032094" MODIFIED="2015-12-16 16:11:07 -0500" MODIFIED_BY="[Empty name]" ORDER="46" O_E="0.0" SE="0.2247647154642346" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.05051917731771834" WEIGHT="10.308785175705047"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.6857098985207475E-30" CI_END="1.0095008161362047" CI_START="0.7243424096435751" DF="0" EFFECT_SIZE="0.8551165146909829" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" I2="100.0" ID="CMP-008.02.03" LOG_CI_END="0.004106674387441049" LOG_CI_START="-0.14005608647540416" LOG_EFFECT_SIZE="-0.06797470604398159" MODIFIED="2015-12-16 16:10:57 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.06455903546956124" STUDIES="1" TAU2="0.0" TOTAL_1="423" TOTAL_2="422" WEIGHT="65.7398401380216" Z="1.8482994486024389">
<NAME>Mixed NIPPV devices</NAME>
<DICH_DATA CI_END="1.0095008161362045" CI_START="0.7243424096435749" EFFECT_SIZE="0.8551165146909828" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="182" LOG_CI_END="0.004106674387440954" LOG_CI_START="-0.1400560864754043" LOG_EFFECT_SIZE="-0.06797470604398165" MODIFIED="2015-12-16 16:10:57 -0500" MODIFIED_BY="[Empty name]" ORDER="53" O_E="0.0" SE="0.08468191934801064" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="423" TOTAL_2="422" VAR="0.0071710274644629785" WEIGHT="65.7398401380216"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.10756378039984922" CI_END="4.049931801561148" CI_START="0.7654733333344899" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.760714285714286" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-008.03" LOG_CI_END="0.6074477100158925" LOG_CI_START="-0.11606993414587088" LOG_EFFECT_SIZE="0.24568888793501084" METHOD="MH" MODIFIED="2017-01-17 18:29:00 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7429350042088615" P_Q="1.0" P_Z="0.18315228602960432" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="70" TOTAL_2="66" WEIGHT="100.0" Z="1.3311116201242388">
<NAME>Abdominal distension requiring cessation of feeds</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.10756378039984922" CI_END="4.049931801561148" CI_START="0.7654733333344899" DF="1" EFFECT_SIZE="1.760714285714286" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" I2="0.0" ID="CMP-008.03.01" LOG_CI_END="0.6074477100158925" LOG_CI_START="-0.11606993414587088" LOG_EFFECT_SIZE="0.24568888793501084" MODIFIED="2017-01-17 18:29:00 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7429350042088615" P_Z="0.18315228602960432" STUDIES="3" TAU2="0.0" TOTAL_1="70" TOTAL_2="66" WEIGHT="100.0" Z="1.3311116201242388">
<NAME>Ventilator-generated NIPPV</NAME>
<DICH_DATA CI_END="3.9391427389533935" CI_START="0.7051731713880003" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.5954017182086463" LOG_CI_START="-0.15170421897593347" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2015-12-16 11:32:11 -0500" MODIFIED_BY="[Empty name]" ORDER="55" O_E="0.0" SE="0.43885372573625553" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.1925925925925926" WEIGHT="92.14285714285714"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:32:11 -0500" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.0" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="66.4433184667098" CI_START="0.12341968180365896" EFFECT_SIZE="2.8636363636363638" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8224513148659036" LOG_CI_START="-0.9086155776031525" LOG_EFFECT_SIZE="0.4569178686313755" MODIFIED="2015-12-16 11:32:11 -0500" MODIFIED_BY="[Empty name]" ORDER="57" O_E="0.0" SE="1.6042422116354729" STUDY_ID="STD-Khalaf--2001" TOTAL_1="21" TOTAL_2="20" VAR="2.5735930735930737" WEIGHT="7.857142857142858"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-008.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-12-15 17:38:37 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Bilevel NIPPV</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-008.03.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-12-15 17:38:37 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Mixed NIPPV devices</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.5664679425717827E-31" CI_END="1.4846864042006065" CI_START="0.5959841811900155" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9406644518272427" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" I2="100.0" I2_Q="100.0" ID="CMP-008.04" LOG_CI_END="0.17163473156059658" LOG_CI_START="-0.22476526729509735" LOG_EFFECT_SIZE="-0.026565267867250365" METHOD="MH" MODIFIED="2017-01-17 18:29:09 -0500" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.792782484394046" Q="8.88051191201309E-34" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="576" TOTAL_2="557" WEIGHT="100.0" Z="0.26269913425718466">
<NAME>Gastrointestinal perforation</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.5664679425717827E-31" CI_END="1.4846864042006065" CI_START="0.5959841811900155" DF="0" EFFECT_SIZE="0.9406644518272427" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" I2="100.0" ID="CMP-008.04.01" LOG_CI_END="0.17163473156059658" LOG_CI_START="-0.22476526729509735" LOG_EFFECT_SIZE="-0.026565267867250365" MODIFIED="2017-01-17 18:29:09 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.792782484394046" STUDIES="6" TAU2="0.0" TOTAL_1="576" TOTAL_2="557" WEIGHT="100.0" Z="0.26269913425718466">
<NAME>Ventilator-generated NIPPV</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:33:24 -0500" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="0.0" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:33:24 -0500" MODIFIED_BY="[Empty name]" ORDER="59" O_E="0.0" SE="0.0" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 16:12:32 -0500" MODIFIED_BY="[Empty name]" ORDER="183" O_E="0.0" SE="0.0" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:33:24 -0500" MODIFIED_BY="[Empty name]" ORDER="60" O_E="0.0" SE="0.0" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:33:24 -0500" MODIFIED_BY="[Empty name]" ORDER="61" O_E="0.0" SE="0.0" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.4846864042006063" CI_START="0.5959841811900155" EFFECT_SIZE="0.9406644518272426" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" LOG_CI_END="0.1716347315605965" LOG_CI_START="-0.22476526729509735" LOG_EFFECT_SIZE="-0.026565267867250417" MODIFIED="2015-12-16 11:33:24 -0500" MODIFIED_BY="[Empty name]" ORDER="62" O_E="0.0" SE="0.2328473215394751" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="430" TOTAL_2="429" VAR="0.054217875148107705" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-008.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-12-15 17:38:41 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Bilevel NIPPV</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-008.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-12-15 17:38:41 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Mixed NIPPV devices</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9064277668229357" CI_END="1.1874094135070667" CI_START="0.6426761240386012" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8735672152271229" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="76" I2="0.0" I2_Q="0.0" ID="CMP-008.05" LOG_CI_END="0.07460048758984546" LOG_CI_START="-0.19200783419710815" LOG_EFFECT_SIZE="-0.05870367330363132" METHOD="MH" MODIFIED="2017-01-17 18:29:43 -0500" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.9236368755339137" P_Q="0.8036319104846978" P_Z="0.3880731591851805" Q="0.4372281877936014" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="614" TOTAL_2="600" WEIGHT="100.0" Z="0.863116984977422">
<NAME>Necrotising enterocolitis</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.5399639211878311" CI_END="1.931822110070008" CI_START="0.2057223063673744" DF="2" EFFECT_SIZE="0.6304116908616859" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" I2="0.0" ID="CMP-008.05.01" LOG_CI_END="0.28596713234245486" LOG_CI_START="-0.6867186154174011" LOG_EFFECT_SIZE="-0.20037574153747312" MODIFIED="2017-01-17 18:29:43 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.763393281761249" P_Z="0.41936975940206433" STUDIES="4" TAU2="0.0" TOTAL_1="117" TOTAL_2="102" WEIGHT="9.642562400427762" Z="0.8075151459624632">
<NAME>Ventilator-generated NIPPV</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:33:48 -0500" MODIFIED_BY="[Empty name]" ORDER="63" O_E="0.0" SE="0.0" STUDY_ID="STD-Friedlich-1999" TOTAL_1="22" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.794781034462849" CI_START="0.10750237766842106" EFFECT_SIZE="0.717948717948718" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.68076877882767" LOG_CI_START="-0.9685819301962298" LOG_EFFECT_SIZE="-0.14390657568427997" MODIFIED="2015-12-16 16:13:27 -0500" MODIFIED_BY="[Empty name]" ORDER="186" O_E="0.0" SE="0.9688367708983225" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="0.9386446886446886" WEIGHT="3.050410508623428"/>
<DICH_DATA CI_END="2.9822977569213727" CI_START="0.037256880488624015" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4745510018709087" LOG_CI_START="-1.4287935113102337" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2015-12-16 11:33:48 -0500" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="1.1180339887498947" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="1.2499999999999998" WEIGHT="3.930336616880186"/>
<DICH_DATA CI_END="6.455662881691861" CI_START="0.1453726100167811" EFFECT_SIZE="0.96875" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8099408432066292" LOG_CI_START="-0.8375174121778957" LOG_EFFECT_SIZE="-0.013788284485633297" MODIFIED="2015-12-16 11:33:48 -0500" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.967725134262757" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.936491935483871" WEIGHT="2.6618152749241473"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.7778003940885467" CI_START="0.38181021280260546" DF="0" EFFECT_SIZE="1.0298507462686568" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" I2="0.0" ID="CMP-008.05.02" LOG_CI_END="0.4437010351883466" LOG_CI_START="-0.4181524591154887" LOG_EFFECT_SIZE="0.012774288036428919" MODIFIED="2015-12-16 16:12:50 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.9536684189946173" STUDIES="1" TAU2="0.0" TOTAL_1="67" TOTAL_2="69" WEIGHT="9.035920947631409" Z="0.058100697264714105">
<NAME>Bilevel NIPPV</NAME>
<DICH_DATA CI_END="2.7778003940885467" CI_START="0.38181021280260546" EFFECT_SIZE="1.0298507462686568" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4437010351883466" LOG_CI_START="-0.4181524591154887" LOG_EFFECT_SIZE="0.012774288036428919" MODIFIED="2015-12-16 16:12:50 -0500" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="0.5062570087976748" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.25629615895676894" WEIGHT="9.035920947631409"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.240338626008517" CI_START="0.6315087969955417" DF="0" EFFECT_SIZE="0.8850337584396099" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="62" I2="0.0" ID="CMP-008.05.03" LOG_CI_END="0.09354026849299439" LOG_CI_START="-0.19962059529073903" LOG_EFFECT_SIZE="-0.05304016339887233" MODIFIED="2015-12-16 16:12:57 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.4781920494253329" STUDIES="1" TAU2="0.0" TOTAL_1="430" TOTAL_2="429" WEIGHT="81.32151665194083" Z="0.7092134240169173">
<NAME>Mixed NIPPV devices</NAME>
<DICH_DATA CI_END="1.240338626008517" CI_START="0.6315087969955417" EFFECT_SIZE="0.8850337584396099" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="62" LOG_CI_END="0.09354026849299439" LOG_CI_START="-0.19962059529073903" LOG_EFFECT_SIZE="-0.05304016339887233" MODIFIED="2015-12-16 16:12:57 -0500" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.17220414255624494" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="430" TOTAL_2="429" VAR="0.029654266713531528" WEIGHT="81.32151665194083"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.098346110986297" CI_END="1.11371332016928" CI_START="0.8144274595999152" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9523857989638724" ESTIMABLE="YES" EVENTS_1="204" EVENTS_2="202" I2="45.9378907451753" I2_Q="61.91454491565471" ID="CMP-008.06" LOG_CI_END="0.04677341391550495" LOG_CI_START="-0.0891475918937696" LOG_EFFECT_SIZE="-0.021187088989132345" METHOD="MH" MODIFIED="2017-01-17 18:29:54 -0500" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0853841767525565" P_Q="0.07239105698850701" P_Z="0.5411794769599372" Q="5.251348567506242" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="600" TOTAL_2="568" WEIGHT="100.00000000000001" Z="0.61103037177659">
<NAME>Chronic lung disease (oxygen supplementation at 36 weeks)</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.938958642057754" CI_END="0.9520567705243269" CI_START="0.5014174876717205" DF="4" EFFECT_SIZE="0.690925404075693" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="55" I2="49.61555815633759" ID="CMP-008.06.01" LOG_CI_END="-0.021337154146669778" LOG_CI_START="-0.2998005234554088" LOG_EFFECT_SIZE="-0.16056883880103928" MODIFIED="2017-01-17 18:29:54 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.09384002936800362" P_Z="0.023800961219514558" STUDIES="5" TAU2="0.0" TOTAL_1="158" TOTAL_2="140" WEIGHT="27.92535105107133" Z="2.2603270359810166">
<NAME>Ventilator-generated NIPPV</NAME>
<DICH_DATA CI_END="1.3728897852588204" CI_START="0.466169977278508" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="15" LOG_CI_END="0.13763567374427166" LOG_CI_START="-0.33145569976038447" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2015-12-16 11:23:43 -0500" MODIFIED_BY="[Empty name]" ORDER="92" O_E="0.0" SE="0.2755465948363832" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" VAR="0.07592592592592592" WEIGHT="7.238421666801201"/>
<DICH_DATA CI_END="0.9069420327208643" CI_START="0.050759286566747525" EFFECT_SIZE="0.21455938697318008" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.04242047002256124" LOG_CI_START="-1.2944844906415995" LOG_EFFECT_SIZE="-0.6684524803320805" MODIFIED="2015-12-16 11:25:37 -0500" MODIFIED_BY="[Empty name]" ORDER="97" O_E="0.0" SE="0.7354686035284823" STUDY_ID="STD-Jasani-2016" TOTAL_1="29" TOTAL_2="28" VAR="0.5409140667761358" WEIGHT="4.419246912362838"/>
<DICH_DATA CI_END="2.6145978068611493" CI_START="0.6799431151944617" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="8" LOG_CI_END="0.41740489255526714" LOG_CI_START="-0.16752741933866733" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2015-12-16 16:14:17 -0500" MODIFIED_BY="[Empty name]" ORDER="187" O_E="0.0" SE="0.3435921354681384" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="36" TOTAL_2="24" VAR="0.11805555555555555" WEIGHT="4.6325898667527685"/>
<DICH_DATA CI_END="1.1642941116095282" CI_START="0.37613565299764" EFFECT_SIZE="0.6617647058823529" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="16" LOG_CI_END="0.06606270103095975" LOG_CI_START="-0.42465549889274506" LOG_EFFECT_SIZE="-0.17929639893089266" MODIFIED="2015-12-16 11:23:43 -0500" MODIFIED_BY="[Empty name]" ORDER="93" O_E="0.0" SE="0.28825029972944977" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" VAR="0.08308823529411763" WEIGHT="8.203544555708028"/>
<DICH_DATA CI_END="1.2303695921450277" CI_START="0.06226611265570253" EFFECT_SIZE="0.2767857142857143" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.09003558925936458" LOG_CI_START="-1.2057482469311824" LOG_EFFECT_SIZE="-0.5578563288359089" MODIFIED="2015-12-16 11:23:43 -0500" MODIFIED_BY="[Empty name]" ORDER="94" O_E="0.0" SE="0.7611498396117639" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.5793490783410138" WEIGHT="3.4315480494464947"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5539689967039805" CI_START="0.5863418296799888" DF="0" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" I2="0.0" ID="CMP-008.06.02" LOG_CI_END="0.1914423499251933" LOG_CI_START="-0.23184912210176722" LOG_EFFECT_SIZE="-0.02020338608828695" MODIFIED="2015-12-16 11:24:22 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.8515859627894947" STUDIES="1" TAU2="0.0" TOTAL_1="64" TOTAL_2="64" WEIGHT="10.616351777975094" Z="0.18709523680778478">
<NAME>Bilevel NIPPV</NAME>
<DICH_DATA CI_END="1.5539689967039805" CI_START="0.5863418296799888" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.1914423499251933" LOG_CI_START="-0.23184912210176722" LOG_EFFECT_SIZE="-0.02020338608828695" MODIFIED="2015-12-16 11:24:22 -0500" MODIFIED_BY="[Empty name]" ORDER="95" O_E="0.0" SE="0.24864350599521612" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="64" TOTAL_2="64" VAR="0.06182359307359307" WEIGHT="10.616351777975094"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3001259506189036" CI_START="0.8819486812651074" DF="0" EFFECT_SIZE="1.0708148148148149" ESTIMABLE="YES" EVENTS_1="139" EVENTS_2="125" I2="0.0" ID="CMP-008.06.03" LOG_CI_END="0.1139854269292695" LOG_CI_START="-0.054556684813530855" LOG_EFFECT_SIZE="0.029714371057869348" MODIFIED="2015-12-16 11:24:55 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.4895073999335465" STUDIES="1" TAU2="0.0" TOTAL_1="378" TOTAL_2="364" WEIGHT="61.458297170953585" Z="0.6910925286798073">
<NAME>Mixed NIPPV devices</NAME>
<DICH_DATA CI_END="1.3001259506189036" CI_START="0.8819486812651074" EFFECT_SIZE="1.0708148148148149" ESTIMABLE="YES" EVENTS_1="139" EVENTS_2="125" LOG_CI_END="0.1139854269292695" LOG_CI_START="-0.054556684813530855" LOG_EFFECT_SIZE="0.029714371057869348" MODIFIED="2015-12-16 11:24:55 -0500" MODIFIED_BY="[Empty name]" ORDER="96" O_E="0.0" SE="0.09900247073462942" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="378" TOTAL_2="364" VAR="0.009801489211561154" WEIGHT="61.458297170953585"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.6581673638214063" CI_END="0.8214986618555935" CI_START="0.2786368639047275" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.478434750871394" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="37" I2="0.0" I2_Q="0.0" ID="CMP-008.07" LOG_CI_END="-0.08539313965339305" LOG_CI_START="-0.5549614265649515" LOG_EFFECT_SIZE="-0.32017728310917226" METHOD="MH" MODIFIED="2017-01-17 18:30:04 -0500" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.7983018174074368" P_Q="0.32189394428398765" P_Z="0.007521641712985021" Q="0.9812365093435098" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="618" TOTAL_2="611" WEIGHT="100.0" Z="2.6728208060611918">
<NAME>Pulmonary air leak</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.9667453129035265" CI_END="0.7936793027387228" CI_START="0.156822749353254" DF="3" EFFECT_SIZE="0.35279876751522266" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" I2="0.0" ID="CMP-008.07.01" LOG_CI_END="-0.10035494490989191" LOG_CI_START="-0.8045909365371696" LOG_EFFECT_SIZE="-0.4524729407235308" MODIFIED="2017-01-17 18:30:04 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8092978748472" P_Z="0.011783545523242941" STUDIES="4" TAU2="0.0" TOTAL_1="127" TOTAL_2="116" WEIGHT="51.89953456670662" Z="2.518561045844442">
<NAME>Ventilator-generated NIPPV</NAME>
<DICH_DATA CI_END="1.4497421980485377" CI_START="0.17244445276996065" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.16129078022171156" LOG_CI_START="-0.763350771549674" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2015-12-16 11:36:38 -0500" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="0.5431390245600108" STUDY_ID="STD-Gao-2010" TOTAL_1="25" TOTAL_2="25" VAR="0.29500000000000004" WEIGHT="21.428404412106588"/>
<DICH_DATA CI_END="3.1322503103103903" CI_START="0.037798763976709754" EFFECT_SIZE="0.34408602150537637" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.495856460934691" LOG_CI_START="-1.422522401402749" LOG_EFFECT_SIZE="-0.4633329702340291" MODIFIED="2015-12-16 16:20:46 -0500" MODIFIED_BY="[Empty name]" ORDER="195" O_E="0.0" SE="1.1268652398655326" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="1.2698252688172043" WEIGHT="7.908101628277431"/>
<DICH_DATA CI_END="3.7672503571186633" CI_START="0.03420600655264412" EFFECT_SIZE="0.358974358974359" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.5760244827204464" LOG_CI_START="-1.4658976254169689" LOG_EFFECT_SIZE="-0.4449365713482612" MODIFIED="2015-12-16 16:14:59 -0500" MODIFIED_BY="[Empty name]" ORDER="190" O_E="0.0" SE="1.1994351539973676" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="1.4386446886446886" WEIGHT="6.236625164717589"/>
<DICH_DATA CI_END="1.2649955552013255" CI_START="0.020607814229536094" EFFECT_SIZE="0.16145833333333334" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.10208899953956095" LOG_CI_START="-1.6859680692781147" LOG_EFFECT_SIZE="-0.7919395348692769" MODIFIED="2015-12-16 11:36:38 -0500" MODIFIED_BY="[Empty name]" ORDER="75" O_E="0.0" SE="1.0503135732487408" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="1.1031586021505377" WEIGHT="16.326403361605017"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-008.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-12-16 16:14:40 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="67" TOTAL_2="69" WEIGHT="0.0" Z="0.0">
<NAME>Bilevel NIPPV</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 16:14:40 -0500" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.0" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2842472300778476" CI_START="0.2935480551873669" DF="0" EFFECT_SIZE="0.6139937106918238" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="18" I2="0.0" ID="CMP-008.07.03" LOG_CI_END="0.10864863769152498" LOG_CI_START="-0.5323207925617146" LOG_EFFECT_SIZE="-0.21183607743509478" MODIFIED="2015-12-16 16:14:35 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.19514443019547711" STUDIES="1" TAU2="0.0" TOTAL_1="424" TOTAL_2="426" WEIGHT="48.10046543329337" Z="1.2955097787892527">
<NAME>Mixed NIPPV devices</NAME>
<DICH_DATA CI_END="1.2842472300778474" CI_START="0.29354805518736693" EFFECT_SIZE="0.6139937106918238" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="18" LOG_CI_END="0.1086486376915249" LOG_CI_START="-0.5323207925617145" LOG_EFFECT_SIZE="-0.21183607743509478" MODIFIED="2015-12-16 16:14:35 -0500" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.37650861618060366" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="424" TOTAL_2="426" VAR="0.14175873805823314" WEIGHT="48.10046543329337"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.7210215336301546" CI_START="-7.921021533630154" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.08" MODIFIED="2017-01-17 18:30:25 -0500" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.20756455723994438" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="27" TOTAL_2="27" UNITS="" WEIGHT="100.0" Z="1.2602906478824867">
<NAME>Rates of apnoea (episodes/24 h)</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.7210215336301546" CI_START="-7.921021533630154" DF="0" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-008.08.01" MODIFIED="2017-01-17 18:30:25 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.20756455723994438" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="27" WEIGHT="100.0" Z="1.2602906478824867">
<NAME>Ventilator-generated NIPPV</NAME>
<CONT_DATA CI_END="1.7210215336301546" CI_START="-7.921021533630154" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="8.2" MODIFIED="2015-12-16 11:37:44 -0500" MODIFIED_BY="[Empty name]" ORDER="84" SD_1="4.4" SD_2="12.0" SE="2.4597500625816378" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.08.02" MODIFIED="2015-12-15 17:40:29 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Bilevel NIPPV</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.08.03" MODIFIED="2015-12-15 17:40:53 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Mixed NIPPV devices</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.715792042124006" CI_END="5.440232382113518" CI_START="-0.005450288447442109" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="2.717391046833038" ESTIMABLE="YES" I2="36.38396321970145" I2_Q="0.0" ID="CMP-008.09" MODIFIED="2017-01-17 18:30:35 -0500" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.1938311149280978" P_Q="1.0" P_Z="0.050460354943834204" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="124" TOTAL_2="120" UNITS="" WEIGHT="99.99999999999999" Z="1.9560407412265615">
<NAME>Duration of hospitalisation (days)</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="4.715792042124006" CI_END="5.440232382113518" CI_START="-0.005450288447442109" DF="3" EFFECT_SIZE="2.717391046833038" ESTIMABLE="YES" I2="36.38396321970145" ID="CMP-008.09.01" MODIFIED="2017-01-17 18:30:35 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1938311149280978" P_Z="0.050460354943834204" STUDIES="4" TAU2="0.0" TOTAL_1="124" TOTAL_2="120" WEIGHT="99.99999999999999" Z="1.9560407412265615">
<NAME>Ventilator-generated NIPPV</NAME>
<CONT_DATA CI_END="7.093619988568964" CI_START="-19.093619988568964" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="86.0" MEAN_2="92.0" MODIFIED="2015-12-16 11:35:26 -0500" MODIFIED_BY="[Empty name]" ORDER="81" SD_1="23.0" SD_2="26.0" SE="6.680541118025518" STUDY_ID="STD-Barrington-2001" TOTAL_1="27" TOTAL_2="27" WEIGHT="4.324393492818235"/>
<CONT_DATA CI_END="5.238521559942841" CI_START="-12.198521559942849" EFFECT_SIZE="-3.480000000000004" ESTIMABLE="YES" MEAN_1="33.3" MEAN_2="36.78" MODIFIED="2015-12-16 16:22:55 -0500" MODIFIED_BY="[Empty name]" ORDER="196" SD_1="18.43" SD_2="16.81" SE="4.448307024370565" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" WEIGHT="9.753466086991649"/>
<CONT_DATA CI_END="18.175583522496325" CI_START="-26.175583522496325" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="72.0" MEAN_2="76.0" MODIFIED="2015-12-16 11:35:26 -0500" MODIFIED_BY="[Empty name]" ORDER="82" SD_1="46.65" SD_2="43.82" SE="11.314281128334244" STUDY_ID="STD-Khalaf--2001" TOTAL_1="34" TOTAL_2="30" WEIGHT="1.5076292572270404"/>
<CONT_DATA CI_END="6.9635603800741155" CI_START="1.036439619925884" EFFECT_SIZE="4.0" ESTIMABLE="YES" MEAN_1="62.0" MEAN_2="58.0" MODIFIED="2015-12-16 11:35:26 -0500" MODIFIED_BY="[Empty name]" ORDER="83" SD_1="6.0" SD_2="6.0" SE="1.5120483863225558" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" WEIGHT="84.41451116296307"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.09.02" MODIFIED="2015-12-15 17:41:36 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Bilevel NIPPV</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.09.03" MODIFIED="2015-12-15 17:41:36 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Mixed NIPPV devices</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.640818028614894" CI_END="0.9904994047364962" CI_START="0.4847303464132133" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6929106144229595" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="64" I2="29.088299255379415" I2_Q="39.89085195717093" ID="CMP-008.10" LOG_CI_END="-0.0041457811246594185" LOG_CI_START="-0.3144997905366737" LOG_EFFECT_SIZE="-0.15932278583066659" METHOD="MH" MODIFIED="2017-01-17 18:30:55 -0500" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.22762601413548467" P_Q="0.1894482824587863" P_Z="0.04418544698339047" Q="3.327280563974982" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="623" TOTAL_2="614" WEIGHT="100.0" Z="2.012327295118918">
<NAME>Death before discharge</NAME>
<GROUP_LABEL_1>NIPPV</GROUP_LABEL_1>
<GROUP_LABEL_2>NCPAP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours NIPPV</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours NCPAP</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.8014675161748" CI_END="0.813281309959567" CI_START="0.17620219768815104" DF="2" EFFECT_SIZE="0.37855244571072855" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="18" I2="28.608845597793884" ID="CMP-008.10.01" LOG_CI_END="-0.08975920811875543" LOG_CI_START="-0.7539886791368838" LOG_EFFECT_SIZE="-0.4218739436278196" MODIFIED="2017-01-17 18:30:55 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2464163720878102" P_Z="0.012785997508214304" STUDIES="4" TAU2="0.0" TOTAL_1="126" TOTAL_2="115" WEIGHT="30.114319447135706" Z="2.4896749439888692">
<NAME>Ventilator-generated NIPPV</NAME>
<DICH_DATA CI_END="2.6183017780452293" CI_START="0.10174120499529542" EFFECT_SIZE="0.5161290322580645" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4180197006512073" LOG_CI_START="-0.9925031230079031" LOG_EFFECT_SIZE="-0.2872417111783479" MODIFIED="2015-12-16 16:23:28 -0500" MODIFIED_BY="[Empty name]" ORDER="197" O_E="0.0" SE="0.8285480888179461" STUDY_ID="STD-Jasani-2016" TOTAL_1="31" TOTAL_2="32" VAR="0.686491935483871" WEIGHT="5.9901301498025585"/>
<DICH_DATA CI_END="0.6376564534210859" CI_START="0.060125296135299884" EFFECT_SIZE="0.1958041958041958" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" LOG_CI_END="-0.19541324066474453" LOG_CI_START="-1.2209427715809407" LOG_EFFECT_SIZE="-0.7081780061228425" MODIFIED="2015-12-16 16:15:39 -0500" MODIFIED_BY="[Empty name]" ORDER="193" O_E="0.0" SE="0.6024011229132237" STUDY_ID="STD-Kahramaner-2014" TOTAL_1="39" TOTAL_2="28" VAR="0.36288711288711284" WEIGHT="19.486669181356977"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-12-16 11:34:40 -0500" MODIFIED_BY="[Empty name]" ORDER="77" O_E="0.0" SE="0.0" STUDY_ID="STD-Khorana-2008" TOTAL_1="24" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.4389760930612585" CI_START="0.21141735004317108" EFFECT_SIZE="0.96875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6472828060572356" LOG_CI_START="-0.6748593750285022" LOG_EFFECT_SIZE="-0.013788284485633297" MODIFIED="2015-12-16 11:34:40 -0500" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="0.7766328618791105" STUDY_ID="STD-Moretti-2008" TOTAL_1="32" TOTAL_2="31" VAR="0.6031586021505376" WEIGHT="4.637520115976174"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.484093004489646" CI_START="0.1537033117368657" DF="0" EFFECT_SIZE="0.6179104477611941" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="0.0" ID="CMP-008.10.02" LOG_CI_END="0.39516785180265446" LOG_CI_START="-0.8133167749625093" LOG_EFFECT_SIZE="-0.20907446157992746" MODIFIED="2015-12-16 16:15:21 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.4976645402202806" STUDIES="1" TAU2="0.0" TOTAL_1="67" TOTAL_2="69" WEIGHT="7.4965427426223314" Z="0.6781690154894959">
<NAME>Bilevel NIPPV</NAME>
<DICH_DATA CI_END="2.484093004489646" CI_START="0.1537033117368657" EFFECT_SIZE="0.6179104477611941" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.39516785180265446" LOG_CI_START="-0.8133167749625093" LOG_EFFECT_SIZE="-0.20907446157992746" MODIFIED="2015-12-16 16:15:21 -0500" MODIFIED_BY="[Empty name]" ORDER="80" O_E="0.0" SE="0.7098698518572377" STUDY_ID="STD-O_x0027_Brien-2012" TOTAL_1="67" TOTAL_2="69" VAR="0.5039152065758166" WEIGHT="7.4965427426223314"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3133344115120864" CI_START="0.5548723087564983" DF="0" EFFECT_SIZE="0.8536585365853658" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="41" I2="0.0" ID="CMP-008.10.03" LOG_CI_END="0.11837532363907724" LOG_CI_START="-0.25580694837799695" LOG_EFFECT_SIZE="-0.06871581236945987" MODIFIED="2015-12-16 16:15:16 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.4716076087493303" STUDIES="1" TAU2="0.0" TOTAL_1="430" TOTAL_2="430" WEIGHT="62.38913781024197" Z="0.7198658380395303">
<NAME>Mixed NIPPV devices</NAME>
<DICH_DATA CI_END="1.3133344115120864" CI_START="0.5548723087564983" EFFECT_SIZE="0.8536585365853658" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="41" LOG_CI_END="0.11837532363907724" LOG_CI_START="-0.25580694837799695" LOG_EFFECT_SIZE="-0.06871581236945987" MODIFIED="2015-12-16 16:15:16 -0500" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="0.2197965188149483" STUDY_ID="STD-Kirpalani-2013" TOTAL_1="430" TOTAL_2="430" VAR="0.048310509683169925" WEIGHT="62.38913781024197"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2017-01-17 18:31:32 -0500" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2017-01-17 18:31:32 -0500" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram: review update.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAoIAAAOkCAYAAAAyclWKAAB0qklEQVR42uzdD6RV2f/H/y8ZSZIh
GUlGJMmVK5KRcWVIkvGVSEbGx8eQJEmGjyRXrkiSJJErIxkx8pGRxEhGMmIkV0YiSZIMV0auZP1+
7/377vPbZ3fO3vvcP3X/PJ5s95yz9157rb3e7/d63bX22ut/UoH/+Z//sdlsDbfphjphf+zPNlft
DxPw3aITA+it4ZMXqHP2x/4w44WgCgVmbjDkv+yP/UHdYwL1qCKBmRoM+S/YH4hBEIKAhhjsj/2B
DYAQBDTEYH/sD2wAhCCgIQb7Y39gAyAEAQ0x2B/7AxsAIQhoiMH+2B/YAD6eEHz48KE7DYFQEAb7
m/Zor9gAIfh/vHz5Mv3v//5vmj9/flqwYEHauXNnevXq1bguEmlMprFNleFNVroTTWcqz59JTjtT
8jodG+J//vkn7d27Ny1cuDDzv/Dfv//++4Pj3r59m1atWtUxjStXrqQvv/wyO3/Dhg3pwYMHGill
bHTt0dHRytUo6vZ/jPvSrU0pt1cf8/7ORHslBGexENy8eXP6+eef0/v377MtPn/zzTefzFDmkoD5
1Odj5jfEBw4cSOfOnWv5748//piJwSLv3r1LO3bs6JjGH3/8kTZu3JiePn2anX/58uW0Zs0adaOM
ja59/fr1D+ytl/0fWwhO9/vJ/vBJhOBnn33W6LecX3/9Nds/b9681NfXl27fvt0ykvJ/fJ2uWfwt
Gp59+/alRYsWpWXLlmU9E1U9goODg2nx4sVZ78fBgwcb5avJf4jDw8NpxYoV2bmRxo0bN1r7x8bG
0p49e7Le0tWrV6e7d+/W/qc5nrLWla/J+eMtY6dzL126lJYsWZLlZf/+/VmPUnH/vXv30tKlS9P6
9esr8//mzZu0fPnytvPz+xr11OnehZiJNOKeDwwMpOfPnze+z73YwWxoiD///PPMNoqir9zTEffw
2bNnHdPYvXt3OnnyZE/5aFr3TXyoSX2Xr1fnC1NpA4RgO8ePH09nzpzpel7d/jJPnjxJ27dvz2wh
6jDs5dq1a43jYNM2pUl7VWeXVTG1rhyEIKaVEMx7BHOuXr2avv76664JFQ3+5s2baeXKlV0Npa7R
Pn36dBoaGsqcN4ajN23a1FVcnT9/PnO8ODYau3DwEydONMpXnUgKh82dPNIoCuGjR49m9yT/77bY
W9KLEKwra1356s6fSBk7ndvf358dH9eLRj56nor7QxzGvhcvXtTmP4YuT5061XaNKE+kW85rHHf2
7NlWD1ekGyKi6X3uxQ5mQ0NcJkRXiKYit27d6ppGNGS9PCvVa93X+VCT+i5fr84XptIGCMF2oqc5
RpDin4AQXyGeetlfZt26dVmvdG4PYRtFe66r+17alKr2qoldVsXUunIQgphWQvDRo0dZr0L+n1F8
jt+6EcacB/U6Q6lrtOM//Gi4cu7fv9/VUUOYFHs+gmKAr8pXnUgq/qdX3h+NVvm64xGCdWWtK1/d
+RMpY6dzi7028Rxa9OpVpVeV/7CnOD/fH3/jmbQ8jWJe1q5d21bO+Bw9k03vcy92MBuF4E8//ZQJ
r6ZpROMVYil6LPJnhDs9Yzjeuq/zoSb1Xb5enS9MpQ0Qgu188cUXmc3lfn3hwoU2+6vb34TocWta
9720KVXt1Xjssq5+iuUgBDGthGD8VxP//eT/ucQwUfwX141oNPIeo2PHjk1ICJZ7peL63Rw1ji13
5xcdqypfExFwdT1nk1XWuvLVnT+RvHXaV264i9fvJiiq8h+9zNFrFMR/ymF3ndIrntP02sXferGD
2SYEX79+nXbt2pX1yjVNI36LHtt4qD/v+Yjh4l7y0avtdmsce7G1Kl+YShsgBKuJugjxN979QTwK
EGIx7DAEWa9xtGmbUtVeTTQO1ZWDEMS0EoLxPFGx0Y/P0TNQ56gxxLNly5Z0+PDhSROCVY7ayTGb
5ms6CsFey1d3/mQLwV6DYF3+o16i1ymI57by4cqJ2ERVAG5iB7OpIQ7x991331XO+O+URgzXFXs+
wv+rZv+Pp+6rfGg89d3EF6bKBgjB3nrwet0fzyZHD/LFixezGBGPA/QSH3qxp6r2aqJxqK4chCCm
lRAsi75oCOIB2SbEayaaOlYQMxOLv8VsxWIjNDIy0jW9EA/RazGefE3EoeOVG+MZGu61rHXlqzt/
soVg8RUiMVQYgqHq3Cb1E8+jxTM8MSzcLS+RTnlIpihM6u5zL3YwWxri6AmMXr24F72msXXr1g/8
v+ofwfHUfZUP9VrfvfrCZNsAIdhODJfGhLBi/eX/8DXZ3+kfk6It9RpHe2lTqtqr8dhl8be6chCC
mFZCMB7Ejv9aokchgnU01DHrqhvxX07MygvKD8hGAxLPTeQOVHxoO2YtxnBgMR8xRBizyvIHe2Pi
SjdnieHr/CHg2OJ7zORqkq+JiKTo2o+hpuC3337rOllkomWtK1/d+ZMtBOPacZ243n/+85+2xwU6
nVuX/yAmEMRMvuJEgk71HLMM83Ti1SjF99/V3ede7GA2NMS///57Nuwe7wMdTxrxLF1s+f2Oex/v
Euwljbq6r/KhuvrudL06X5hKGyAE2zl06FA26Suvv/DtqMOm+zv9s5jPrg0RF7bYSxztpU0pt1e9
xKG6mFpXDkIQ00oIxms9QgzGfzuxhQgsv+qjSAy5xPMO+ZT5PODmDX2eTjEIx7HhRHFsOR/xTGL8
1xizyuL5pCpnOXLkSPafVqQfAiCfRViXr4mIpLgX8QB9pBnpx8PHnY6baFnrytfk/MkUghHE4lme
ePA+gnlxAkG3c+vyHz1Xsa88fNnttQ2xxUy9x48fN77PvdjBbGiIYxJO0xf2dvs9Gryo57ze/vrr
r57zUVX3VT5UV9/drlflC1NpA4Tgh+3HDz/8kNV7TDSMfwh62V/mzp072USjqLcQ9PFPSq9xtGmb
Um6veolDdTG1rhyEIKaVEAQ4/MxtiMH+2B/YAAhBcHgNMdgf+wMbACGIiTMZa0YLhIIw2B/YHwhB
QCAUhMH+wP5ACAICoSAM9gf2B0IQEAgFYbA/sD8QgoBAKAiD/YH9gRAEBEJBGOwP7A+EICAQTrcg
/PDhw2lRD9MlH+wPc8mO2QAhOOMNKVYXiLe89/f3cxrMmoa4Lk+Tmefya4WKaZf9a6LXrTq/Kh+z
2VYIwanP71z0J20aIThnKK5RC8yVhngy81yV1mT7V9PlEwlBQvBj5nc2+hMhOMeFYKxTWl5XOBbg
7uvra32PBcNjzcZYb/HgwYMfGEas6xnrlK5fv77tP5lY5zPSuX37dldDytdyjMW/Y5H6WAC8eOzw
8HC2eHe+ZmidY3RLr+k6rOWydCv/mzdvau9d+Trd7uOXX36ZrcEbPH36NDvvjz/+yL6/fPky2w9C
sEmP4Pv377O1wmPN32XLlqUrV640tsM6n+vkQ8W/3fY1uW6TfBfz2OlasV5yt1jRzbfr4k9dHUSZ
Is+xhu7Zs2c/WEu2Kk+zyf6axs1inIy1e+O+r169Ot29e7endqF8vTr7qWqT5ro/EYKEYNq7d286
depU22+nT5/OjCyIBbvDkMOw3r17lxlULNRdNIz9+/dn+/NF5ovGfvPmzWzh7U6GFNeN4BnnxhbX
iuBQPDYWr8+DQKQZaXejSXp1Rl4uS1X56+5d8XpV6Xz33Xfpl19+yT7//PPP2XBBHJ9/L5YBhGDV
72F/Q0NDmZ29evUqbdq0qbEdNvG5qp64qn11163Ld5MewW3btlXmu+zb44kXxd+iPIcPH27l+auv
vvrgflTlaTbZXy9xMzh69Gi6evVq9vn69etpzZo1PcXx8vXq7KeqTeJPhOCcF4KPHj3KerbCYPL/
JKIHKjfceD4h35dTFnbF/9aC+E8td/IqQ1q7dm32n2Hxv8QlS5ZUpl1liE3SqzPy8vWqyl9374rX
q0rn0qVLmagM/v3vf6fdu3dnW/D9999nTg5CsIkQjB6Sog/cv3+/sR028bnxNlx1163LdxMhWJfv
8v7xxIvibxs3bsx67Lvludf4NZPtr5e4GYTwK++fSLtQZz9VbRJ/IgTnvBAMvv766+y/i+Dy5cvZ
fzDF/6TK3dTRxV1lGPEfV/wexnrs2LGuhlRMp3i9poG4zHjSq0u7rvxV9678H2m3dEJQrlu3Lvsc
wxYPHjzIBGYQwyYxXAxCsIkQLPc4RWPR1A6b+Nx4G66669blu4kQ7CXfkxF/yg/6l/Pca/yaDfY3
3vqeaL3U2U9Vm8SfCEFCMP1/XfMhOHIhcuvWrUqnbGIY8QxHpLtly5Zs+KSJkzUJ3nUP1/aaXl3a
deWvund1ordIPGMUXfi5AIxnSkZGRlrfQQiORwj2aodT1XDVXbcu31MhBCcaf+oa27ksBMdT3xOp
lyb2061N4k+EICH4f4TwiOcKyhMTQtyMjo6O2zCid6ubcUfa5SGA4n/ZvQbS8aRXl3Zd+avuXbms
Vens2LEj/etf/2oNCefDw/l3EIJNGuIYriz6QPwz0YsdTlXDVXfdunxPhRDsNV7kE7lyNmzYkP3z
lvPnn38Sgg3re9WqVV2HhscTx3uxn3KbxJ8IQULw/4gHTWN2UfGB0yAe3M0fOo0tvscsrirDiOc/
YpZWUPVwbKQVs+rytM+dO5cFiPEG0vGkV5d2Xfmr7l25rFXpRL7jOZjIc3DhwoVsxlw+7AxCsElD
HI8nHD9+vPWQ+ObNm3uywzqfC5uMZ57yRqZpw1V33bp8l6nKR1MhWBcvihMMnj17lj32UTVZJMpD
CDar75gsEsO1wW+//fbBZJFe43id/VS1SfyJECQE/494fUn811X8DzfnyJEj2TT02B/BMJ+p1c0w
ogs+HvjNp8vnDtjp+Pw1AbHFzLDHjx9PKJD2ml6TtKvKX3XvyulVpfP777+3vTYmf7j3r7/+YrmE
YE8N8cmTJ7N/KuLVEjG7sBc7rPO5+Gcnzst7aJo2XE38qC7f5X++uuWjqRCsixe5YIg4FkIk4lg5
nWhsI7/xj2DkeSIjGrNJCNbVd7x2a+fOndn9jbYi4t1E43iV/VS1SfyJECQEAczohhjTgxA3U/1M
L/vDXI1/IAQBQpD/TiuityUmH+TvcoterKpJCOwP4h8IQUAgFIRnCfGGgHhfWwzNxaz/Q4cOZYKQ
/UH8AyEICISCMNgf2B8IQUAgFITB/sD+QAgCAqEgDPYH9gdCEBAIBWGwP7A/EIKAQCgIg/2B/YEQ
BATCj3/thw8fqlj2N+5rz0X7mas+Q0MQggAnmiFCsJdji6thaAzYX6/XLtvPdLSPyc7TTCgzIQhC
ECAEp6RM4gj7q/p9LgjBmVBmQhCEIDBHGuJY2WLfvn3ZuqOx5u2VK1fajn3y5Em2FmkscB/rrK5e
vTpdu3atlWZxqzs+P+f58+fZGrBxzNatW9vWiq07P9Z5zdfw7evrS7dv324rz+DgYLY+aqwze/Dg
QUY3je2vk/3E3zNnzqQVK1a01vaNdZuL58Tav0uXLs1eyJ2Try8cdjMwMJDZWN21y3YTPhAv9z57
9uwH6/ZW5akT3fIznjLX2XW3e8L+QAgCAmHttU+fPp2GhoYyQfjq1au0adOmtmPXrVuXLl++nO2P
LRrJaHC6pdvk+I0bN6aXL19m+3/55Zf0/fffNz6/2EjevHkzrVy5srXv/PnzaXh4uLVsW4jaEydO
MLxpbH+dese2bdvWEk5R11Hnxf379+/P6vjFixfZb6dOncrsJLeZsIP4R6OpEAybieX9ch/46quv
PhCCVXkq02t+6tKvs+tO94T9gRAEBMJG144ehLGxsdb36J2ry2f0WvRSpvLxxR7AaLz6+/sbnx+i
8OrVqx2Pi3QivSJFocj+ZoYQLPbmlY/ptH/t2rVtNhyfYy3npkIw/8ekmw/U5alMr/mpS7/Orjud
z/5ACAICYaNrl3s2osEpHxvDTkePHk27d+/OGrlyI1mm1+PLeag6P3oB43s0jseOHfsgnfLQW1FE
sr+Z+Yxgnf10quNyL2JVmuXJG2UfaDK0PJH81KVfZ9czpW2mIQhBgBPNACFYPvbSpUtpzZo16eLF
i+nWrVvZ0FNVI9nr8eWGuO78XChev349bdmyJRvSq2qAMfuFYJ0NNxFakykEe81PXfp1dk0I4qPV
oYoEZm4Q7Hb9GBYrDmONjIy0HRsP0I+Ojra+P336tLJRa3L8o0ePWt/j2suXL298fpEHDx607YvJ
I8VzMTeEYNR7eSi2+M9F+ZyyTW3YsCF7NjDnzz//nJAQ7DU/denX2TUhiI8qBFUmMDMDYLc8xMSM
48ePtx6U37x5c9uxMZMxn7UbIjEazeL+mBUZzyflDV/d8fH5m2++Sa9fv86uGRNVipNF6s6P3sKY
ORyUH6qPh/TziS+xxfeYsYnpKwTL9jMeIRj1HLNu83o/d+5cWrVqVWt/cYLRs2fPslnpVZNFwmYm
IgTr8tNrmevsmhDERxeCeYXabLZm23QPwidPnsweZo/XU8QMxeKxd+7cyR5Mj8Y0RFhM1Cjuj9mL
0duR93jUHR+f4xpxrTgnRGHxQfe682NYOJ4bzF+zkYvCnCNHjmS9ipF2NPjTeRYlIfih/YxHCAb5
61piixm6jx8/bu3L/2EImwlBFjZTTif+GQqbjFcohX1W9eA1uZdV+em1zHV2TQjikwhBcDSwDbCB
2Wh/b9++bXtcAWIQCEGOBrYBNjBL7S96w2PyUf6evujNK05CghgEQpCjgW2ADcxS+4vZ6fE+zRh2
jZVFDh06lAlCiEEgBDka2AbYAPsDGwAhyNHANsAG2B/YACEIjga2ATbA/sAGCEFwNLANsAH2BzZA
CIKjgW2ADbA/sAFCEBwNbANsgP2BDRCC4GhgG5OWR/ZNCIL9gRAER8McFYIgBMH+QAiCo2ESbSPW
Xc3XYe3r60u3b99u2z84OJitwRprph48eLBt35MnT7J1TxcsWJClsXr16nTt2rW2a8bawEuXLs1e
2BuMjY1la6/GOXH83bt3244/c+ZMWrFiRWst4VgntlMZ4vPw8HDXY/O8x/qs8ZLgs2fPznn/mI5C
sM7+8jV7w14GBgba1qVusi5xL/ZXZ+91eYX2iRAER8OMs42igLp582ZauXJla9/58+czsZUvvXXl
ypV04sSJ1v5169aly5cvZ/tjC7EVjW7xmvv378/2vXjxIvvt6NGj6erVq9nnWNZrzZo1bcdv27at
1dhHviJ/3Rr5EKHdjo18xzJhce1Xr16lr776ihCchkKwyv5OnTqV2VRuX2GPIeJ6EYK92F+dvVfl
FdonQhAcDTPSNkK45Q1jmf7+/qxRLFLX+EVvSfGaxR6cIBrecppVx5cb9qbHbty4Mb18+bL1/f79
+4TgNBSCVfa3du3arAcvJz7HusC9CMFe7K/O3qvyCu0TIQiOhhlpG9GzEfuiETx27FjbvugBiX3F
rSj0ghh6i16W3bt3Zw13N+FWTLOXPFYJwapjY93YItHAE4L/M6Psr2xrZfvpxV6a2F+dvVflFdon
QhAcDTPWNkLMxTDZli1bsuHUqoa4yKVLl7IelosXL6Zbt25lw2/TRQiWr0MITt/JIt3sr5Ot9GID
vdpfnb1X5RXaJ0IQHA0z3jYePHjQdlw8ED86Otr1+JiIUdz/9OnT2oZ41apVlUPDkyUEN2zYkD0b
mPPnn38SgtN81nAn+ysPDRd7estpTtT+6uy9Kq/QPhGC4GiYkbYRPXoxGzIoT7iIh/WHhoZaD+vH
95i5mRMzdvNZwiMjI5n4qmuIYxg5htiC33777YPJIpMlBMuTRSLfhOD/zDj7i1nkuf2dO3cuE3I5
xckbz549yyYPTcT+6uy9Kq/QPhGC4GiYkbYRQ13xbF/+Cpa8ocs5cuRI1vMXPTHR0OazL4M7d+5k
D9PHedFIxoP0dQ3x27dv086dO7Nz4roxiWMqhGBw/Pjx7FUgy5Yty2aElp8bZAPT3/7y18fEFjOG
Hz9+3NqXi7E4NwRinDsR+6uz97q8QvtECIKjgW1MU0IALF++nA2wP7ABEIIcDWxjthOvGYmH+vN3
wkXP0lx/uJ8QhBgEQpCjgW3MCWIWc6wmEUN8sbLIoUOHMkHIBtgf2AAIQY4GtgE2wP7ABkAIcjSw
DbAB9gc2AEKQo4FtgA2wP7ABEIIcDWwDbID9gQ2AEORoYBtgA+wPbEAdugUcDWwDbID9gQ0QguBo
mEW2EUtubdu2rfX9n3/+SXv37s1Wc4jXr8RKDH///Xdrf3yOVRcWLFiQHbNr1662dX1z4iXOxSXB
OlFejaQbU52nWGM28lHeciLtWJJMfBCbwAYIQXA0zCrb6O/vT48ePWp9P3DgQLaua77maryMOYRX
zuDgYDp27Fhr/08//ZQtzVUk3tm3Y8eOyuvG+rBN1wCe6jzFy6eL6ZWJ+xPvJRQfxCawAUIQHA2z
xjZ+//339M0337T9Fi9gDjFVFFDFdXrj+JGRkbb9W7dubUsjBF4IvSqb3LJlS/rrr78a2e1U5ynW
JT5z5kxlHuIacb/EB7EJbIAQBEfDrLCN6Gm7dOlS5bljY2Np6dKlre+LFi1qE2X5b0ViZY+q64bw
Onv27LjtdrLzFD2FIfQWL16cnRc9jmUuXryY3S/xQWwCGyAEwdEwK2xjw4YNbT1pnYhh1qNHj7a+
f/bZZx8c0+m3btf9448/2nohx2O3k52nL774IkszCEF54cKFtvSDuE9xv8QHsQlsgBAER8OssI2Y
XFHuSSvy+vXrbOJFcZ3eefPmjVt0vXnzJnvW7uXLl+O228nOUyfinoQ4LP8WE1HEB7EJbIAQBEfD
rLCNTgIqJ4TWd99998Hs2/KQa7ffOl33+++/T7/88kvXY7rN2p3KPHWjF3EpPohNYAOEIDgaZpxt
dOsRjF63eF3L06dPP9gXkzzidS458UqWmIjR5LqdXtHSTfR9rDwFS5YsyXorc+IZxNWrV38gQvUI
ik9Q94QgOBtmjW3EM2/3799v+y1mxn799ddtw7dF4lUtQ0NDrVe1xCSKeHXLeG2yyTFTnadDhw5l
aeTnnzhxIntdTZE///zTM4JiFNQ5IQgOh9ljGzEL9vz5822/LV++vLLH7sWLF2nz5s3Z61tii5dR
F1/uPBVCcKrzFD2IP/zwQ3ZuvKomRGWZmEBi1vDk5MM2dzYQgiAEMY1t4+7du12HUNHOpk2b0r17
98QHuP8gBCHQYPbYRqws8vDhQzepgnh1TNwn8QHuPwhBCDSYVbZx48aN9O2337pJFcT9sdYw3H8Q
ghBowDbABuD+gxCEQAO2ATYA9x+EIAQasA2wAbj/IAQh0IBtgA3A/QchCIEGbANsAO4/CEEINGAb
YAPuP0AIQqAB2wAbcP8BQhACDdgG2ID7DxCCEGjANsAG3H+AEIRAA7YBNuD+A4QgBBqwDbAB9x8g
BCHQgG2ADbj/ACEIgQZsA2zA/QcIQQg0YB9Q9+oAIAQh0ICNQJ2rB4AQFGiAOjuxzZ0N4jNACAo0
AP/gH2B/ACEo0AD8A2B/ACEo0AD8A2B/ACEo0AD8A2B/ACEo0AD8A2B/ACEo0AD8A2B/ACEo0AD8
A2B/IAQh0AD8A2B/IAQh0AD8A2B/IAQh0AD8A2B/IAQh0AD8A2B/IAQh0AD8A2B/IAQh0AD8A+wP
IAQh0AD8A+wPIAQh0AD8A+wPIAQh0AD8A+wPIAQh0AD8A+wPIAQh0AD8A+wPIAQh0AD8A+wPIAQh
0AD8A+wPIAQh0ACN/cNm+5QbQAiCEAQgvgAgBCFQAxBfABCCEKgBiC8ACEEI1ADEFwCEIARqAOIL
AEIQAjUA8QUAIQiBGoD4AoAQhEANQHwBQAhCoAYgvgAgBAVqABBfABCCAjUAiC8ACEGBGgDGG1es
mQuA5xOCAAhBcQYgBEEIApirYhAAIQhCEAAhCIAQBCEIgBAEQAiCEARACAIgBEEIAhBfABCCEKgB
iC8ACEEI1EAzO7bZbM02gBAEIQg2DPAZgBAUEFQT2C/AdwBCUDAA2C7AhwBCUCAA2C7AhwBCUCAA
2C7AhwBCUCAA2C7AhwBCUCAA2C7AhwBCUCAA2C7AhwBCUCAA2O4c4+HDh27CDL0PfAiEIAQCzDrb
/eeff9LevXvTwoUL0/z589POnTvT33//3XZeeZs3b94H6bx9+zatWrWKb5f49ddf02effZb6+/uz
73GPZ1p5imlNVrof6z6I/yAEIRAAFbZ74MCBdO7cufT+/fts+/HHHzMx2I3//ve/6ciRI22/vXv3
Lu3YsWNG+8dU5T1E4I0bNz56DJkqITiXY6n4D0IQAgFmne1+/vnnmQAsirpuvTVx3Lp169KbN2/a
fh8YGEjPnj1r5B9xzL1799LSpUvT+vXrW78PDg6mxYsXZz2TBw8ebDtnbGws7dmzJy1YsCCtXr06
3b17t21/iNc4L/ZHXp4/f155vSjHvn370qJFi9KyZcvSlStX2vKe9+JFz2dfX1+6fft21/I8efIk
bd++Pbt2nBP5u3btWuvaTdawrSp7t/tVrpeq8nSql/L+S5cupSVLlmR52L9/f9bD2+3YJvXSy31p
ch96qRPxH4QgBAJgnLYbjXuIjk6cP3/+g97A4NatW42vEceE0Ajx8uLFi1a6w8PD2W8hREPInDhx
onXO0aNH09WrV7PP169fT2vWrGntO3XqVDp79myrRzPSCnFSdb3Tp0+noaGh7LdXr16lTZs2teW9
2It38+bNtHLlyq7lCWF8+fLl1vUjL8X7V74n5e91Ze+U/zJ15WkiBGPoOgR0pBGCLHqK64RgVb30
el/q7kMvdSL+gxCEQACM03Z/+umnrIHvJnqePn06oWvEMcUeuyBESLFXMig29CEwyvtz1q5dm4nX
opCNnq2q60XPWvGc+/fvt+U9BEsucMZD8RnKOiFYV/ZO+S9TV54mQrDYmxfPjS5fvrxWCFbVS6/3
pe4+TLROxH8QghAIwHZreP36ddq1a1fWI1Pm0aNHacOGDRO+RqdjorenakJK7G8iLjod3+16RUKA
FI+LHqe8l+zYsWO1ZYqh2xDPu3fvzoRplQgrf68re5N7WleeJkKwLMK63cNyz+lk3Ze6+9BrnYj/
IAQhEAA92G6Iv++++y4bWuzEmTNnsmfxpkIIdhJzVUKnbl+dCKo7JxcxMdy5ZcuWdPjw4a7Xj2fr
omfs4sWL2RB5DN/2IgTryj4eIdjkHvRyj8YjBHu9L3X3oZc6Ef9BCEIgAHqw3egJjFfIVA37xqzg
aISnQgjGw/+jo6Ndz4nX0nQbgoxzy0PDxckuna63cePGtnNGRka65v3BgweV5YoJGsW8xz3sRQjW
lb3JPa0rTzmNTnmMcubE64OiXHVCsKpeer0vdfehlzoR/0EIQiAAGtru77//nr7++uv08uXLyvPj
ea1ukxUmKgRjwkc+2SG2+B6zf3NieDGGBoPffvvtg8ki0VuZnxuvwim+z7DT9WISw/Hjx1uTKzZv
3vzBs28xSzWICQpVPV8rVqxozYYNARbD51WCJ2bRxjN/uXCrK3uTe1pXnuJEi5jdHbN5y3mMa8a5
kcZ//vOfTPjXCcGqeqm7L73eh17qRPwHIQiBAGhouzEpoOrVJkUxUTcxYLxCMIjZyNGLFL15IVSK
ojNeZRLvNow8xLNmMRmiSP76mNhixvDjx49rr3fy5MlsUkm8riRmrBaPiyHIuE4MV8Y1cwHSiTt3
7mQiOY4LsRITGqqEYMyEjTIWey2ryt405lSVJxdOUZ4QyVGech5DtH3xxRfZpIxDhw598FLxTp+r
6qXuvvR6H3qpE/EfhCAEAoDtgm24TyAEIRAAbBdsw30CIQiBAGwX+ICZuO4vHwIhCIEAYLsAHwIh
CIEAYLsAHwIhCIEAYLsAHwIhCIEAYLsAHwIhCIEAbJftAnwIhCAEArBdAHwIhCAEArBd5QTYFghB
CARgu8oJsC0QghAIMKdsN36PdVxjjdn169e3fh8cHMzWrY31ew8ePPjBORcvXszWtv3888/Tzz//
nE6dOpWtExvrwMbatkXytYAXLFiQBgYG0vPnz9ObN2+ydY5jvdoiY2Njqa+vr1E+Yu3jffv2Zddd
tmxZunLlCh+F+A9CEAIB0IsQ3L9/fyaqXrx4kf12/vz5NDw8nP327t27TGCdOHGi7Zzvv/8+2/ff
//43E2I//PBD9j1EYIjBnBCIZ8+ezdKKLdLes2dPtm/v3r3Z/iKnT5/OxF+TfMSxQ0ND2f5Xr16l
TZs28VGI/yAEIRAAvQjB6KEr0t/fn4mrIitXrux6TnwfHR3teK21a9dmvXw58Tl6EoNHjx5lvYL5
teLvl19+2Uq7Lh/Rg1lM+/79+3wU4j8IQQgEQC9CsEz06MXvxW3evHldz6n6XjyvmH7O119/nfX6
BZcvX07bt29vnI9iOrmQ5KMQ/0EIQiAAJiAEO4m3psKv/L0s1sr7r1+/nlavXp19jmcDb9261Tgf
dWkD4j8IQQgEQI9CMARZcah3IkIw0ioPDc+fP7/t+BUrVmTP+8WwcC/52LhxY1vaIyMjfBTiPwhB
CATARIRgTODIJ2HEFt9jtu94hGCce+bMmVZa586dS6tWrWo7PiaAxKzf4kSQJvmIoeTjx4+3Jots
3ryZj0L8ByEIgQCYiBAMjhw5ks0Gjt67eG4vn1HcqxAM8tfHxBYzhh8/fty2//Xr19l1Qsz1ko/g
5MmT2eSTeMVMzDLmoxD/QQhCIADYLsCHQAhCIADYLsCHQAhCIADbBcCHQAhCIADbBcCHQAhCIADb
BcCHQAhCIADbBcCHQAhCIADbBcCHQAhCIADbBcCHQAhCIADbBfgQQAgKBADbBfgQQAgKBADbBfgQ
QAgKBADbBfgQQAgKBADbBfgQQAgKBADbBfgQQAgKBADbBfgQQAgKBADbBfgQQAgKBAD7BfgOCEEI
BgAbBvgMCEEICMAU2rHNZmu2AYQgCEEA4gsAQlCgVk0AxBcAhKBADQDiCwBCUKAGAPEFACEoUAOA
+AKAEBSoAUB8AUAICtQAIL4AIAQFagAQXwAQggI1AIgvAAhBgRqA+CK+AIQgBGoA4gsAQhACNQDx
BQAhCIEagPgCgBCEQA1AfAFACEKgBiC+ACAEIVADEF8AEIIQqAGILwAIQQjUAMQXAIQgBGoA4gsA
QhACNQDxBQAhCIEagPgCgBCEQA1AfAFACEKgBiC+ACAEIVADEF8AEIIQqAGILwAIQYEaAMQXAISg
QA0A4gsAQlCgBgDxBQAhKFADgPgCgBAUqAFAfAFACArUACC+ACAEBWoAEF8AEIICNYA5H1fKGwBC
EIQgAEIQACEIQhDAXBGDAAhBEIIACEEAhCAIQQCEIABCEIQgAEIQACEIQhCA+AKAEIRADUB8AUAI
QqAGZoef2ebOBnbP7glBQhAAH1Pn7gHmdJ2zAs4K8C+oe2XHHK17lsBhAb4FNqDMmKM2wBo4LcC3
wAaUGYQgOC3At8AGlBmEIDgtwLfABpQZhCA4LcC3wAaUGYQgOC3At8AGlBmEIDgtwLfABpQZhCA4
LTDLfOuff/5Je/fuTQsXLkzz589PO3fuTH///XfbeeVt3rx5H6Tz9u3btGrVKrFHGWeF3QdXrlxJ
X375ZbZ/w4YN6cGDBz3tZxOEIBglMO1968CBA+ncuXPp/fv32fbjjz9mjWI3/vvf/6YjR460/fbu
3bu0Y8eOGe2/hCC7L9r9H3/8kTZu3JiePn2a7b98+XJas2ZN4/1sghAEowRmhG99/vnnWUNWFHXR
w9GJOG7dunXpzZs3bb8PDAykZ8+eNfLfOObevXtp6dKlaf369a3fBwcH0+LFi7MemoMHD7adMzY2
lvbs2ZMWLFiQVq9ene7evdu2PxrxOC/2R16eP39eeb0ox759+9KiRYvSsmXLsp6dYt5//fXX9Nln
n2U9n319fen27dvi6xyz+927d6eTJ092TbduP7snBCFQATPSt6LxicajE+fPn/+gNzC4detW42vE
Mfv3788apRcvXrTSHR4ezn6LBjkaqBMnTrTOOXr0aLp69Wr2+fr16209L6dOnUpnz55t9exEWtF4
Vl3v9OnTaWhoKPvt1atXadOmTW15j8bwxo0b2eebN2+mlStXiq9zzO5XrFiRHj582PX4uv3snhCE
QAXMSN/66aefsgaoE9EbGENhE7lGHFPsuQj6+/vbemeCYiMUDWB5f87atWuzRrzYoC9ZsqTyetFD
Ujzn/v37bXkPQZA3wOLr3LT7EEUhhqInLnrcys8Q1u1n94QgBCpgxvnW69ev065du7LeiTKPHj3K
Hoif6DU6HRONatWElNjfjU4TV4rHd7tekWhsi8dFAx/fo6E+duyY+DoH7T7Oi8kko6OjrR63GA5u
up/dE4IQqIAZ5VvRCH733XfZkFEnzpw5kz2TNBVCsFOjVtWA1e1rC/wNGsROx8XzVTEct2XLlnT4
8GHxdY7ZfTxHV+w9C9FUfIawbj+7JwQhUAEzxreiRyR6N6qGfWNWcDQQUyEE48H06FnpRryWptsQ
WZxbHiIrNsidrhezPYvnjIyMdM17vBJktsQlQrC53W/durXte9hfDAE33c/uCUEIVMCM8K3ff/89
ff311+nly5eV58ezS/lD55MtBOPB9/wh9tjie8yCzIlnt2LYKvjtt98+eGg+eivzc+OVIMX3GXa6
Xrzq4/jx462H5jdv3tx2XKQfMyiDeHi+qmdGfJ2ddh/PysWW21XYWPHRiLr97J4QhEAFzAjfWr58
eceXRpeJRqFb78REhWAQs5FjuC16NbZv394mOuNl1fEwfuQhHpKPh9yL5K/RiC1mTj5+/Lj2evHq
j3i4Pl7dEc93FY+L4bG4TgzdxTXzxlF8nVt2H0IrJlDkNvnXX3/1tJ/dE4IQqAC+BTagzCAEwWkB
vgU2oMwgBMFpAb4FNqDMIATBaQG+BTagzCAEwWkBvgU2oMwgBFUYAL4FNqDMIAQFKgB8C2xAmUEI
cloAfAts4MMyVZWL3YMQFKgA8C3MciHY7cXQ7B6EoEAFYA77lpjy4b3oJp5m6zZTbO1Tn08IQtAG
+JZyuxczrkzTpUeQECQEIVABM863Yj3RWFc01hft6+tLt2/fbu0bGxvL1jBdsGBBWr16dbp7925b
erE2aay1un79+tbvg4OD2Tqmsf7pwYMHP7he1f5Ic3h4OK1YsaK13umNGzcanx9rIe/bty9bu3XZ
smXpypUrYsocEYLjKXM3W9q1a1f67bff2nxk69atjXyi6rrF35rYKlsnBAUqAFPuW0WxdfPmzbRy
5crWvqNHj6arV69mn69fv57WrFnTlt7+/fuzBunFixfZb7GIfQi5+O3du3dZ43TixInWOXX7I83t
27en58+fZ98jX5G/puefPn06DQ0NZftfvXqVNm3aJKbM8fjarcxVthT2vGHDhmzf27dvM5949OhR
I59oKgTrbJWtE4IqDMBH8a3o0csbtjLRyEVD0y29XLDl9Pf3f3B8UVjW7e+UZjHfdedHz2T02OTc
v39fTCEEO/5eZ0shxEJshfg6cOBAY59oKgTrbJWtE4IqDMBH8a3oBYx90fAcO3asbV+xN65JenF8
+VmtGOJtur+u8WySfpFoSMUUQrATdbaUi7ElS5ak169f9+wTTWy5ylbZOiGowgB8NN+KZ/1imGvL
li3p8OHD4xaC5Ya01/11jWfd+Z3yK6YQguOxxWDbtm1ZD+DHEIJsnRAEQwY+uW89ePCg7bhVq1Y1
GgbLickmo6OjXdOv21/XeNadv3HjxrbhspGRETGFEByXLZ47dy57Ru/ixYttQ8NNfaJ83adPn7b9
VmerbJ0QVGEAPopvRY9HzIoMypMz4sH4GDoOYhZltwfjc06dOtV6gD22+D4wMNB4f50QrDv/8uXL
6fjx460H6Ddv3iymEIIdf6+ypZgs8tVXX7WJsr/++qsnnyhOwnr27Fk2Caq4v85W2TohqMIAfBTf
imHhtWvXtl7XkovCIGZM7ty5M/s9jokH0uvSO3LkSPZKi/nz52eNXz6juMn+OiHYJP2TJ09mz3XF
azfigX8xhRDsRjdbCpsvvj4mPsf+Xnwi/6cq/Cp6EcOvynmps1W2TggKVAD4FtiAMoMQ5LQA+BbY
gDKDEOS0APgW2IAygxDktAD4FtiAMoMQ5LQA+BbYgDKDEOS0APgW2AC7ByHIaQHwLRCCYPeEIKcF
+BbYgDKDEASnBfgW2IAygxAEpwX4FtiAMoMQBKcF+BbYgDKDEASnBfgW2IAygxAEpwX4FtiAMoMQ
BKcF+BbYgDKDEASnBfgW2IAygxAEpwX4FtiAMoMQBKcF+BfUvbJj2tY9S+CwAB/jY+rcPcAcrXNW
wFkB/J+f2ebOBnbP7glBQhCA+CK+AHM7BrgFAjUA8QUAIQiBGoD4AoAQhEANQHwBQAhCoAYgvgAg
BCFQAxBfABCCEKgBiC8ACEEI1ADEFwCEIARqAOILAEIQAjUA8QUAIQiBGoD4AoAQhEANQHwBQAhC
oAYgvgAgBCFQAxBfABCCEKgBiC8ACEEI1ADEFwCEoEDtJgAQXwAQggI1AIgvAAhBgRoAxBcAhKBA
DQDiCwBCUKAGAPEFACEoUAOA+AKAEBSoAUB8AUAICtQAIL4AIAQFagDii5sAEIIQqAGILwAIQQjU
AMQXAIQgBGoA4gsAQhACNQDxBQAhCIEagPgCgBCEQA1AfAFACEKgBiC+ACAEIVADEF8AEIIQqAGI
LwAIQQjUAMQXAIQgBGoA4gsAQhACNQDxBQAhCIEagPgCgBCEQA1AfAFACEKgBiC+ACAEBWoAEF8w
yfVvmzsbIShQA4D4AnWvzglBzgoA4ot6x1yve5bAYQGIL1DnmKM2wBo4LQDxBeochCA4LQDxBeoc
hCA4LQDxBeochCA4LQDxBeochCA4LQDxBeochCA4LQDxBep8anj48OG0Smeq0yQEIVADEF8wLer8
7du3adWqVbXp/Prrr+mzzz5L/f39vYuPmjzMnz9/Uso6WelUpdnUh6aTrxGCAjUAiC/q/APevXuX
duzY0cguQgTeuHFjfOKjJv3JssupsO/xpkkIQqAGIL5gWtf5wMBAevbsWSOhVl7DtuPyZV3EX1X6
3dbHHRwcTIsXL04LFy5MBw8ebP2+a9eu9Ntvv7W+R0/l1q1bG62z++TJk7R9+/a0YMGCTNiuXr06
Xbt2rS0v9+7dS0uXLk3r16+vLffY2Fjas2dPll6kdffu3a5l7lYeQhACNQDxBZ+kzm/dutXYLj5Y
qmyShGCn/efPn0/Dw8Pp/fv3Wa/llStX0okTJ7J9L168SBs2bMj2xbD2ypUr06NHjxpdZ926deny
5cvZubGdPXs2E33FfOzfvz/bF9epK/fRo0fT1atXs8/Xr19Pa9as6XhcVXkIQQjUAMQXfNI6n25C
MJ5DDNFUJARfUVidPn06E1MHDhyYkH3Pmzev7fznz583LncIv3I+Ox1XVx5CEAI1APEFhOD/EcO2
5WHZomDLxdWSJUvS69eveypHDP1GT97u3bvT2rVra/NZVe7IZ5MyNSkPIQiBGoD4glktBLs9x1dO
q4lI2rZtW9Yj14sQvHTpUnbOxYsXs2HxGP79GELwY4o+QlCgBgDxBR9dCD59+nTSegT7+vrS6Oho
1+PPnTuXPXMXgq6XoeFFixa1pVuV5ybljtfuNBkarisPIQiBGoD4ghklBIuvk4mZxzEbd7xCMGbd
xrN5MQs3OHXqVBoaGmpN6ojvMcM5iF68r776qk1k/fXXXx3TKbNixYrWLOGRkZFs0kldPstplieL
3Lx5M/scM5m7TRapKg8hCIEagPiCGScEQwSGGIxhz+gZi9e4jFcIxqSPeHFz8eXNR44cyXrw4rcQ
mfks3p07d7a9PiY+x/5u6RS5c+dONkkj8h2iLWb81uWznGbxmJi1HPmJ9OJ5w/v373dNq1t5CEEI
1ADEF6hzEILgtADEF6hzEIIqDADEF6hzEIKcFgDEF6hzEIKcFgDEF6hzEIKcFgDEF6hzEIKcFgDE
F6hzEIKcFgDEF6hzEIKcFgDEF6jzSeLhw4eEIDgtAPEF6nyqrvWpz69Kr7xayUzyJUKQ0wKA+KLO
CcFJTJsQhEANQHzBjK7zwcHBtHjx4rRw4cJ08ODB1u+7du1qW8831hHeunVr9nlsbCzt2bMnLViw
IK1evTrdvXu3s+DocN3ib+/fv0/79u3L1t9dtmxZunLlygfndMtf0/O78eWXX6bXr19nn58+fZqd
98cff2TfX758me0v5jf+Frf8tzNnzqQVK1Zk6y3HesOx/jIhCIEagPiCaV/n58+fT8PDw5mgevfu
XSakTpw4ke178eJF2rBhQ7bv7du3aeXKlenRo0fZvqNHj6arV69mn69fv57WrFkzLiF4+vTpNDQ0
lF3j1atXadOmTW37q/LX5Pwqvvvuu/TLL79kn3/++eds2Deul38PoVtXnvi+bdu29Pz58+x7iMAQ
g4QgBGoA4gumfZ339/dnIqpICL6iEAuxFeLrwIEDrd9D+JXPG48QXL9+fda7mHP//v22/XX5qzu/
ikuXLqW9e/dmn//973+n3bt3Z1vw/fffZ6KziRDMReB09y9CUKAGAPFFnbcRvVflIc8Y4iyLxSVL
lrSGUfPzGgmOGiFYTidEX3l/Vf7qzq8iejfXrVuXfe7r60sPHjxIy5cvz77HcHcMFzcRgjPFvwhB
gRoAxBd13kZZ9HUihj6jB/BjCMHy/rr81Z1fx+eff54NKecCMJ71GxkZaX0nBCFQAxBfMGvrPHrC
RkdHu5537ty57Bm9ixcvtg0Nr1q1alxDw/mkjJyNGze2De2GCCvur8tf3fl17NixI/3rX/9qDQnn
w8P5d0IQAjUA8QWzts5PnTrVmmwRW3wfGBjI9sVkka+++qpNlP3111/Z55gscvPmzexzzCzuNlmk
OIv22bNnafv27W37L1++nI4fP96a7LF58+a2/VX5a3J+HTHjN4a9Q/AGFy5cyGZCh/jtVJ7YF88E
5uKTEIRADUB8wYyu8yNHjmSvX4lZsyHUQgAGO3fubHt9THyO/UHMIo79IfTWrl2bTdLodK18Fm0M
8UYvYryCppyXkydPZmIsXhETk1PK+7vlr+n5VWX//fff214bk082yQVv+fyYNBP5yF8sTQhCoAYg
vkCdT2NiRjAIQU4LAOKLOp+DxDA2CEFOCwDiizoHGyAEOS0A8QXqHIQgOC0A8QXqHIQgOC0A8QXq
HIQgOC0A8QXqHIQgOC0A8QXqHIQgOC0A8QXqHIQgOC0A8QXqHIQgOC0A8QXqHIQgOC0A8QUzq87j
93v37qWlS5em9evXt34fHBzM1u5duHBhOnjwYNs5T548ydb8XbBgQbaO8OrVq9O1a9da+2M94Xx9
4b6+vnT79u2283/88ccs3Th/YGAgPX/+vC0/w8PDacWKFdn5kU6sV9w0bRCCAjUAiC/oQQju378/
vX//Pr148SL77fz585kYi9/evXuXrly5kk6cONE6Z926deny5cvZ/tjOnj2bCcmconi7efNmWrly
ZWvfqVOnsuPzc+Nae/bsactPiMxcHEY6kV6TtEEICtQAIL6gRyFY7JEL+vv7M5FWpE5wRQ9dTojC
q1evdjxu7dq1aWxsrPU9Pi9ZsqQyP8W8V6UNQlCgBgDxBT0KwTLR6xa/F7ei0AtiOPno0aNp9+7d
mbgrphM9dfE9BOWxY8e6Csbi9ary0zRtEIICNQCIL5igEOwk1opcunQprVmzJl28eDHdunUrG1Iu
pxNC8fr162nLli3p8OHDHUVfR4FSIwSr0gYhKFADgPiCCQrBmIQxOjraNa1Fixa17X/69GnX9B88
eNC2L9IuDw3Pnz+/JyHYLW0QggI1AIgvmKAQjAkdQ0NDrQkd8T1m9+bEjN58lvDIyEjasGFDWzrR
Wxize4PyZI9I68yZM620z507l1atWtVYCFalDUJQoAYA8QUTFILBkSNHsp6/6K2LWbz5jOLgzp07
2eSREGEhzGLyRjGdGLqN5wbz17/kwi0nf31MbDFj+PHjx42FYF3aIAQFagAQX6DOQQhyWgAQX6DO
QQhyWgAQX9Q52AAhyGkBiC/iizoHIQhOC0B8gToHIQhOC0B8gToHIQhOC0B8gToHIQhOC0B8gToH
IQhOC0B8gToHIQhOC0B8gToHIQhOC0B8gToHIQhOC0B8gToHIQhOC0B8gToHIQhOC0B8gToHIQhO
C0B8gToHIQhOC0B8gToHIQhOC0B8gToHIQhOC0B8gToHIQhOC0B8wQyr84cPH7rR0/heEYKcFgDE
F3Xekbdv36ZVq1ZN6Brz58+fUbZZd62J5qXq/Mm4V4SgQA0A4gsmXOfv3r1LO3bsmFLhQwh+eh8k
BAVqABBf1PkHDAwMpGfPnjWyi19//TV99tlnad68eamvry/dvn27lX5x63bN4m/v379P+/btS4sW
LUrLli1LV65cyfY/fvw4rVu3rqNgXb58eXrz5s0H+548eZK2b9+eFixYkOVv9erV6dq1a7XXaro/
GBwcTIsXL04LFy5MBw8ebNvX5PziPSjfq+DHH3/M0o4yRJ08f/6cEOS0ACC+YGrr/NatW43tIkTW
jRs3ss83b95MK1eu7HqNOiF4+vTpNDQ0lImoV69epU2bNrX2b968uSUyc4aHh9MPP/zQMV8hHC9f
vpylFdvZs2fT0qVLG12ryf7z589n14/9IUhD6J04caLx+XX1cerUqSzPef7jenv27CEEOS0AiC/4
OHXe5JgQV1evXm10fp0QXL9+fRobG2t9v3//fmv/9evX05YtW9rOjeP//PPPxmWOXssm12qyv7+/
PxNoRYoiuO78unu1du3atvPj85IlSwhBTgsA4gumjxCMXsA4LoTRsWPHJiQEo3exSAit4v4VK1ak
R48etYRViK0q7t27l44ePZp2796dCatertVkf3lItyg0686vu9fFtLqlSQhyWgAQX/BJhWAuuPIe
u8OHD0+aECzvP378eNq7d2/2OYZJL1y40DVPly5dSmvWrEkXL17MhrpfvHjR07Xq9ncSanWirRch
2Ov5hCCnBQDxBZ9ECOY8ePCgXVzUCMGnT5+2/bZx48a24dCRkZG2/fGsXUycePnyZTZJI15x042Y
pDE6Ojrua9Xtj4kxxfTL1J1fd68j/fLQ8GS/YoYQFKgBQHxR5xM6JnrdYuZwEJNGij1ZIdpipmsu
aIoTS2JWcszqLV4jJndEr18+wSImiJTzED2B3377bdq/f39lvmIYOZ8lHCJsw4YNPV2rbn9M5sgn
g8QW32Nmby9lKVK+V5HemTNnWumfO3duwu91JAQFagAQXzCpQjCGheP5uxgqDaGXi8IgZtFGL1be
k5ULxTg2RE0cW77GyZMns0kR0eMXM2XL++/evZv9VrcSx507d7LJG3G9EKsxoaXXa9XtP3LkSNbz
GOULURvDz72cX6R8r4L89TGxhQCO1+gQgpwWAMQXzNk6D7EVvX0gBDktAIgvmEN1HkOk0QtXnp0M
QpDTAoD4glle5/Ec3TfffFM5SQSEIKcFAPEF6hyEIKcFAPEF6hyEIKcFAPEF6hyEIKcFAPFFnatz
NkAIcloAEF/UOQhBt4PTAhBfoM4/NnUvhgYhCIEagPiCWVTnxWuX189li4QgBGoA4gvmSJ2zPUIQ
nAWA+IJpUudPnjzJ1s2NlzfHOr2rV69O165dy/Z9+eWX6fXr19nnp0+fZmn88ccf2feXL19m++vS
KF47/ha3D8TJ//t5eHg4W1IuX8s41isuMjg4mK33+/nnn6ezZ8+yZUJQoAYA8QXjrfN169aly5cv
Z8u5xRbiaunSpdm+7777Lv3yyy/Z559//jkb1j1//nzr+549e2rT6CT2uoqT//dzCMrnz59n30ME
hhjMCZF4+PDh7BqvXr1KX331FVsmBAVqABBfMJl1Hr1xwaVLl9LevXuzz//+97/T7t27sy34/vvv
05UrV2rT6FUI5iKw0/6NGzdmPZE59+/fZ8uEIKcFAPEFE6nze/fupaNHj2Yib+3ata1jHz16lPX2
BX19fenBgwdp+fLl2fcY/o3h4ro0ehWCVfkuTzSJnkG2TAgK1AAgvmCcdR69fmvWrEkXL15Mt27d
Si9evGg7Np7Fi2HYXADG83sjIyOt703SmCwhWBwmJgQJQYEaAMQXTLDOY+LF6Oho63s+KSRnx44d
6V//+ldrSDgfHs6/N0ljsoTghg0bMlGa8+eff7JlQlCgBgDxBeOt8+jhy2f4Rk9fiK3isWfOnElL
lixJ586dy75fuHAhmx0cEzeaplH8HOfGc4BjY2M9C8HyZJGBgQG2TAgK1AAgvmC8dX7nzp20cuXK
bNg1hnevXr3aduzvv//e9tqYfILGX3/91TiN4ucTJ05kz/rlz/v1IgSD48ePp8WLF6dly5ZlM5jL
zw2CEBSoAUB8wRyo87dv37Y9qwhCkNMCQE1c6fRSX2hTZgIxRH39+vVsaPjdu3fpxx9/zIaKQQhy
WgAgBDHL25SYkbx+/fpsODhmMx86dCgThCAEOS0AjEMMQpsCQhCcFgAhCG0KCEFwWgCEILQpIATB
aQEQgtCmgBAEpwUgvkCdgxAEpwUgvkCdzygePnzIAAhBTgugs5/Z5s6mTZl+7VDxGr/++mu2Okl/
f/+kXr+8+shctQVCkBAEwMfUubJP2/sVIvDGjRvqnRAEwwX4F9T9xyj32NhY2rNnT1qwYEFavXp1
unv3bsdznjx5krZv354dF4Itjr127Vprf96bN2/evNTX15du377daF9+jU69t8XrV+WzKm916Qax
QsnChQuz8wcGBtLz58/b8jc8PJxWrFiR5X+qxCohCMEK4FtgAx+9zEePHk1Xr17NPsfybWvWrOl4
zrp169Lly5ez5d1iO3v2bFq6dGlrf1Eg3bx5M61cubLRvjZxUspj8XtVPuvyVpXuqVOnsuPzc8+f
P58JzuKxITJzcRjliPIQghCoAL4FNjDjyxyCKgTQeO5T9JDlhPDKhVqZqn1NhWBVPuvyVpXu2rVr
s97GnPgcaxoXjy32EM5k+yEEBSoAfAuEYBtVvVvlc+7du5f1zO3evTsTUMX90dMX32Oix7Fjx9rO
q9rXVAjW9cJV5a0q3aJg7HStTveNEIRABfAtsIE5JQQvXbqU9cpdvHgx3bp1K7148aKjUIxh2y1b
tqTDhw832jcZQrAub72mW3UuIQiBCuBbYAOzpsyrVq1qNDS8aNGiNDo62vr+9OnTrmk+ePCg8b6m
gq0qn3V5q0o3Jq+Uh4aLr5shBCFQAXwLbGDWljmGU2PoNvjtt9+6ThaJWbP5TNyRkZG0YcOGD57h
i9nBQXlCRdW+XiaLdMtnXd5iNnA855cLvvJkkTNnzrQmi5w7dy4TnYQgBCqAb30yJmslhKlYUWE2
rNJACP7/vH37Nu3cuTMTZ/Fs3f379zuec+fOnWy2bxwXIiwmfxT3x9BvnJ+/YiUXfnX7mgrBqnzW
5e3EiRNZL1/e09ft9TGxxYzhx48fE4IQqIC55lsxtNTLahTlVRB6CsI1/l1eCWG8TFY6VWk2jVXT
KaYRgpjrsY81cFqAb5WIB9mjx6Epvb5YthchOFn+PxVxZLxpEoLKDEIQnBaYtr51/Pjx7FmhpmnU
rVZQJf6q/Ltbj+Tg4GBavHhxNnx18ODB1u+7du3KnpnKiZ7KrVu3NurZrFstIs6LYb14D9z69esn
tPpDOQ/dypOXodtKFOKrMoMQ5LQAJt23duzYkb755ptMnMQsxHhuqJd0JksIdtofqx3EMlfxMPu7
d+/SlStXsueegnhVRjwcH/viOap4VurRo0eNrtNkRYb9+/dn++I6deVuukpFVXmCqpUoxFdlBiHI
aQFMum998cUX6aeffso+h0C5cOFCJmymgxCM5xDLr84oiqMQVqdPn87E1IEDByYUR8orMtStqtB0
9YficXXlqVqJQnxVZhCCnBbAlPtWCJUQh9NBCEYPWXlYtrwiQoirWBrr9evXPZW1lxUZ6srd9OXE
deWpWolCfFVmEIKcFsBH8a1Oy09NphDs9hxfOa2qfORs27Yt65HrRQj2uiLDZAnBJuWpWqVCfFVm
EIKcFsCk+lb0pr1586b1PSY+xISH8QrBqtUNeu0RjAkTxZUTysRLcOOZuxB0vQwN97oiQ125m65S
UVeeIlWrVIivygxCkNMCmBTfOnToUDaTNZ84Ec/bhcBqmk5xgsOzZ8+y2bjjFYLllRBi9YOhoaFW
3uL7wMBAti968b766qs2kfXXX391TKdM3YoMnfJZtUpD01UqqsoTVK1EIb4qMwhBTgtg0n0rZtz+
8MMP2QuTP//880yo9JJOLlhi2DN6xkLIjFcIlldCCI4cOZL14MVvITLzWbzx7sPi62Pic+zvlk6R
uhUZOuWzapWGpqtUVJUnqFqJQnxVZhCCnBYA3wIbUGYQgpwWAN8CG1BmEIKcFgDfAhtQZhCCnBYA
3wIbYPcgBDktAL4FQpDds3tCkNMC4FsgBMHuWQOnBfgW2IAygxAEpwX4FtiAMoMQBKcF+BbYgDKP
k4cPHzKuaXyvCEFOC2CO+1ZV2WP1jljFo7+/nw3MwTLHqjCxIs5E6LaCzXStm17X/J7M9CfjXhGC
AhUAvjVpZS+ulcwG5laZ3717l3bs2DGlwocQ/PQ2SAgKVAAqfOvJkyfZmrcLFizIRNHq1avTtWvX
WvvzHrNY/7avry/dvn270b5gcHAwLV68OC1cuDAdPHiwbd9Upfv+/fu0b9++bD3fZcuWpStXrnQt
e/xe3HJ+/PHHLO24JwMDA+n58+dt58SawEuXLk3r168XX2dwmaNunz171ui+dLPJTjbUKb3ib91s
9PHjx2ndunUdBevy5cvTmzdvevbfOn9o4i+f0t8IQY0VgCn2rWh4Ll++nAX02M6ePZuJnJxij9nN
mzfTypUrG+07f/58Gh4eztKMhiwaiBMnTkx5uqdPn05DQ0PZ/levXqVNmzb11ENx6tSp7B7k9yOu
t2fPnrbj9+/fn+178eKF+DqDy3zr1q3G96XKJsvn1wnBKhvdvHnzB//4hL3/8MMP4/LfOn+o2/+p
/Y0Q1FgB+AS+Fb0eOdGoXL16teNxVfvimbsI7EWKjedUpRu9dGNjY63v9+/f76lhWrt2bdv58XnJ
kiVtx092j4X4+mnL3OSYKpvsVQhW2ej169fTli1b2s6N4//8889x+W+dP9Tt/9T+RghqrAB8BN+K
oc6jR4+m3bt3Z4G5eGz0fsT3aBCOHTvWdl7VvuhBKQ8FFRuoqUo39heJRqyXhqmYVqc0Z3KMIgTH
f0yVTfYqBOtsdMWKFenRo0ctYVX3CEKV/9Zdq8n+T+lvhKDGCsAU+9alS5fSmjVr0sWLF7Ohshju
LB8bDU3eU3H48OFG+zoF+E4N2GSn26kR6aVhqjufEJybQrDKJicqBMv7jx8/nvbu3Zt9jmHSCxcu
dM1Tnf/WXatu/6f2N0JQYwVgin0rHvIeHR1tfX/69GnXYx88eNB4XzxQX0y3islMd+PGjW1DTSMj
Iz01TJF+eaiq+MoLQnD6lWmis1R7vS9lm6wTgmWfqrPReNYuJk68fPkym6QRr7jpRp3/1l2rbv+n
9jdCUGMFYIp9K4ah8lmGEcQ3bNjQdmz0NsSMySAeli/+B1+1Lx4Czx8ijy2+x4zAqU43HpyPHpX8
4fV4+L7Xh9fPnDnTSv/cuXNt75kjBKenEOw2I3WyhGCVTYZoi+dGc0FTnFgSs5JjVm/xGk1sNHoC
v/3222xiUhV1/lt3rbr9k+1v5XtV52+EoMYKwBT71p07d7KHv6PxisYuHogvHhvDYfHcUQwRxTF5
Y1i3Lzhy5EjWYxH/4UdjWJxlO1XpBidPnsweOI/elJiF2GuPUf46i9iiQY7XeswmIdhNPM3WbTLa
nSqbjFm0YYt5T1YuFOPYEDVxbPkadTZ69+7d7Le6lTjq/LfJter2T6a/le9Vnb8RghorAHwLbKCy
TBPtEZyOhNiK3j4QggIVAL4FNlAjBGdTmWOINHrhyrOTQQgKVAD4FtjALC9zPEf3zTffVE4SASHI
aQHwLbABZQYhyGkB8C2wAWUGIchpAfAtsAF2D0KQ0wLgWyAE2T27JwQ5LQC+BUIQhKDbwWkBvjUz
qXuxLsRXZQYhyGkBTLJvjfflvL2c1+3Y4ufJXn+UDSizfBGC4BwA3/oIPjleASk2iK/KDEKQ0wKY
Yt8aHBzM1gmNtT4PHjzYPYiW0ojzYg3Szz//PJ09e7ayZy8Wmo91RONluVu3bk3379+vvUa3tXHX
rVv3QRnevXuXli9fnt68eaOyxddGZc7XuA2bHBgYyGy0eN7w8HC2zFu+vnCsIdzU/pukP5nXAiEo
UAEYl2/FIvHRCMWyViGmrly5ki0MXyfS4pzDhw9n57169Sp99dVXlYJu48aN6eXLl9nxv/zyS/r+
++8bC8Hy582bN6fbt2+3lSPy88MPP6ho8bVRmU+dOpUJqrDH2MIP4h+V4nnbt29vibcQZiHQmtp/
k/Qn61ogBAUqAOP2rf7+/qyBKbJy5cpaMZYLu5zo4asSccUewLheXHe8QvD69etpy5YtbXlev359
+vPPP1W0+NqozGvXrk1jY2Ot7/F5yZIlbecVe/B6tf8m6U/WtUAIClQAxu1b0fNQHnqN4ak6MVae
vBHiromIK153vEIwiGG0R48etRrGEIIQX5uWuWjjdTY5HvvvJf2JXguEoEAFYFIbxK5BtPC52KiN
RwgWG7fxCMHjx4+nvXv3Zp9jyO3ChQsqWXzt6R+gprY+HvvvJf2JXguEoEAFYNy+1dfXl0ZHR3sW
ghs2bMieV8qJYdmqhi7vvQtimCwmdkxECMa14yH8GDKLiS5v375VyeJrT3ZfHrrt9s/JeOy/l/Qn
ei0QggIVgHH7VjzUPjQ01HqoPb7HDMe6Bqv8AHucUyXivvnmm/T69evs+Lher5NFQvTFc1TFxjV6
Ar/99tu0f/9+FSy+9mz3Z86cadn9uXPn0qpVqxqLszr77yX9iV4LhKBABWBCvnXkyJHs1RTRYxGz
F1+8eNGowYrh2eiNW7ZsWTYrsqrHI/bHsXFMiMKqV2l0+hwzmePc4jXu3r2bHWPVEfF1PGXOX+8S
W/xT8fjx48birM7+e0l/Mq4FQlCgAvBJfSuGZovDvR+DEKwxaQTi66cu88e0/0/ha4QgBCqAb7UR
r8KI17jk7x+M3o8YvvpYxHWjJ/PYsWMqV3z96GX+mPb/qX2NEIRABfCtD7h161b2ypYYoorVDg4d
OpQ1Uh+LeGYwhphNEhFfP0WZP6b9f2pfIwQhUAF8C2xAmUEIgtMCfAtsQJlBCILTAnwLbECZQQiC
0wJ8C2xAmUEIgtMCfAtsQJlBCILTAnwLbECZQQiC0wJ8C2xAmUEIgtMCfAtsQJlBCILTAnwLbECZ
QQiC0wJ8C2xAmUEIqjBOC/AtsAFlBiGowgDwLbABZQYhyGkB8C2wAWUGIchpAfAvqHtlR+91zxI4
LMDH+Jg6dw8wR+ucFXBWAP/nZ7a5s4Hds3tCkBAEIL6IL8DcjgFugUANQHwBQAhCoAYgvgAgBCFQ
AxBfABCCEKgBiC8ACEEI1ADEFwCEIARqAOILAEIQAjUA8QUAIQiBGoD4AoAQhEANQHwBQAhCoAYg
vgAgBCFQAxBfABCCEKgBiC8ACEEI1ADEFwCEIARqAOILAEIQAjUA8QUAIShQuwkAxBcAhKBADQDi
CwBCUKAGAPEFACEoUAOA+AKAEBSoAUB8AUAICtQAIL4AIAQFagAQXwAQggI1AIgvAAhBgRqA+OIm
AIQgBGoA4gsAQhACNQDxBQAhCIEagPgCgBCEQA1AfAFACEKgBiC+ACAEIVADEF8AEIIQqAGILwAI
QQjUAGZAXClvAAhBEIIACEEAhCAIQQBzRQwCIARBCAIgBAEQgiAEARCCAAhBEIIACEEAhCAIQQDi
CwBCEAI1APEFACEIgRqYHX5mmzsbAEKQEATAx9Q5QAhCwAL4F9Q9QAhCsAL4FtgAQAhCoAL4FtgA
QAhCoAL4FtgAQAhCoAL4FtgAQAhCoAL4FtgAQAhCoAL4FtgAQAhCoAL41rTk4cOHKl18BQhBgQpA
lW/9888/ae/evWnhwoVp/vz5aefOnenvv/+uTOfKlSuV6detcrF27dr0/PnztvOvXbuW7b9+/Xrb
73FcHN8rUZbJvGezITaJryAEIVABfKuNAwcOpHPnzqX3799n248//piJwap01q9fn96+fTtu0XTk
yJF04cKFtt/279+fNm3alOWnSBz3n//855PEktkWj8RXEIIQqAC+1cbnn3+eCcCcd+/eVfamRToh
zo4dOzZuIXj37t307bfftv0WvX6///77B71/cVwc34lff/01ffbZZ2nevHmpr68v3b59u3X9ci9k
pzwVf4t7sG/fvrRo0aK0bNmyrNezqkyDg4Np8eLFWU/qwYMHG+VLfAUIQQhUwLT2rbGxsbR06dLa
dDZs2NA2vNvrMGqIrVyAvnz5Mq1Zsyb7vHr16vTixYuWKP3iiy+6phFi68aNG9nnmzdvppUrV3bN
Q50QPH36dBoaGsry9OrVq6x3sluZzp8/n4aHh7NjI48hGk+cONEoX+IrQAhCoAKmrW/99NNP6ejR
o7Xp3LlzJ+3ataurEKx6RjD417/+lfWcBSGk8iHh+Hv58uXsczwv+P3333fNSwjWq1evNipvnRCM
4e4QwTn379/vKgT7+/vbelGDotirypf4ChCCEKiAaelbr1+/zsRd9HI1SSeODUHYSQjWEZND4rnA
PJ3oOQviby4wY6g2jutGHBvXCmFWNVTdRAhGL16REHrdyhTHlgVuDAM3yZf4ChCCEKiAaedbIf6+
++67bFi0aTrPnj3LhojHIwTjeqtWrco+F4eJ4288e5fvL/bSdeLevXtZz+GWLVvS4cOHJ00IVpWp
KPp6zZf4ChCCEKiAaeVb0RMYr5B5+vRpz+lEj1dMHhnPq1a2b9+eic///d//bfs9JojEb9u2bWtc
vgcPHlTmofw9ylr8bePGjW2ic2RkpGt6MQFkdHR0XPkSXwFCEAIVMG18K2bqfv3119mEjfGkE6+R
iSHQ8QjBXEDG5Ismv5eJCSb5c4YxOaPYq7dgwYJsMksu7ooTOKInM0RoMZ/xXOLx48dbk0U2b97c
tUynTp1qTSyJLb4PDAw0ypf4ChCCEKiAaeNby5cvr5zU0SSdTq9aqZssEsTs4PgthFmR+B6/l186
XSaGX+N1MzFUG2IrF19BzOKN1+Dkr8LJBVkcG0POcWw5PydPnkxLlizJhqZDhFaJ23gXYrxqJtIP
UZnPdK7Ll/gKEIIQqAC+BTYAEIIQqAC+BTYAEIIQqAC+BTYAEIICFQC+BTYAEIICFQC+BTYAEIIC
FQC+BTYAEIICFQC+BTYAEIICFQC+BTYAEIICFQC+BTYAEIICFYBmvjVZPjfRdD71+eIrQAhCoAL4
FiHIBgBCEAIVMDd8q7ye7vDwcFqxYkVrndxYozdnbGws7dmzJy1YsCCtXr063b17t2s6Vdd5//59
2rdvX7ZW77Jlyz5YqzgYHBzM1vxduHBhOnjwYNu+JudDfAUIQYEKQI9CcPv27en58+fZ9xCBIQZz
jh49mq5evZp9vn79elqzZs24hODp06fT0NBQJuhevXqVNm3a1Lb//PnzmSCN/e/evcuE3okTJxqf
D/EVIAQFKgDjEIK5COy0P4RfiK8m6VTtX79+fda7mHP//v22/f39/R9cZ+XKlY3Ph/gKEIICFYBx
CMGq/cXewclMJ0RfeX98L24xVN30fIivACEoUAGYIUKwvL8o+jpRdz7EV4AQFKgATLIQXLVq1biG
hp8+fdr228aNG9uGdkdGRtr29/X1pdHR0a5lqTsf4itACApUACZZCMZkkZs3b2aff/vtt66TRYqz
jZ89e5ZNQCnuv3z5cjp+/HhrssfmzZvb9p86dao1GSS2+D4wMND4fIivACEoUAGYZCH49u3btHPn
zkzorV27Npuk0em4fLZxDPFGL+Kvv/76QdonT55MS5YsyV4RE7OEy/uPHDmSvR5m/vz5mZB88eJF
T+dDfAUIQYEKAN8CGwAIQYEK4FtgAwAhCIEK4FtgAwAhCIEK4FtgAwAhCIEK4FtgAwAhCIEK4Ftg
AwAhCIEK4FtgAwAhCIEK4FtgAwAhCIEK4FtgAwAhCIEK4FtgAwAhCIEK4FtgAwAhCIEK4FtgAwAh
CIEK4FtgAwAhCIEK4FtgAwAhCIEK4FtgAwAhCIEK4FtgAwAhCIEK4F9Q9wAhKFgB4GNQ5wAhKGAB
mAI/s82dDQAhSAgCEF/EF4AQhEANQHwBQAhCoAYgvgAgBCFQAxBfABCCEKgBiC8ACEEI1ADEFwCE
IARqAOILAEIQAjUA8QUAIQiBGoD4AoAQhEANQHwBQAhCoAYgvgAgBCFQAxBfABCCEKgBiC8ACEEI
1ADEFwCEIARqAOILAEIQAjUA8QUAIShQA4D4AoAQFKgBQHwBQAgK1AAgvgAgBAVqABBfABCCszBQ
22w221RtAAhBAHp4AACEIABCEABACAIgBAEAhCAAQhAAQAgCIAQBAIQgAEIQAEAIAiAEAQCEIABC
EABACAIgBAEAhCAAQhAAQAgCIAQBAIQggMkTgNaQBQAQggAhSAgCAAhBYK6KQQAACEGAEAQAgBAE
CEEAAAhBgBAEAGg33AJg9olBAAAIQYAQBACAEMTcEkK2ub0BAAhBzFERCLADACAEofEHewAAEILQ
6INdAAAIQWjwwS4AAIQgNPhgFwBACAIafLALACAEAQ0+2AUAEIKABh/sAgAIQUCDX8fDhw9VBLsA
AEIQmG4N/tu3b9OqVas++P3vv/9O27dvTwsWLEgLFy5Mu3btSq9evRpXHubPnz+p5SBiCEEAIASB
CTb47969Szt27Oh4zODgYDp27Fh6//59tv3000/pyJEjn0x0EC6EIAAQgsAkNvgDAwPp2bNnHY/5
5ptv0sjISJto3Lp1a9e0fv311/TZZ5+lefPmpb6+vnT79u3W9ctr3Xa6XvG3EJ779u1LixYtSsuW
LUtXrlyp7BEM0bp48eKs5/LgwYON8sUuhDgAIAQxpxv8W7dudT0mRFgIsvJv3QixdePGjezzzZs3
08qVK7vmoU4Inj59Og0NDWXXj+HoTZs2dRWC58+fT8PDw9mxIVZDNJ44caJRvtgFAIAQxJxv8Dsd
EwKqyW85S5cuTVevXm2Ufp0QXL9+fRobG2t9v3//flch2N/f/4FgLYq9qnyxCwAAIQhCsMMxMZTa
ixCM3rZIJ4RZPFs4ESFYvk4IvW5CMI4tDz8X816VL3YBACAEQQh2GRpu8luRe/fupevXr6ctW7ak
w4cPT5oQLO8vfu4kWJvmi10AAAhBEIIdjgnR9M8//7S+x2tmYnJJEx48eFA5uaP8/enTp22/bdy4
sW1oOCatdEsvJoCMjo6OK1/sAgBACIIQ7PL6mHzCRmwXL16sHFpds2ZNNkM3iMkZxV69eBfh8+fP
W+KuOIEjZi3H+wqLebh8+XI6fvx4a7LI5s2buwrBU6dO/T/t3V1kXWv+wPGLY1RE1VBxVNURqiKi
IlQddUSUGlW9GIfRi5qrUlUjF3VuoioiQkUdvYhSUSNihKNGVEWpqhG5CFUVvagSFVFxlKgREfH8
/Z7/7Fh7Z7/2ZdppPh+2k531stfOeXR9rbXXXmXbGc+LwVpvu4wLAIQgQrDKPKurqznA4sug43H2
7Nn8JdO1xOnX7u7ufKo2YqsUXyGu4i2tpxhkMW98mXXMW7kNN2/eTAcPHsxfCxNXBtc7whjfbxin
rWP9EZWx7c1sl3EBgBDEDh/jAgAhiB0+xgUAQhA7fIwLACEIdvgYFwBCEOzwMS4AhCDY4WNcAAhB
sMPHuAAQgmCHj3EBIATBDh/jAkAIwte3w/9UIfCx6/mcy4sdIQggBLHD/4rX/6WXNy4AEILsuR1+
5b17Jycn05EjR3buyRv3Ay7Z3NxMFy9eTG1tbenYsWNpfn6+5nrqvc729na6cuVKvi/woUOH0vT0
9K5lhoeH8/2F29vb0+DgYNm0Zpb/0PdoXAAgBNmzIXju3Lm0srKSn0cgRSiVXL9+Pc3MzOSfZ2dn
U1dX1weF4K1bt9Lo6GgOurW1tXTq1Kmy6RMTEznWYvrW1lYOvbGxsaaX/5j3aFwAIATZsyFYCqRq
0yP8Ir6aWU+96X19ffnoYsni4mLZ9N7e3l2v09nZ2fTyH/MejQsAhCB7NgTrTa935Oxj1hPRVzk9
nhcfcRq32eU/ZtuMCwCEIELwvxiCldOL0VdNo+WFoBAEEILwiUPw6NGjH3RqeHl5uex3J0+eLDu1
u7S0VDa9p6cnra+v13wvjZYXgkIQQAjCJw7BuFhkbm4u//z48eOaF4sUr8R98+ZNvjijOH1qaiqN
jIzsXOwxMDBQNn18fHznYpB4xPP+/v6mlxeCQhBACMInDsGNjY30888/59Dr7u7OF2lUm690JW6c
4o2jiA8ePNi17ps3b6aDBw/mr4iJq4Qrpw8NDeWvh9m3b18OydXV1ZaWF4JCEEAIgh0+xgWAEMQO
H4wLACGIHT4YFwBCEDt8jAsAhCB2+BgXAAhB7PAxLgAQgtjhY1wACEGww8e4ABCCYIf/kV68ePFZ
50cIAghB+MI7/Fp39Yg7hrSicn4BIwQBhCD8D4Xgx2yPYBGCAEIQPsMO/5dffsn39e3o6Ej37t1r
6d68r1+/zvcCbmtry/cXPnbsWLp//37VeUs/x3+Lj0brqTZ//Pf9+/fp8OHD+R7IRZubm6mnp2fn
+fDwcL4ncXt7exocHDQYhCCAEMQOP9y6dSuNjIyk7e3ttLq6mvr6+loKwePHj6epqam8fDxu376d
g7JeCFZbbyvrKT6/fPlyGh8f3/WeIv7CxMREmpyczOvc2tpK09PTaWxszIAQggBCEDv83t7esiNq
8/PzLYVgNd99913LIdjKeorPX758mY8KRuiF+O8PP/yQVlZWdt5faVpJZ2enASEEAYQgdvhxGrYo
oqnVEFxYWEjXr19PFy5cSN3d3U3FX7X1Nrueyuc//fRTPuoX4qhinGIuvr/KU8vFwDQu/BMHIAQR
gjXmbRSC8ZnCrq6udPfu3fTo0aN8evlDQrCV9VQ+n52dzZ8pDPHZwFi+RPQJQQAhiIFcY4f/448/
pnfv3u08X1paqhtgy8vLZb+Li0zW19drTm82BFtZT7XnR44cyZ8NjNPCRRGGxfUiBAGEIHb4//Hb
b7/lq4bjlPDa2loaGBgomzeOGD58+DD//ObNm3zatTg9Aqx0dW9E5IkTJ5qKv7g6OD7HF1f4NrOe
yvkr309cAHLo0KFdF4LEhSSjo6M7F6HE8/7+fgNCCAIIQezwQ1xZG1fofv/99znGivNGBEYMxinW
o0ePpgcPHpRNf/r0ab74IuaJU7szMzNNhWAEW3xJdOmLohutp3L+yvfz+++/52kRs5WGhobyEceY
HiEbp50RggBCEDt8cWBcACAEscMXB8YFAEKQPb7Db/U+wAhBACEIdvgYFwBCEOzwMS4AhCDY4WNc
AAhBsMPHuAAQgmCHj3EBIAThW9zhv3jxwh/duAAQgrAXd/iVX0HzOV9fzPjbAQhB+Ip2+JWvJziM
CwAhCF/ZDj/uHVy6l3BPT0968uRJevXqVTp+/Piuebe2ttLhw4fT+/fv8/omJyfTkSNH8rKxjrgv
cem1io/S73799deq85cMDw+nAwcOpPb29jQ4ONhwO6u9t3rzIQQBhCB2+AXFIJubm0udnZ3554GB
gV0RFeF36dKlnfWdO3curays5OexjlhXrdeL52fPnq05/8TERF7/9vZ2Ds7p6ek0NjbWcDsrX6ve
fAhBACGIHX5BR0dHmpmZ2fX72dnZdObMmbLf9fX1pWfPnu2srxR11V6jWgjWm7+3tzdHYFEx4mpt
Z+V66s2HEAQQgtjhF8RRs5gWIXbjxo2yaXEa9+XLl/nnxcXFHIL11tcoBOvNH0fyKk8px+ndZraz
uJ568yEEAYQgdvgVFhYWdo4AXrt2bef3IyMj6fLly/nnixcvpjt37ny2ECxGX6vbWbnuWvMhBAGE
IHb4NTx//rxsvrW1tdTW1pbevn2bL+LY2Nj4bCEYF3asr6839V4qt7PWe6ucDyEIIASxwy/o6urK
V9qGygs4QhwJPH/+fLp69WpLYRcBGZ8J3NzcbGr+8fHxNDo6mj8nGI943t/f39R2FtfT6P0gBAGE
IHb4/xGnUbu7u3e+0qUUUSXz8/N52co7hTQKu7jiN75UuvTF0o3mD0NDQ2n//v15mbgieXV1tant
LK6n0ftBCAIIQezwmxQxFheNYFwACEHYQzv8OEUbR+lcfWtcAAhB2GM7/Pic3+nTp8suEsG4ABCC
YIePcQEgBMEOH+MCQAiCHT7GBYAQBDt8jAsAIQh2+BgXAEIQ7PAxLgCEINjhY1wACEGww8e4ABCC
YIePcQEgBMEOH+MCQAiCHT7GBYAQBDt8jAsAIQh2+BgXAEIQ7PQxHgCEINj5YxwACEGoHQEee/sB
gBCEPRvCACAEQQgCgBAEIQgAQhCEIAAIQRCCAAhBQAgCIAQBIQiAEASEIABCEBCCAAhBQAgCIAQB
IQiAEASEIABCEBCCAAhBQAgCIAQBIQiAEASEIABCEBCCAAhBQAgCIAQBIQiAEASEIABCEBCCAAhB
QAgCIAQBIQiAEASEIABCEIQgAAhBEIIAIARBCAKAEAQhCIAQBIQgAEIQEIIACEFACAIgBAEhCIAQ
BL7mAKx8AIAQBCEIAEIQ9koMAoAQBCEIAEIQhCAACEEQggDYb/gTwLcXgwAgBEEIAoAQZG8Gkcfe
eQAgBGEnAvH/HAAhiCDA/3sAhCBCAGMAACGICMAYABCCIAIwBgCEIIgAjAEAIQgiAGMAQAiCCMAY
ABCCIAIaefHihf8RQhBACMLXFgEbGxvp6NGju37/7t27dO7cudTW1pba29vTX/7yl7S2tvZB27Bv
375P+j6EjRAEEILwkRGwtbWV/vznP1edZ3h4ON24cSNtb2/nx9///vc0NDT0xUJEzPjbAQhB+IQR
0N/fn968eVN1ntOnT6elpaWyaPzTn/5Uc10PHjxIf/jDH9J3332Xenp60pMnT3Zev/L+t9Ver/i7
CM8rV66k/fv3p0OHDqXp6em6RwQjWg8cOJCPXA4ODja1XcYAAEKQPR0Bjx49qjlPRFgEWeXvaonY
evjwYf55bm4udXZ21tyGRiF469atNDo6ml8/TkefOnWqZghOTEykycnJPG/EakTj2NhYU9tlDAAg
BNnzEVBtngioZn5X0tHRkWZmZppaf6MQ7OvrS5ubmzvPFxcXa4Zgb2/vrmAtxl697TIGABCCCMEq
88Sp1FZCMI62xXoizOKzhR8TgpWvE6FXKwRj3srTz8Vtr7ddxgAAQhAhWOPUcDO/K1pYWEizs7Pp
zJkz6dq1a58sBCunF3+uFqzNbpcxAIAQRAhWmSei6d///vfO8/iambi4pBnPnz+ve3FH5fPl5eWy
3508ebLs1HBctFJrfXEByPr6+gdtlzEAgBBECNb4+pjSBRvxuHv3bt1Tq11dXfkK3RAXZxSP6sV3
Ea6srOzEXfECjrhqOb6vsLgNU1NTaWRkZOdikYGBgZohOD4+Xrad8bwYrPW2yxgAQAgiBKvMs7q6
mgMsvgw6HmfPns1fMl1LnH7t7u7Op2ojtkrxFeIq3tJ6ikEW88aXWce8ldtw8+bNdPDgwfy1MHFl
cL0jjPH9hnHaOtYfURnb3sx2GQMACEFEAMYAAEIQEYAxACAEQQRgDAAIQRABGAMAQhBEAMYAgBAE
EYAxACAEQQRgDAAIQRABGAMAQhBEAMYAgBCEry8CPlUcfOx6PufyAsjfAUAIIgK+4vV/6eWNAQCE
IHsuAirv3Ts5OZmOHDmyc0/euB9wyebmZrp48WJqa2tLx44dS/Pz8zXXU+91tre305UrV/J9gQ8d
OpSmp6d3LTM8PJzvL9ze3p4GBwfLpjWz/Ie+RyEIgBBkz4bguXPn0srKSn4egRShVHL9+vU0MzOT
f56dnU1dXV0fFIK3bt1Ko6OjOejW1tbSqVOnyqZPTEzkWIvpW1tbOfTGxsaaXv5j3qMQBEAIsmdD
sBRI1aZH+EV8NbOeetP7+vry0cWSxcXFsum9vb27Xqezs7Pp5T/mPQpBAIQgezYE602vd+TsY9YT
0Vc5PZ4XH3Eat9nlP2bbhCAAQhAh+F8MwcrpxeirptHyQlAIAghB+MQhePTo0Q86Nby8vFz2u5Mn
T5ad2l1aWiqb3tPTk9bX12u+l0bLC0EhCCAE4ROHYFwsMjc3l39+/PhxzYtFilfivnnzJl+cUZw+
NTWVRkZGdi72GBgYKJs+Pj6+czFIPOJ5f39/08sLQSEIIAThE4fgxsZG+vnnn3PodXd354s0qs1X
uhI3TvHGUcQHDx7sWvfNmzfTwYMH81fExFXCldOHhoby18Ps27cvh+Tq6mpLywtBIQggBEEEYAwA
CEFEAMYAAEIQEYAxAIAQRARgDAAgBBEBGAMACEFEAMYAgBAEEYAxACAEQQRgDAAIQRABn8iLFy8+
aNqnmN8YAEAIIgK+oLhzSK3trJz2MevC3wNACCIC/oe2q9VtFjr+PgBCEFqMgF9++SXf17ejoyPd
u3evpXvzvn79Ot8LuK2tLd9f+NixY+n+/ftl805OTqYjR47kew/HPHEv4tK04qO47mrT6r1WrXW9
f/8+HT58ON8nuWhzczP19PTsPB8eHs73LW5vb0+Dg4NCEEAIwrcfAbdu3UojIyNpe3s7ra6upr6+
vpZC8Pjx42lqaiovH4/bt2/noCzOG/G2srKSn0cERsTVWn+9127mtaqt6/Lly2l8fHzX+474CxMT
EzlWY51bW1tpeno6jY2NCUEAIQjfdgT09vaWHS2bn59vKQSriSN/xXlLEdhM7DV67UavVW1dL1++
zEcFI/RC/PeHH37Y2a74G5SmlXR2dgpBACEI33YEFI/OlSKp1RBcWFhI169fTxcuXEjd3d0tLd9q
CLbyWsXnP/30Uz7qF+KoYhylLP4NKk8tFwNTCAIIQdgTIdhMjBV/F58p7OrqSnfv3k2PHj3Kp5c/
Vwi2+lrF57Ozs/kzhSE+GxjLl3yL0ScEAYQgNIyAH3/8Mb17927n+dLSUt24Wl5eLvtdXGSyvr5e
c/qnDMFWX6vyeVywEp8NjNPCRRGGxfUKQQD8i8meiIDffvstXzUcp4TX1tbSwMBA2bzFq3zfvHmT
T6kWp0dcla7cjYg8ceJESyEYVwDHZ/XiKt5G0xq9Vr11hbgA5NChQ7suBIkLSUZHR3cuQonn/f39
QhBACMK3HwFx1Wxcffv999/n0CrOW7rKN06fHj16ND148KBs+tOnT/OFFTFPnLadmZlpKQQjyuKL
oEtfBl1vWqPXqreu8Pvvv+dpEbyVhoaG8hHHmB6xG6edhSCAEIQ9FwGCwRgAEIIgBBGCAEIQ9lIE
tHqPX4QggBAEEYAxACAEQQRgDAAIQRABGAMAQhBEAMYAgBAEEYAxACAE4VuMgBcvXvijC0EAIQh7
MQIqv4Lmc76+wPF3AhCC8BVFQOXriRAhCCAE4SuLgLh3cOlewj09PenJkyfp1atX6fjx47vm3dra
SocPH07v37/P65ucnExHjhzJy8Y64r7EpdcqPkq/+/XXX6vOXzI8PJwOHDiQ2tvb0+DgYMPtrPbe
6s1nDPhnDUAIIgIKikE2NzeXOjs7888DAwO7IirC79KlSzvrO3fuXFpZWcnPYx2xrlqvF8/Pnj1b
c/6JiYm8/u3t7Ryc09PTaWxsrOF2Vr5WvfmMAf+sAQhBREBBR0dHmpmZ2fX72dnZdObMmbLf9fX1
pWfPnu2srxR11V6jWgjWm7+3tzdHYFEx4mptZ+V66s1nDPhnDUAIIgIK4qhZTIsQu3HjRtm0OI37
8uXL/PPi4mIOwXrraxSC9eaPI3mVp5Tj9G4z21lcT735jAH/rAEIQURAhYWFhZ0jgNeuXdv5/cjI
SLp8+XL++eLFi+nOnTufLQSL0dfqdlauu9Z8xoB/1gCEICKghufPn5fNt7a2ltra2tLbt2/zRRwb
GxufLQTjwo719fWm3kvldtZ6b5XzGQP+FgBCEBFQ0NXVla+0DZUXcIQ4Enj+/Pl09erVlsIuAjI+
E7i5udnU/OPj42l0dDR/TjAe8by/v7+p7Syup9H7MQYAEIKIgP+I06jd3d07X+lSiqiS+fn5vGzl
nUIahV1c8RtfKl36YulG84ehoaG0f//+vExckby6utrUdhbX0+j9GAMACEFEQJMixuKiEYQggBCE
PRQBcYo2jtK5+lYIAghB2GMREJ/zO336dNlFIghBACEIIgBjAEAIggjAGAAQgiACMAYAhCCIAIwB
ACEIIgBjAEAIwl6LgMovokYIAghB+IoiYG5uLp09e/azvG7pziLfeiA1u464Y8rjx4+FIIAQhK8j
Anp7e9PLly/3bHz8N7cx/s59fX1CEEAIwpePgH/961/5S6Mr57179246ePBg+uMf/5j+8Y9/pPHx
8Xwf4Lh/78OHD8vmHx4eTgcOHEjt7e1pcHCwbD3FR3j9+nU+KhZfVh3rOnbsWLp//37dbW+0TKx7
cnIy3wqvdI/h4jY2s/yrV6/S8ePHd7321tZWOnz4cHr//n2+b3EsH6/R09OTnjx5UvXvW2++EH/v
+LsLQQAhCF80Av72t7+le/fu7Zr3r3/9a46gf/7znzkAL126lJ9HYEXklExMTOQIi9vRxfTp6ek0
NjZW83UjtqampvL88bh9+3bq6Oiou+2NlonXiNBbWVnJzyu3sZnlw8DAwK5oi/cW7z0UAzNOp3d2
dlZ9n/XmCxHZ8XcXggBCEL5oBJw4cSItLS3tmrcUVaXn6+vrVdcVp5UjropqBVItceSsVcVlKre3
mdetXD7Mzs6mM2fOlM0Xp3GfPXuWf454nJmZafj3rTdfiL93/N2FIIAQhC8aAXG6tDLkKuet9zyO
flWeAq4WWUULCwvp+vXr6cKFC6m7u7upQKm3TLXlK3/X7PJxern0ecnFxcWyz/PF0b2YN+L3xo0b
NV+v3nwh/t5xGl0IAghB+KIRUO1oXCsh2OhoXuWycRq6q6srnx599OhRWl1d3Zmn2mcKGy3TTAi2
svzIyEi6fPly/vnixYvpzp07u4KydOTw2rVrdcOz2nzFgBaCAEIQvmgEfOwRwbgYonjauNHrxucN
i/MvLy83DJRGyzQKwVaWX1tby3+Tt2/f5gtgNjY2qm7T8+fPG25DtflCfJbSEUEAIQhfPALis2px
CvRDQzCuJh4dHd25ECOe9/f3l4VmfH5vc3MzP49Tr6UrdkuflWsUKI2WaRSCrS4fRwLPnz+frl69
Wvb7OKoYVwSHygtSiuuoN1+Izxz6jCCAEIQvHgFx9Wpc+fuhIRiGhobyUbf48ui4ejdOvZbEFcTx
+9IXSz99+jRfTBJxFMEUF1U0CpRGyzQKwVaXn5+fz7+rvCtKnO6NzxeWvqKmFHuV66g3X4jTza4a
BhCC8MUjIKKneASPlEM2jiJ+LqdOncqxKAQBhCB88QiIq1vdE/j/xentOMJZ7WrfTyFOTcff+2sb
AwAIQfZoCMbn2OIzcfz/Zxrjzh+1LhL5WPF3dq9hACEIIgBjAEAIggjAGAAQgiACMAYAhCCIAIwB
ACEIIgBjAEAIggjAGAAQgiACMAYAhCCIAIwBACEIIgBjAEAIggjAGAAQghjQIsAYMAYAhCAiAGMA
ACGICMAYAEAIIgTw/x4AIYggwP9zACEI324YeOydBwCt+z94HXa5E7sDOQAAAABJRU5ErkJggg==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2017-01-17 18:08:41 -0500" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAATEAAAKBCAIAAACwJQvXAAAfnElEQVR42u3dv24kVRbH8ZaQEIGD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==
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2017-01-17 18:32:24 -0500" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2017-01-17 18:32:24 -0500" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2017-01-17 18:32:24 -0500" MODIFIED_BY="[Empty name]">Standard search methods</TITLE>
<APPENDIX_BODY MODIFIED="2015-12-14 13:16:17 -0500" MODIFIED_BY="[Empty name]">
<P>PubMed: ((infant, newborn[MeSH] OR newborn OR neonate OR neonatal OR premature OR low birth weight OR VLBW OR LBW or infan* or neonat*) AND (randomized controlled trial [pt] OR controlled clinical trial [pt] OR Clinical Trial[ptyp] OR randomized [tiab] OR placebo [tiab] OR clinical trials as topic [mesh: noexp] OR randomly [tiab] OR trial [ti]) NOT (animals [mh] NOT humans [mh]))<BR/>
<BR/>Embase: (infant, newborn or newborn or neonate or neonatal or premature or very low birth weight or low birth weight or VLBW or LBW or Newborn or infan* or neonat*) AND (human not animal) AND (randomized controlled trial or controlled clinical trial or randomized or placebo or clinical trials as topic or randomly or trial or clinical trial)<BR/>
<BR/>CINAHL: (infant, newborn OR newborn OR neonate OR neonatal OR premature OR low birth weight OR VLBW OR LBW or Newborn or infan* or neonat*) AND (randomized controlled trial OR controlled clinical trial OR randomized OR placebo OR clinical trials as topic OR randomly OR trial OR PT clinical trial)<BR/>
<BR/>Cochrane Library: (infant or newborn or neonate or neonatal or premature or very low birth weight or low birth weight or VLBW or LBW)</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;10 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;10 studies included in qualitative synthesis&lt;/p&gt;" WIDTH="125">
<FLOWCHARTBOX TEXT="&lt;p&gt;8 studies included in previous version of review&lt;/p&gt;"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;2 NEW studies included&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;5 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;271 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;271 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;216 records identified through database searching (2014-2015)&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;55 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;266 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;1 full-text article excluded, with reasons&lt;/p&gt;&lt;p&gt;1 study added to awaiting classification&lt;/p&gt;&lt;p&gt;1 study added to ongoing&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>